<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d723118dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND REORGANIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>among: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTORATION
ROBOTICS, INC., </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RADIANT MERGER SUB LTD. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VENUS CONCEPT LTD.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of March 15, 2019 </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_1">SECTION&nbsp;1. DESCRIPTION OF TRANSACTION
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_2">Structure of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_3">Closing; Effective Time</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_4">Effects of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;1.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_5">Articles of Association; Certificate of Incorporation and Bylaws; Directors
 and Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_6">Effect of the Merger on Share Capital; Exchange of
Certificates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_7">Payment Procedures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_8">Lost Certificates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_9">Transfers; No Further Ownership Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_10">Further Action</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_11">Withholding Tax</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;1.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_12">Appraisal Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_13">SECTION&nbsp;
2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_14">Organization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_15">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_16">Authority</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_17"><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT>
Consents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_18">Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_19">Absence of Changes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_20">Title to Assets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_21">Properties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_22">Intellectual Property</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_23">Material Contracts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_24">Absence of Undisclosed Liabilities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_25">Compliance with Laws; Regulatory Compliance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_26">Taxes and Tax Returns</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_27">Employee Benefit Programs</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_28">Labor and Employment Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_29">Environmental Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_30">Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_31">Government Programs</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_32">Transactions with Affiliates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_33">Legal Proceedings; Orders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_34">Anticorruption and Anti-Bribery Laws</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_35">Warranty and Related Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_36">Inapplicability of Anti-takeover Statutes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_37">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_38">No Financial Advisor</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;2.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_39">Financing Consent Letters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;2.27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_40">No Other Representations or Warranties; Disclaimer of Other Representations
 and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_41">SECTION&nbsp;
3. REPRESENTATIONS AND WARRANTIES OF RADIANT AND MERGER SUB </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_42">Organization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_43">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_44">Authority</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_45"><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT>
Consents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_46">SEC Filings; Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_47">Absence of Changes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_48">Title to Assets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_49">Properties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_50">Intellectual Property</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_51">Material Contracts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_52">Absence of Undisclosed Liabilities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_53">Compliance with Laws; Regulatory Compliance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_54">Taxes and Tax Returns</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_55">Employee Benefit Programs</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_56">Labor and Employment Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_57">Environmental Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_58">Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_59">Government Programs</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_60">Transactions with Affiliates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_61">Legal Proceedings; Orders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_62">Anticorruption and Anti-Bribery Laws</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_63">Warranty and Related Matters; Product Liability</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.23</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_64">Antitrust.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.24</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_65">Inapplicability of Anti-takeover Statutes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_66">Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;3.26</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_67">No Financial Advisor</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;3.27</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_68">No Other Representations or Warranties; Disclaimer of Other Representations
 and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_69">SECTION&nbsp;4. CERTAIN COVENANTS OF THE PARTIES
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_70">Access and Investigation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_71">Operation of Radiant&#146;s Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_72">Operation of the Company&#146;s Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_73">Negative Obligations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_74"><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> by
Radiant</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_75">Notification of Solicitation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_76">Standstill</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_77">Cooperation with Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;4.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_78"><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> by the Company
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_79">SECTION&nbsp;5. ADDITIONAL AGREEMENTS OF THE
PARTIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_80">Disclosure Documents; Merger Proposal; Registration</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_81">Shareholder Approval</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_82">Regulatory Approvals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_83">Company Options and Company Warrants</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_84">Radiant Stock Options</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_85">Indemnification of Officers and Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_86">Additional Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_87">Disclosure</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_88">Listing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_89">Tax Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_90">Directors and Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_91">Section&nbsp;16 Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_92">Allocation Certificate</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_93">Shareholder Litigation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_94">Confidentiality</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;5.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_95">Effect of Knowledge</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_96">SECTION&nbsp;
6. CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_97">No Restraints</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_98">Shareholder Approval</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_99">Effective Registration Statement and Proxy Statement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_100">Listing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_101">Statutory Waiting Periods</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;6.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_102">Equity Commitment Letter</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_104">SECTION&nbsp;
7. ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF RADIANT AND MERGER SUB </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;7.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_105">Accuracy of Representations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;7.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_106">Performance of Covenants</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;7.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_107">Officers&#146; Certificate</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;7.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_108">No Company Material Adverse Effect</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_109">SECTION&nbsp;
8. ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;8.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_110">Accuracy of Representations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;8.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_111">Performance of Covenants</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;8.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_112">Documents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;8.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_113">No Radiant Material Adverse Effect</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;8.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_114">Tax Rulings</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_115">SECTION&nbsp;9. TERMINATION </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;9.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_116">Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;9.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_117">Effect of Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;9.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_118">Expenses; Termination Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><A HREF="#ex21toc723118_119">SECTION&nbsp;10. MISCELLANEOUS PROVISIONS
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_120"><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations
 and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_121">Amendment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_122">Waiver</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_123">Entire Agreement; Counterparts; Exchanges by Facsimile</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_124">Governing Law; Jurisdiction; Waiver of Trial by Jury</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_125">Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_126">Assignability</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_127">Notices</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_128">Cooperation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_129">Severability</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_130">Other Remedies; Specific Performance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;10.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#ex21toc723118_131">Construction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Definitions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Radiant Voting Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Voting Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT D</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Radiant <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Equity Commitment Letter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">EXHIBIT G</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Articles of Association of Merger Sub</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER AND REORGANIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</B> (this &#147;<B>Agreement</B>&#148;) is made and entered into as of March&nbsp;15,
2019, by and among <B>RESTORATION ROBOTICS, INC.</B>, a Delaware corporation (&#147;<B>Radiant</B>&#148;), <B>RADIANT MERGER SUB LTD.</B>, a company organized under the laws of Israel and a direct, wholly-owned subsidiary of Radiant (&#147;<B>Merger
Sub</B>&#148;), and <B>VENUS CONCEPT LTD.</B>, a company organized under the laws of Israel (the &#147;<B>Company</B>&#148;). Certain capitalized terms used in this Agreement are defined in <I>Exhibit A</I>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Radiant and
the Company intend to merge Merger Sub with and into the Company (the &#147;<B>Merger</B>&#148;) in accordance with this Agreement and in accordance with the provisions of Sections <FONT STYLE="white-space:nowrap">314-327&nbsp;of</FONT> the
Companies Law 5759-1999 of the State of Israel (together with the rules and regulations thereunder, the &#147;<B>ICL</B>&#148;). Upon consummation of the Merger, Merger Sub will cease to exist, and the Company will become a wholly-owned subsidiary
of Radiant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. For U.S. federal income tax purposes, Radiant, Merger Sub and the Company intend that (i)&nbsp;the Merger will qualify as
a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code, (ii)&nbsp;this Agreement will constitute a &#147;plan of reorganization&#148; for purposes of Section&nbsp;354 and 361 of the Code, and within the meaning of <FONT
STYLE="white-space:nowrap">Section&nbsp;1.368-2(g)</FONT> of the Treasury Regulations, and Radiant and the Company shall file the statement required by <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-3(a)</FONT> of the Treasury Regulations, and
(iii)&nbsp;Radiant, Merger Sub and the Company will each be a &#147;party to the reorganization&#148; within the meaning of Section&nbsp;368(b) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. The Board of Directors of Radiant (i)&nbsp;has determined that the Merger is advisable, and in the best interests of Radiant and its
shareholders, (ii)&nbsp;has approved this Agreement, the Merger, the issuance of shares of Radiant Common Stock to the security holders of the Company pursuant to the terms of this Agreement and to the investors pursuant to the Equity Commitment
Letter, and the other actions contemplated by this Agreement and has deemed this Agreement advisable and (iii)&nbsp;has determined to recommend that the shareholders of Radiant vote to approve the issuance of shares of Radiant Common Stock to the
security holders of the Company pursuant to the terms of this Agreement and to the investors pursuant to the Equity Commitment Letter, and such other actions as contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. The Board of Directors of Merger Sub (i)&nbsp;has determined that the Merger is advisable, fair and in the best interests of Merger Sub and
its sole shareholder, (ii)&nbsp;has approved this Agreement, the Merger, and the other actions contemplated by this Agreement and has deemed this Agreement advisable, fair and in the best interests of Merger Sub and its sole shareholder,
(iii)&nbsp;has determined that, considering the financial conditions of the merging companies, no reasonable concern exists that the Surviving Company (as defined below) will be unable to fulfill the obligations of the Company or Merger Sub, as
applicable, to its creditors, and (iv)&nbsp;has determined to recommend that the sole shareholder of Merger Sub vote to approve the Merger and such other actions as contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. The Board of Directors of the Company (i)&nbsp;has determined that the Merger is advisable, fair and in the best interests of the Company
and its shareholders, (ii)&nbsp;has approved this Agreement, the Merger and the other actions contemplated by this Agreement and has deemed this Agreement advisable, fair and in the best interests of the Company and its shareholders, (iii)&nbsp;has
determined that, considering the financial conditions of the merging companies, no reasonable concern exists that the Surviving Company (as defined below) will be unable to fulfill the obligations of the Company or Merger Sub, as applicable, to its
creditors and (iv)&nbsp;has determined to recommend the approval and adoption of this Agreement and the approval of the Merger to the shareholders of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. In order to induce the Company to enter into this Agreement and to cause the Merger to be
consummated certain shareholders of Radiant listed on <I>Schedule <FONT STYLE="white-space:nowrap">I-B</FONT></I> hereto, are executing voting agreements in favor of the Company concurrently with the execution and delivery of this Agreement in the
form substantially attached hereto as <I>Exhibit B</I> (the &#147;<B>Radiant Voting Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. In order to induce Radiant
and Merger Sub to enter into this Agreement and to cause the Merger to be consummated, certain shareholders of the Company listed on <I>Schedule <FONT STYLE="white-space:nowrap">I-C</FONT></I> hereto, are executing voting agreements in favor of
Radiant concurrently with the execution and delivery of this Agreement in substantially the form attached hereto as <I>Exhibit C</I> (the &#147;<B>Company Voting Agreements</B>&#148; and, together with the Radiant Voting Agreements, the
&#147;<B>Voting Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">H. In order to induce the Company to cause the Merger to be consummated, certain of Radiant&#146;s
executive officers, directors and shareholders of Radiant listed on <I>Schedule <FONT STYLE="white-space:nowrap">I-D</FONT></I> are executing <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements in favor of the Company concurrently with the
execution and delivery of this Agreement relating to sales and certain other dispositions of shares of Radiant Common Stock and certain other securities after the Closing in substantially the form attached hereto as <I>Exhibit D</I> (the
&#147;<B>Radiant <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I. In order to induce Radiant and Merger Sub to
cause the Merger to be consummated, certain holders of Company Share Capital listed on <I>Schedule <FONT STYLE="white-space:nowrap">I-E</FONT></I> are executing <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements in favor of Radiant
concurrently with the execution and delivery of this Agreement relating to sales and certain other dispositions of Radiant Common Stock and certain other securities after the Closing in substantially the form attached hereto as <I>Exhibit E</I> (the
&#147;<B>Company <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</B>&#148; and together with the Radiant <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements, the &#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J. Immediately prior to the execution and delivery of this Agreement, and as a condition of the willingness of
Radiant, Merger Sub and the Company to enter into this Agreement, certain investors have executed the Equity Commitment Letter, in the form attached hereto as <I>Exhibit F</I>, with Radiant and the Company, pursuant to which such investors have
agreed to purchase shares of Radiant Common Stock immediately following, but contingent upon, the Closing in connection with the Radiant Post-Closing Financing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties to
this Agreement, intending to be legally bound, agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_1"></A>Section&nbsp;1. DESCRIPTION OF
TRANSACTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_2"></A>1.1 Structure of the Merger</B>. Upon the terms and subject to the conditions set forth
in this Agreement, and in accordance with the ICL, at the Effective Time (as defined in <I>Section</I><I></I><I>&nbsp;1.2</I>), Merger Sub (as the target company (<I>Chevrat Ha</I><I>&#146;</I><I>Ya</I><I>&#146;</I><I>ad</I>) in the Merger) shall be
merged with and into the Company (as the absorbing company (<I>HaChevra Ha</I><I>&#146;</I><I>Koletet</I>) in the Merger), and the separate existence of Merger Sub shall cease. The Company will continue as the surviving company in the Merger (the
&#147;<B>Surviving Company</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_3"></A>1.2 Closing; Effective Time</B>. Unless this Agreement is earlier
terminated pursuant to the provisions of <I>Section</I><I></I><I>&nbsp;9.1</I> of this Agreement, and subject to the satisfaction or waiver of the conditions set forth in <I>Section</I><I></I><I>&nbsp;6</I>, <I>Section</I><I></I><I>&nbsp;7</I> and
<I>Section</I><I></I><I>&nbsp;8</I> of this Agreement, the consummation of the Merger (the &#147;<B>Closing</B>&#148;) shall take place at the offices of Gornitzky&nbsp;&amp; Co., 45 Rothschild Boulevard,
<FONT STYLE="white-space:nowrap">Tel-Aviv</FONT> 6578403, Israel, as promptly as practicable (but in no event later than the second Business Day following the satisfaction or waiver of the last to be satisfied or waived of the conditions set forth
in <I>Section</I><I></I><I>&nbsp;6</I>, <I>Section</I><I></I><I>&nbsp;7</I> and <I>Section</I><I></I><I>&nbsp;8</I>, other than those conditions that by their nature are to be satisfied at the Closing but subject to the satisfaction or waiver of
each of such conditions), or at such other time, date and place as Radiant and the Company may mutually agree in writing. The date on which the Closing actually takes place is referred to as the &#147;<B>Closing Date</B>.&#148; As soon as
practicable after the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determination of the date on which the Closing is to take place, each of the Company and Merger Sub shall (and Radiant shall cause Merger Sub to), in coordination with each other, deliver to the
Registrar of Companies of the State of Israel (the &#147;<B>Companies Registrar</B>&#148;) a notice of the contemplated Merger which shall inform the Companies Registrar that all conditions to the Merger under the ICL and this Agreement have been
met and set forth the proposed date of the Closing on which the Companies Registrar is requested to issue a certificate evidencing the Merger in accordance with Section&nbsp;323(5) of the ICL (the &#147;<B>Certificate of Merger</B>&#148;). The
Merger shall become effective upon the issuance by the Companies Registrar of the Certificate of Merger in accordance with Section&nbsp;323(5) of the ICL (such date and time being hereinafter referred to as the &#147;<B>Effective Time</B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_4"></A>1.3 Effects of the Merger</B>. The Merger shall have the effects set forth in this Agreement and in the
applicable provisions of the ICL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, by virtue of, and simultaneously with, the Merger and without any further action on the part of Radiant, Merger Sub, the
Company or any shareholder of the Company, (a)&nbsp;the Company will become a direct wholly-owned subsidiary of Radiant, (b)&nbsp;the Company will continue to be governed by the laws of the State of Israel, (c)&nbsp;the Company will maintain a
registered office in the State of Israel, (d)&nbsp;Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall cease and the Company shall continue as the Surviving Company, (e)&nbsp;all the properties,
rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving Company, and (f)&nbsp;all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of
the Surviving Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_5"></A>1.4 Articles of Association; Certificate of Incorporation and Bylaws; Directors
and Officers</B>. At the Effective Time: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> the articles of association of the Surviving Company, shall be, subject to and
conditioned upon the consummation of the Merger, amended and restated, by means of Company shareholder action, to be in the form attached hereto as <I>Exhibit G</I>, until thereafter amended as provided by the ICL and such articles of association;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> the Radiant Charter shall be the certificate of incorporation of Radiant immediately prior to the Effective Time, until
thereafter amended as provided by the DGCL and such certificate of incorporation; provided, however, that at the Effective Time, Radiant shall file one or more amendments to its certificate of incorporation, to the extent approved by the holders of
Radiant Common Stock as contemplated by <U>Section</U><U></U><U>&nbsp;5.2</U>, to (i)&nbsp;change the name of Radiant to a name mutually agreed upon by Radiant and the Company in good faith (ii)&nbsp;effect the Reverse Stock Split, and
(iii)&nbsp;make such other changes as are mutually agreeable to Radiant and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_6"></A>1.5 Effect of
the Merger on Share Capital; Exchange of Certificates</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <U>Effect on Securities</U>. At the Effective Time, by virtue of
the Merger and without any action on the part of Radiant, Merger Sub, the Company or the holders of any securities of the Company or Merger Sub: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <U>Conversion of Company Ordinary Shares and Company Preferred Shares</U>. Subject to the remaining provisions of this
<I>Section</I><I></I><I>&nbsp;1.5</I>, each Company Ordinary Share and each Company Preferred Share issued and outstanding immediately prior to the Effective Time (other than shares described in
<I>Section</I><I></I><I>&nbsp;1.5(a)(ii)</I>)&nbsp;shall be deemed to have been transferred to Radiant solely in consideration for the right to receive from Radiant, in accordance with the terms of this Agreement, 8.6506 validly issued, fully paid
and nonassessable shares of Radiant Common Stock (such ratio, as such number may be adjusted in accordance with the provisions of this <I>Section</I><I></I><I>&nbsp;1.5,</I> the &#147;<B>Exchange Ratio</B>&#148; and such shares of Radiant Common
Stock, the &#147;<B>Merger Consideration</B>&#148;), in each case without interest. Each Company Ordinary Share and each Company Preferred Share shall be deemed to have been transferred to Radiant solely in consideration for the right to receive the
Merger Consideration as provided in this<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i),</I> shall no longer be held by the applicable former Company shareholder and shall be deemed to have been transferred to Radiant, and the holders of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificates (the &#147;<B>Certificates</B>&#148;) or book-entry shares (&#147;<B>Book-Entry Shares</B>&#148;), which immediately prior to the Effective Time represented such Company Ordinary
Shares or Company Preferred Shares, shall cease to have any rights with respect to such Company Ordinary Shares and Company Preferred Shares other than the right to receive, upon surrender of such Certificates or Book-Entry Shares in accordance
with<I>&nbsp;Section</I><I></I><I>&nbsp;1.6</I>, the Merger Consideration as set forth above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <U>Treasury Stock (Dormant
Shares) and Radiant-Owned Company Share Capital</U>. No consideration or payment shall be due or delivered with respect to any and all Company Share Capital held by the Company as treasury stock (dormant shares) or held directly by Radiant or Merger
Sub immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> <U>Share Capital</U>. Each ordinary share of Merger Sub issued and outstanding
immediately prior to the Effective Time shall cease to exist at the Effective Time and no consideration or payment shall be due or delivered thereof or in respect thereof. Each share of the Company issued and outstanding immediately prior to the
Effective Time shall by virtue of the shareholder action set forth in <I>Section</I><I></I><I>&nbsp;1.4(a),</I> subject to and conditioned upon the consummation of the Merger, be reclassified at the Effective Time into an ordinary share of the
Surviving Company par value NIS 0.001 each. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> <U>Fractional Shares</U>. No fraction of a share of Radiant Common Stock will be
issued in connection with the Merger, and any fractional shares will be rounded down to the nearest whole share. Company Shareholders will not be entitled to any voting rights, rights to receive any dividends or distributions or other rights as a
shareholder of Radiant with respect to any such fraction of a share that would have otherwise been issued to such Company Shareholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <U>Adjustments</U>. Without limiting the other provisions of this Agreement, if at any time during the period between the date of
this Agreement and up to and including the Effective Time, any change in the number or type of outstanding shares of Radiant Common Stock or Company Share Capital shall occur as a result of a reclassification, recapitalization, exchange, stock split
(including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration and any other similarly dependent items, as the case may be, shall
be appropriately adjusted to provide the holders of Company Share Capital the same economic effect as contemplated by this Agreement prior to such event. Nothing in this<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(b)</I> shall be construed to permit any
party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <U>Treatment of
Company Options and Company Warrants</U>. Each Company Option and each Company Warrant that is outstanding and unexercised immediately prior to the Effective Time will be treated in accordance with <I>Section</I><I></I><I>&nbsp;5.4.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_7"></A>1.6 Payment Procedures</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <U>Designation of Exchange Agent; Deposit of Exchange Fund</U>. Prior to the Closing, Radiant shall enter into one or more
exchange agreements in customary form and reasonably satisfactory to the Company with one or more of the transfer agent of Radiant, the transfer agent of the Company or another financial institution or trust company designated by Radiant that is
recognized in Israel and the United States and reasonably acceptable to the Company (the &#147;<B>Exchange Agent</B>&#148;) for the payment of the Merger Consideration as provided in<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i) </I>and<I> </I>to
assist,<I>&nbsp;inter alia</I>, in obtaining any requisite residency certificate and/or other declaration for Tax withholding purposes and/or such other documentation as may be required to be delivered pursuant to the Withholding Tax Ruling or the
Options Tax Ruling, as applicable. Prior to or substantially concurrently with the Effective Time, Radiant shall deposit or cause to be deposited with the Exchange Agent, for payment to the holders of Company Share Capital (excluding Company
Ordinary Shares issued upon previous exercise or settlement of Company 102 Options and held by the 102 Trustee (&#147;<B>Company 102 Shares</B>&#148;) in respect of which payment shall, subject to the Options Tax Ruling, be transferred directly to
the 102 Trustee) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in accordance with this <I>Section</I><I></I><I>&nbsp;1 </I>through the Exchange Agent, book-entry shares representing the full number of whole shares of Radiant Common Stock issuable pursuant
to<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I> in exchange for outstanding Company Share Capital (such aggregate number of shares of Radiant Common Stock, together with any such dividends or other distributions with respect thereto, the
&#147;<B>Exchange Fund</B>&#148;). In the event the Exchange Fund shall at any time be insufficient to make the payments contemplated by<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I>, Radiant shall promptly deposit, or cause to be deposited,
additional shares, with the Exchange Agent in an amount which is equal to the deficiency in the amount required to make such payment. The Exchange Fund shall not be used for any purpose other than to fund payments pursuant
to<I>&nbsp;Section</I><I></I><I>&nbsp;1.6</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <U>Payment Procedures with Respect to Company Share Capital</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> Promptly following the Effective Time, and in no event later than the third
(3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) Business Day thereafter, Radiant shall cause the Exchange Agent to mail to each holder of record of&nbsp;Certificates and Book-Entry Shares as of immediately prior to the Effective Time, in
each case, whose shares were deemed transferred to Radiant solely in consideration for the right to receive the Merger Consideration pursuant to<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I> (in each case, other than Company 102 Shares which, for
the avoidance of doubt, will be eligible to receive the applicable Merger Consideration pursuant to <I>Section</I><I></I><I>&nbsp;1.6(f) </I>not this <I>Section</I><I></I><I>&nbsp;1.6(b)</I>), (A)&nbsp;in the case of such holders of Certificates, a
letter of transmittal in customary form and reasonably satisfactory to the Company, Radiant and the Exchange Agent (which shall specify that delivery shall be effected, and risk of loss and title to the Certificates shall pass only upon delivery of
the Certificates (or affidavits of loss in lieu thereof as provided in<I>&nbsp;Section</I><I></I><I>&nbsp;1.7</I>&nbsp;below), to the Exchange Agent), (B)&nbsp;a declaration in which the beneficial owner of Company Share Capital provides certain
information necessary for Radiant and the Exchange Agent to determine whether any amounts need to be withheld from the Merger Consideration payable to such beneficial owner pursuant to the terms of the Ordinance (subject to the provisions of
<I>Section</I><I></I><I>&nbsp;1.6(f), </I><I>Section</I><I></I><I>&nbsp;1.10 </I>and <I>Sections 5.10(d), (e) and (f)</I>), the Code, or any applicable provision of state, local, Israeli, U.S. or foreign Law and (C)&nbsp;instructions for use in
effecting the surrender of the Certificates and Book-Entry Shares in exchange for the number of shares of Radiant Common Stock (which shall be in book-entry form) representing, in the aggregate, the whole number of shares that such holder has the
right to receive in respect of such Certificates and/or Book-Entry Shares pursuant to<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> In the case of Certificates, upon surrender of a Certificate for cancellation (or delivery of an affidavit of loss in lieu
thereof) to the Exchange Agent, together with a letter of transmittal, the declaration for Tax withholding purposes and/or a Valid Tax Certificate, in each case, duly completed and validly executed in accordance with the instructions thereto, the
Withholding Tax Ruling and <I>Section</I><I></I><I>&nbsp;1.10</I>, and such other documents as may be required pursuant to such instructions, the holder of such Certificate shall be entitled to receive in exchange therefor, and Radiant shall cause
the Exchange Agent to pay and deliver in exchange therefor as promptly as reasonably practicable the number of shares of Radiant Common Stock (which shall be in book-entry form) representing, in the aggregate, the whole number of shares that such
holder has the right to receive in respect of such Certificate pursuant to<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> In the case of Book-Entry Shares, upon receipt of the declaration for Tax withholding purposes and/or a Valid Tax Certificate
and/or any other relevant documentation, in each case, duly completed and validly executed in accordance with the instructions thereto, the Withholding Tax Ruling and <I>Section</I><I></I><I>&nbsp;1.10</I>, and such other documents as may be
required pursuant to such instructions, the holder of such Book-Entry Shares shall be entitled to receive in exchange therefor, and Radiant shall cause the Exchange Agent to pay and deliver in exchange therefor as promptly as reasonably practicable
the number of shares of Radiant Common Stock (which shall be in book-entry form) representing, in the aggregate, the whole number of shares that such holder has the right to receive in respect of such Book-Entry Shares pursuant
to<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> Until surrendered, in the case of a Certificate, or in the case of a
Book-Entry Share, in each case, as contemplated by this<I>&nbsp;Section</I><I></I><I>&nbsp;1.6(b)</I>, each Certificate or Book-Entry Share shall be deemed, from and after the Effective Time, to represent only the right to receive the Merger
Consideration as contemplated by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this<I>&nbsp;Section</I><I></I><I>&nbsp;1.6(b).</I> The Exchange Agent shall accept such Certificates (or affidavits of loss in lieu thereof) and make such payments and deliveries with respect to
Book-Entry Shares upon compliance with such reasonable terms and conditions as the Exchange Agent may impose to effect an orderly exchange thereof in accordance with normal exchange practices. No interest shall be paid or accrued for the benefit of
holders of the Certificates or Book-Entry Shares on the Merger Consideration payable hereunder. Radiant shall cause the Exchange Agent to accept such Certificates and transferred Book-Entry Shares upon compliance with the foregoing exchange
procedures. Notwithstanding anything to the contrary in this <I>Section</I><I></I><I>&nbsp;1.6(b)</I>, any Merger Consideration payable in respect of Company 102 Shares shall be, subject to the Options Tax Ruling, transferred by Radiant to the 102
Trustee in accordance with <I>Section</I><I></I><I>&nbsp;1.6(f).</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> If any payment of the Merger Consideration is to be made
to a Person other than the Person in whose name the surrendered Certificate or Book-Entry Share so surrendered is registered, it shall be a condition precedent of payment that (i)&nbsp;the Certificate so surrendered shall be properly endorsed or
shall be otherwise in proper form for transfer (or the Book-Entry Share so surrendered shall be in proper form for transfer) and (ii)&nbsp;the Person requesting such payment shall have paid any transfer and other similar Taxes required by reason of
the payment of the Merger Consideration to a Person other than the registered holder of such Certificate or Book-Entry Share (as applicable) surrendered or shall have established to the reasonable satisfaction of Radiant that such Tax either has
been paid or is not required to be paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <U>Termination of Exchange Fund</U>. Any portion of the Exchange Fund which remains
undistributed to the holders of the Certificates or Book-Entry Shares for one (1)&nbsp;year after the Effective Time shall be delivered to Radiant or its designee upon demand, and any such holders prior to the Merger who have not theretofore
complied with this<I> Section</I><I></I><I>&nbsp;1</I>&nbsp;shall thereafter look only to Radiant as general creditors thereof for payment, without interest, of their claims for Merger Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <U>No Liability</U>. None of Radiant, Merger Sub, the Company or the Exchange Agent shall be liable to any Person in respect of
any shares of Radiant Common Stock, or dividends or distributions with respect thereto, delivered to a Governmental Authority pursuant to and as required by any applicable abandoned property, escheat or similar Law. If any Certificate shall not have
been surrendered or Book-Entry Share not paid, in each case, in accordance with<I>&nbsp;Section</I><I></I><I>&nbsp;1.6(b)(i)</I>, immediately prior to the date on which any Merger Consideration, or dividends or distributions with respect thereto, in
respect of such Certificate or Book-Entry Share would otherwise escheat to or become the property of any Governmental Authority, any such Merger Consideration, or dividends or distributions with respect thereto, in respect of such Certificate or
Book-Entry Share shall, to the extent permitted by applicable Law, become the property of Radiant free and clear of all claims or interest of any Person previously entitled thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <U>Payment Procedures with Respect to Company 102 Shares</U>. Immediately after the Effective Time, subject to the Options Tax
Ruling, Radiant shall transfer the aggregate Merger Consideration with respect to Company 102 Shares to the 102 Trustee, on behalf of the holders of Company 102 Shares, in accordance with Section&nbsp;102 of the Ordinance and the Options Tax Ruling
(the &#147;<B>102 Amount</B>&#148;). The 102 Amount shall be held in trust by the 102 Trustee pursuant to the applicable provisions of Section&nbsp;102 of the Ordinance and the Options Tax Ruling and shall be released by the 102 Trustee to the
beneficial holders of the Company 102 Shares in accordance with the terms and conditions of Section&nbsp;102 of the Ordinance, the Options Tax Ruling, and the trust agreement between the Company and the 102 Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_8"></A>1.7 Lost Certificates</B>. If any Certificate shall have been lost, stolen or destroyed or is missing, then
upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen, destroyed or missing, in a form reasonably satisfactory to Radiant, and, if required by the Exchange Agent, the posting by such Person of a
bond, in such reasonable amount as the Exchange Agent may require, as indemnity against any claim that may be made against Radiant with respect to such Certificate, the Exchange Agent will issue in exchange for such lost, stolen, destroyed or
missing Certificate the Merger Consideration and any other required amounts to which the holder thereof is entitled pursuant to this<I> Section</I><I></I><I>&nbsp;1</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_9"></A>1.8 Transfers; No Further Ownership Rights</B>. From and
after the Effective Time, all issued and outstanding Company Share Capital shall automatically be deemed to have been transferred to Radiant, and each holder of a Certificate or Book-Entry Share theretofore representing any Company Share Capital
shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration payable therefor upon the surrender or acknowledgment of the conversion or deemed transfer thereof in accordance with the provisions
of<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. The Merger Consideration paid in accordance with the terms of this<I> Section</I><I></I><I>&nbsp;1</I>&nbsp;shall be deemed to have been paid in full satisfaction of all rights pertaining to such
Company Share Capital. From and after the Effective Time, there shall be no registration of transfers on the shareholders register of the Company of Company Share Capital immediately prior to the Effective Time of Company Share Capital that was
outstanding immediately prior to the Effective Time. If Certificates or Book-Entry Shares are presented to the Surviving Company, Radiant or the Exchange Agent following the Effective Time, they shall be deemed to have been transferred to Radiant as
of the Effective Time against delivery of the Merger Consideration and other required amounts, as provided for in<I>&nbsp;Section</I><I></I><I>&nbsp;1.5(a)(i)</I>, for the Company Share Capital formerly represented by such Certificates or Book-Entry
Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_10"></A>1.9 Further Action</B>. If, at any time after the Effective Time, any further action is
determined by Radiant or the Surviving Company to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Company or Radiant with full right, title and possession of and to all rights and property of Merger Sub
and the Company with respect to the Merger, the officers and managers of Radiant shall be fully authorized (in the name of Merger Sub, the Company, the Surviving Company and otherwise) to take such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_11"></A>1.10 Withholding Tax</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Each of Radiant, Merger Sub, the Surviving Company, the 102 Trustee and the Exchange Agent (each, a &#147;<B>Withholding Payor</B>&#148;)
shall deduct and withhold from the Merger Consideration otherwise payable in connection with the transactions contemplated by this Agreement such amounts as shall be reasonably determined by Radiant according to any applicable law that each
Withholding Payor is required to deduct and withhold under the Withholding Tax Ruling and the Options Tax Ruling or under any applicable Tax Law with respect to (i)&nbsp;the payment or delivery of the Merger Consideration in accordance with
<I>Section</I><I></I><I>&nbsp;1</I> to each holder of Company Share Capital and (ii)&nbsp;the securities that each holder of Company Options or Company Warrants receives in accordance with <I>Section</I><I></I><I>&nbsp;5.4</I><I>.</I> With respect
to the withholding of Israeli Tax, in the event any holder of record of Company Share Capital or Company Options or Company Warrants provides the Withholding Payor with a Valid Tax Certificate issued by the ITA regarding the withholding (or
exemption from withholding) of Israeli Tax from the consideration payable then the deduction and withholding of any amounts under the Ordinance or any other provision of Israeli Law or requirement, if any, from the Merger Consideration payable to
such holder of record of Company Share Capital, Company Options or Company Warrants, as applicable, shall be made only in accordance with the provisions of such Valid Tax Certificate. To the extent amounts are so withheld, they shall be subsequently
paid over to the appropriate Governmental Authority on or prior to the last day on which such payment is required under any applicable Law. To the extent any Withholding Payor withholds any amounts, such Withholding Payor shall provide the affected
Person, as soon as practicable, with (i)&nbsp;confirmation of such withholding, and (ii)&nbsp;evidence regarding payment to of such withheld amounts to the appropriate Governmental Authority. To the extent that amounts are so withheld by a
Withholding Payor and paid over to the appropriate Governmental Authority, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to such affected Person in respect of which such deduction and withholding was
made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the provisions of <I>Section</I><I></I><I>&nbsp;1.10(</I><I>a) </I>with respect to Israeli Taxes and subject to
the provisions of Withholding Tax Ruling or the Options Tax Ruling, as applicable, the consideration payable to each holder of Company Share Capital, Company Options or Company Warrants (other than the 102 Trustee with respect to Company 102 Options
and Company 102 Shares) shall be retained by the Exchange Agent for a period of up to the later of: (i)&nbsp;one hundred eighty (180)&nbsp;days from Closing and (ii)&nbsp;the date upon which shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
comprising the Merger Consideration shall be registered pursuant to the Registration Statement (the &#147;<B>Withholding Drop Date</B>&#148;) (during which time no Withholding Payor shall make
any payments to any holder of Company Share Capital, Company Options or Company Warrants (other than to the 102 Trustee) or withhold any Israeli Taxes in respect of said consideration, except as instructed by the ITA, including via the Withholding
Tax Ruling or the Options Tax Ruling, as applicable). If no later than five (5)&nbsp;Business Days prior to the Withholding Drop Date a Valid Tax Certificate is delivered to the Withholding Payor, then, subject to as may be otherwise instructed by
the ITA, including by way of the Withholding Tax Ruling or the Options Tax Ruling, as applicable, with respect to the affected holders, the deduction and withholding of any Israeli Taxes shall be made only in accordance with the provisions of such
Valid Tax Certificate (and, unless otherwise provided in the Withholding Tax Ruling or the Options Tax Ruling, as applicable, together with such Valid Tax Certificate the holder of Company Share Capital, Company Options or Company Warrants shall
deliver an amount in cash equal to the amount of the applicable withholding Tax) and the balance of the payment that is not withheld shall be paid to such holders subject to any <FONT STYLE="white-space:nowrap">non-Israeli</FONT> withholding which
is applicable to the payment (if any). If any such holder (i)&nbsp;does not provide the Withholding Payor with or is not the subject of a Valid Tax Certificate, by no later than five (5)&nbsp;Business Days before the Withholding Drop Date, or
(ii)&nbsp;submits a written request to the Withholding Payor to release its portion of the consideration prior to the Withholding Drop Date (together with an amount in cash equal to the amount of the applicable withholding Tax) and fails to submit a
Valid Tax Certificate at or before such time, then the amount to be withheld from such holder&#146;s portion of the consideration shall be calculated according to the applicable withholding rate as reasonably determined by Radiant in accordance with
applicable Law increased by interest plus linkage differences, as defined in Section&nbsp;159A of the Ordinance, for the period between the fifteenth (15th) day of the calendar month following the month during which the Closing occurs and the time
the relevant payment is made, and calculated in NIS based on a $ to NIS exchange rate not lower than the effective exchange rate at the Closing Date as reasonably determined by the Withholding Payor in consultation with the Exchange Agent and
otherwise deducted, withheld and paid in accordance with <I>Section</I><I></I><I>&nbsp;1.10(a)</I>. If the amount in cash as aforesaid was not provided by such holder, in the event such shares so withheld have been registered pursuant a Registration
Statement under the United States securities laws, then the Exchange Agent shall be entitled to sell such shares and remit the proceeds therefrom to the ITA, all in accordance with the Withholding Tax Ruling and the Ordinance.<I> </I>To the extent
that amounts are so withheld by a Withholding Payor and in due course paid over to the appropriate Governmental Authority, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to such affected Person in
respect of which such deduction and withholding was made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_12"></A>1.11 Appraisal Rights</B>. In accordance with
Israeli law, no statutory dissenters&#146; or statutory appraisal rights shall be available with respect to the Merger or the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_13"></A>Section&nbsp;2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company represents and warrants to Radiant and Merger Sub as follows, except as set forth in the written disclosure schedule delivered by
the Company to Radiant (the &#147;<B>Company Disclosure Schedule</B>&#148;). The Company Disclosure Schedule shall be arranged in parts and subparts corresponding to the numbered and lettered Sections and subsections contained in this
<I>Section</I><I></I><I>&nbsp;2</I>. The disclosures in any part or subpart of the Company Disclosure Schedule shall qualify other Sections and subsections in this <I>Section</I><I></I><I>&nbsp;2</I> only to the extent it is reasonably apparent from
the face of the disclosure that such disclosure is applicable to such other Sections and subsections herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_14">
</A>2.1 Organization</B>. The Company is a private company, duly organized and validly existing under the Laws of the State of Israel and is not a &#147;defaulting company&#148; as defined under the ICL, and each of the Company&#146;s Subsidiaries
is a corporation or legal entity validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its organization. The Company and each of its Subsidiaries have all requisite corporate power and authority to own, lease
and operate all of its properties and assets and to carry on its business as it is now being conducted. The Company and each of its Subsidiaries are duly licensed or qualified to do business, to the extent applicable, and each is, to the extent
applicable, in corporate good standing in each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned, leased, or operated by it makes such licensing or qualification
necessary, except where the failure to be so licensed or qualified and, to the extent applicable, in corporate good standing would not, either individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_15"></A>2.2 Capitalization</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> As of the date of this Agreement, the authorized share capital of the Company consists of 83,856,877 Company Ordinary Shares,
2,192,736 Company Preferred A Shares, 4,714,034 Company Preferred B Shares, 8,015,320 Company Preferred C Shares, 98,807 Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Shares and 1,122,216 Company Preferred D Shares. As of the date of
this Agreement, there are 8,282,309 Company Ordinary Shares issued and outstanding, 2,192,736 Company Preferred A Shares issued and outstanding, 4,564,034 Company Preferred B Shares issued and outstanding, 8,003,319 Company Preferred C Shares issued
and outstanding, 98,807 Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Shares issued and outstanding and 1,122,216 Company Preferred D Shares issued and outstanding. As of the date of this Agreement, there are no Company Ordinary
Shares and no Company Preferred Shares which are dormant or held in the treasury of the Company. The Company has no Company Ordinary Shares or Company Preferred Shares reserved for issuance other than as described above and in
<I>Section</I><I></I><I>&nbsp;2.2(b) </I>and <I>Section</I><I></I><I>&nbsp;2.2(d) </I>below. The outstanding Company Ordinary Shares and Company Preferred Shares have been duly authorized and are validly issued, fully paid and nonassessable, and
were not issued in violation of the material terms of any agreement or understanding binding upon the Company at the time at which they were issued and were issued in compliance with the Company Charter in effect upon such issuance and in accordance
with all applicable Laws. Other than as set forth in <I>Sections</I><I></I><I>&nbsp;2.2(a) and 2.2(b) </I>of the Company Disclosure Schedule the Company does not have and is not bound by any outstanding subscriptions, options, warrants, calls,
commitments, rights agreements, or agreements of any character calling for the Company to issue, deliver, or sell, or cause to be issued, delivered, or sold any Company Ordinary Shares or any other equity security of the Company or any Subsidiary of
the Company or any securities convertible into, exchangeable for, or representing the right to subscribe for, purchase, or otherwise receive any Company Ordinary Shares or any other equity security of the Company or any Subsidiary of the Company or
obligating the Company or any such Subsidiary to grant, extend, or enter into any such subscriptions, options, warrants, calls, commitments, rights agreements, or any other similar agreements. Other than as set forth in
<I>Section</I><I></I><I>&nbsp;2.2(a) </I>of the Company Disclosure Schedule or as contemplated by this Agreement, there are no registration rights, repurchase or redemption rights, anti-dilution rights, voting agreements, voting trusts, preemptive
rights or contractual restrictions on transfer relating to any share capital of the Company. Other than the Company Charter and as set forth in <I>Section</I><I></I><I>&nbsp;2.2(a) </I>of the Company Disclosure Schedule, the Company is not a party
to or bound by or subject to any shareholder agreement or other agreement governing the affairs of the Company or the relationships, rights and obligations of shareholders and is not subject to a shareholder rights plan or similar plan. Except as
disclosed in <I>Section</I><I></I><I>&nbsp;2.2(a)</I> of the Company Disclosure Schedule, there are no agreements, arrangements or understandings among holders of any of the Share Capital of the Company with respect to Radiant Common Stock which
would cause such shareholders to be deemed a group for purposes of Section&nbsp;13(d) of the Exchange Act after the Effective Time. As of the date of this Agreement, there are 6,785,900 Company Ordinary Shares authorized for issuance under the
Company Option Plan, of which: (i)&nbsp;5,744,050 Company Ordinary Shares are issuable upon exercise of all outstanding Company Options, subject to vesting restrictions and subject to adjustment on the terms set forth in the Company Option Plan,
(ii) 982,133 Company Ordinary Shares were issued prior to the Effective Date upon exercise of Company Options; and (ii) 59,717 Company Ordinary Shares remain available for issuance under the Company Option Plan.
<I>Section</I><I></I><I>&nbsp;2.2(a)</I> of the Company Disclosure Schedule sets forth a true, correct and complete list, as of the date of this Agreement, of all issued and outstanding Company Ordinary Shares and Company Preferred Shares, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">holder-by-holder</FONT></FONT> basis and with respect to affiliated partnerships, on a group by group basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <I>Section 2.2(b) </I>of the Company Disclosure Schedule sets forth a true, correct and complete list, as of the date of this
Agreement, of (i)&nbsp;the name of the holder of each Company Option, (ii)&nbsp;the date each Company Option was granted, (iii)&nbsp;the number and type of securities subject to each such vested or unvested Company Option, (iv)&nbsp;the expiration
date of each such Company Option, (v)&nbsp;the number of vested Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Options, (vi)&nbsp;the price at which each such Company Option (or each component thereof, if applicable) may be exercised, (vii)&nbsp;the number of shares of Company Ordinary Shares issuable
upon the exercise of such, or upon the conversion of all securities issuable upon the exercise of such, Company Options, (viii)&nbsp;the vesting schedule of each Company Option granted to Key Employees and (ix)&nbsp;whether such Company Option is <FONT
STYLE="white-space:nowrap">non-qualified,</FONT> or qualifies as a Company 102 Option or is subject to Tax pursuant to Section&nbsp;3(i) of the Ordinance. To the Knowledge of the Company, each Company Option intended to qualify for a preferential
tax rate under Section&nbsp;102 of the Ordinance so qualifies. All Company 102 Options have been deposited with the 102 Trustee in accordance with the requirements of Section&nbsp;102 of the Ordinance and applicable Law. To the Knowledge of the
Company, each grant of a Company Option was duly authorized by all necessary corporate action, including, as applicable, approval by the Board of Directors of the Company (or a duly constituted and authorized committee thereof) and any required
shareholder approval by the necessary number of votes or by unanimous written consent, and to the Knowledge of the Company the award agreement governing such grant (if any) was executed and delivered by each party thereto. The Company does not have
any outstanding restricted stock or restricted stock units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> As of the date of this Agreement, there are no shares of the
Company Share Capital outstanding subject to any vesting schedule or subject to a repurchase option or risk of forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> As
of the date of this Agreement, there are issuable upon exercise of all outstanding Company Warrants, 150,000 shares of Company Ordinary Shares and 162,000 shares of Company Preferred Shares, out of which 150,000 are Company Preferred B Shares and
12,000 are Company Preferred C Shares. <I>Section</I><I></I><I>&nbsp;2.2(d) </I>of the Company Disclosure Schedule sets forth a true, correct and complete list, as of the date of this Agreement, of (i)&nbsp;the name of the holder of each Company
Warrant, (ii)&nbsp;the date each Company Warrant was issued, (iii)&nbsp;the number and type of securities subject to each such Company Warrant, (iv)&nbsp;the price at which each such Company Warrant (or each component thereof, if applicable) may be
exercised, (v)&nbsp;the number of shares of Company Ordinary Shares or Company Preferred Shares issuable upon the exercise of such Company Warrant and (vi)&nbsp;whether any consent of the holders of Company Warrants shall be required to effect the
transactions under <I>Section</I><I></I><I>&nbsp;5.4(b)</I> below, at the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <I>Section 2.2(e)</I> of the
Company Disclosure Schedule lists each Subsidiary of the Company as of the date of this Agreement and indicates for each such Subsidiary as of such date (i)&nbsp;the percentage of equity securities owned or controlled, directly or indirectly, by the
Company and (ii)&nbsp;the jurisdiction of incorporation or organization. No Subsidiary of the Company has or is bound by any outstanding subscriptions, options, warrants, calls, commitments, rights agreements, or agreements of any character calling
for it to issue, deliver, or sell, or cause to be issued, delivered, or sold any of its equity securities or any securities convertible into, exchangeable for, or representing the right to subscribe for, purchase or otherwise receive any such equity
security or obligating such Subsidiary to grant, extend or enter into any such subscriptions, options, warrants, calls, commitments, rights agreements, or other similar agreements. There are no outstanding contractual obligations of any Subsidiary
of the Company to repurchase, redeem, or otherwise acquire any of its capital stock or other equity interests. Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.2(e)(ii) </I>of the Company Disclosure Schedule, all of the shares of capital
stock of each of the Company&#146;s Subsidiaries (i)&nbsp;have been duly authorized and are validly issued, fully paid (to the extent required under the applicable governing documents) and nonassessable, (ii)&nbsp;are owned by the Company free and
clear of any claim, lien, Encumbrance (other than Permitted Encumbrances), or agreement with respect thereto, (iii)&nbsp;were not issued in violation of the material terms of any agreement or understanding binding upon the Company or any of its
Subsidiaries at the time at which they were issued and (iv)&nbsp;were issued in compliance with the applicable governing documents and all applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_16"></A>2.3 Authority</B>. The Company<B> </B>has full corporate power and authority to execute and deliver this
Agreement and to consummate the transactions contemplated hereunder and to perform its obligations hereunder. The Board of Directors of the Company (a)&nbsp;has determined that the Merger is advisable, fair and in the best interests of the Company
and its shareholders, (b)&nbsp;has approved this Agreement, the Merger and the Contemplated Transactions and has deemed this Agreement advisable, fair and in the best interests of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company and its shareholders, (c)&nbsp;has determined that, considering the financial conditions of the merging companies, no reasonable concern exists that the Surviving Company will be unable
to fulfill the obligations of the Company or Merger Sub, as applicable, to its creditors, (d)&nbsp;has approved and determined to recommend the approval and adoption of this Agreement and the approval of the Merger to the shareholders of the
Company; and (e)&nbsp;has duly authorized the execution and delivery of each of the Ancillary Agreements to which it is a party and the consummation of the transactions contemplated hereby and thereby. Except as otherwise explicitly provided in this
Agreement, no other proceedings on the part of the Company are necessary to approve and authorize the execution and delivery of this Agreement and the Ancillary Agreements to which it is a party and the consummation of the Contemplated Transactions,
other than the Company Shareholder Approval. This Agreement and each Ancillary Agreement to which it is a party has been duly executed and delivered by the Company, and, assuming the due authorization, execution and delivery by Radiant, this
Agreement and the Ancillary Agreements to which it is a party constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their respective terms, subject to: (a)&nbsp;Laws of general application
relating to bankruptcy, insolvency and the relief of debtors; and (b)&nbsp;rules of Law governing specific performance, injunctive relief and other equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_17"></A>2.4 <FONT STYLE="white-space:nowrap">Non-Contravention</FONT></B><B>; Consents</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.4</I> of the Company Disclosure Schedule, the execution, delivery and
performance by the Company of this Agreement and the Ancillary Agreements and the performance by the Company of the transactions contemplated by this Agreement and the Ancillary Agreements do not and will not: (i)&nbsp;violate or result in a
violation of, conflict with or constitute or result in a material default (whether after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any Company Material Contract,
permit, license or authorization to which the Company is a party or by which its assets are bound, (ii)&nbsp;violate or result in a violation of, conflict with or constitute or result in a default (whether after the giving of notice, lapse of time
or both) under, or accelerate any obligation under, any provision of the Company&#146;s or its Subsidiaries&#146; organizational documents; or (iii)&nbsp;subject to obtaining the Company Shareholder Approval and compliance with the requirements set
forth in <I>Section</I><I></I><I>&nbsp;2.4(b), </I>violate or result in a violation of, or constitute a default by the Company (whether after the giving of notice, lapse of time or both) under, any provision of any Law or any order of, or any
restriction imposed by, any court or Governmental Authority applicable to the Company or any of its Subsidiaries, provided however, that in the cases of clause (i)&nbsp;and (iii) of this <I>Section</I><I></I><I>&nbsp;2.4(a)</I>, except for any such
conflicts, violations, defaults, terminations, cancellations, accelerations or losses that, individually or in the aggregate, are not material. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.4</I> of the Disclosure Schedule, no material consent, approval, license,
permit, order or authorization of, or registration, declaration, notice or filing with any Governmental Authority is required by or with respect to the Company or any of its Subsidiaries in connection with the execution and delivery of this
Agreement by the Company or the consummation by the Company of the Contemplated Transactions, except for: (i)&nbsp;obtaining the Company Shareholder Approval; (ii)&nbsp;the filings and notifications required by the ICL; (iii)&nbsp;receipt of a
Certificate of Merger from the Companies Registrar in accordance with the ICL; (iv)&nbsp;such consents, approvals, orders, authorizations, registrations, declarations, notices and filings as may be required under applicable state securities laws and
the laws of any foreign country and (v)&nbsp;such other consents, licenses, permits, orders, authorizations, filings, approvals and registrations which, if not obtained or made, have not had, and would not reasonably be expected to result in a
Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_18"></A>2.5 Financial Statements</B>. <I>Section</I><I></I><I>&nbsp;2.5</I> of
the Company Disclosure Schedule includes true and complete copies of the Company&#146;s audited consolidated balance sheet as of December&nbsp;31, 2017 and the related consolidated audited statements of operations, cash flows and shareholders equity
for the twelve months ended December&nbsp;31, 2017, together with the notes thereto and the reports and opinions of Deloitte&nbsp;&amp; Touche relating thereto, and the unaudited balance sheet of the Company as of December&nbsp;31, 2018 and the
related unaudited statements of operations, cash flow and shareholders&#146; equity for the twelve-months&#146; period then ended </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(collectively, the &#147;<B>Company Financial Statements</B>&#148;). Except as set forth in <I>Section</I><I></I><I>&nbsp;2.5</I> of the Company Disclosure Schedule, the Company Financial
Statements (a)&nbsp;were prepared in accordance with GAAP applied on a consistent basis (unless otherwise noted therein) throughout the periods indicated and (b)&nbsp;fairly present, in all material respects, the financial condition and operating
results of the Company and its Subsidiaries as of the dates and for the periods indicated therein (except that the unaudited financial statements do not contain footnotes and are subject to normal and recurring
<FONT STYLE="white-space:nowrap">year-end</FONT> adjustments, which will not, individually or in the aggregate, be material). The unaudited balance sheet of the Company as of December&nbsp;31, 2018 is hereinafter referred to as the &#147;<B>Company
Balance Sheet</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_19"></A>2.6 Absence of Changes</B>. Except as set forth in
<I>Section</I><I></I><I>&nbsp;2.6</I> of the Company Disclosure Schedule, since the date of the Company Balance Sheet, the Company and its Subsidiaries have conducted their respective businesses in all material respects in the Ordinary Course of
Business. After the date of the Company Balance Sheet and on or before the date of this Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Other than as set forth in
<I>Section</I><I></I><I>&nbsp;2.6(a)</I> of the Company Disclosure Schedule, there has not been any change, event, circumstance or condition to the Knowledge of the Company that, individually or in the aggregate, has had, or would reasonably be
expected to have, a Company Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> there has been no split, combination or reclassification of any of the
outstanding share capital of the Company, and the Company has not declared or paid any dividends on or made any other distributions (in either case, in stock or property) on or in respect of the outstanding share capital of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> none of the Company or its Subsidiaries has allotted, reserved, set aside or issued, authorized or proposed the allotment,
reservation, setting aside or issuance of, or purchased or redeemed or proposed the purchase or redemption of, any shares in its capital stock or any class of securities convertible or exchangeable into, or rights, warrants or options to acquire,
any such shares or other convertible or exchangeable securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> except as required as a result of a change in applicable
Laws or GAAP, there has not been any material change in any method of accounting or accounting practice by the Company or its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> none of the Company or its Subsidiaries has (i)&nbsp;acquired or sold, pledged, leased, encumbered or otherwise disposed of any
material property or assets or agreed to do any of the foregoing or (ii)&nbsp;incurred or committed to incur capital expenditures, in each case in excess of $500,000, in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> there has been no transfer (by way of a license or otherwise) of, or agreement to transfer to, any Person&#146;s rights to any of
the Company Intellectual Property, other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses and sublicenses provided to distributors and users of Company Products in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> there has been no notice delivered to the Company or any of its Subsidiaries of any claim of ownership by a third party of any of
the Company Intellectual Property owned or developed by the Company or its Subsidiaries, or of infringement by any of the Company or its Subsidiaries of any Intellectual Property rights of any Person (&#147;<B>Third Party Intellectual
Property</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> there has not been any: (i)&nbsp;grant of any severance, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, or termination pay to any employee or other service provider of the Company or its Subsidiaries or any Contract entered or amended providing for the grant of any severance, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, or termination pay to any employee or other service provider of the Company or its Subsidiaries, in each case, other than as required by law
other than any arrangement that does not entail such severance, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, or termination pay exceeding $100,000 for any employee; (ii)&nbsp;entry
into any employment, deferred compensation, severance, equity, pension, post-retirement or other similar plan or agreement (or any amendment to any such existing agreement) with any new or current employee or other service provider of the Company or
its Subsidiaries; (iii)&nbsp;increase in the compensation, bonus or other benefits (including accelerated equity vesting) payable or to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
become payable to any employee or other service provider of the Company or its Subsidiaries, except, with respect to (ii)&nbsp;and (iii) of this subsection (h), in the Ordinary Course of Business
consistent with past practice, or as required by any preexisting plan or arrangement set forth in <I>Section</I><I></I><I>&nbsp;2.6 </I>of the Company Disclosure Schedule; or (iv)&nbsp;termination or resignation of any of the officers or Key
Employees of the Company or any of its Subsidiaries; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> there has not been any agreement to do any of the foregoing or any
action or omission that would result in any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_20"></A>2.7 Title to Assets</B>. Except as set
forth in <I>Section</I><I></I><I>&nbsp;2.7</I> of the Company Disclosure Schedule and except with respect to Company Intellectual Property which is covered in <I>Section</I><I></I><I>&nbsp;2.9</I>, each of the Company and its Subsidiaries owns, and
has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or assets and equipment used or held for use in its business or operations or purported to be owned by it. All of
said <FONT STYLE="white-space:nowrap">non-leased</FONT> properties and assets are owned by the Company or a Subsidiary of the Company free and clear of any Encumbrances, except for: (a)&nbsp;any lien for current Taxes not yet due and payable or for
Taxes that are being contested in good faith and for which adequate reserves have been made on the Company Balance Sheet; and (b)&nbsp;minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate)
materially detract from the value of the assets subject thereto or materially impair the operations of the Company and its Subsidiaries, taken as a whole and (c)&nbsp;Encumbrances described in <I>Section</I><I></I><I>&nbsp;2.7</I> of the Company
Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_21"></A>2.8 Properties</B>. <I>Section</I><I></I><I>&nbsp;2.8 </I>of the Company
Disclosure Schedule sets forth a list of the Company Leased Real Property. True and complete copies of all leases relating to Company Leased Real Property have been made available to Radiant. With respect to each lease listed on
<I>Section</I><I></I><I>&nbsp;2.8</I> of the Company Disclosure Schedule: (a)&nbsp;the Company has a valid and enforceable leasehold interest to the leasehold estate in the Company Leased Real Property granted to the Company pursuant to each
pertinent lease, subject to applicable bankruptcy, insolvency, moratorium or other similar Laws relating to creditors&#146; rights and general principles of equity; (b)&nbsp;each of said leases has been duly authorized and executed by the Company
and is in full force and effect; (c)&nbsp;the Company is not in default under any of said leases, nor, to the Knowledge of the Company, has any event occurred which, with notice or the passage of time, or both, would give rise to such a default by
the Company; and (d)&nbsp;the Company has not assigned, subleased, transferred, conveyed, mortgaged, deeded in trust or encumbered any interest in any such lease. Neither the Company nor any of its Subsidiaries owns or has ever owned any real
property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_22"></A>2.9 Intellectual Property</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <I>Section 2.9(a)</I> of the Company Disclosure Schedule contains a complete and accurate list of all (i)&nbsp;issued Patents or
pending patent applications owned or controlled (i.e., exclusively licensed) by the Company or any of its Subsidiaries or used or held for use by the Company or any of its Subsidiaries in the Company Business (&#147;<B>Company Patents</B>&#148;),
all registered trademarks, tradenames, and service mark registrations and applications to register any trademarks (including domain names) therefor, including material unregistered trademarks, tradenames, and service marks (&#147;<B>Company
Marks</B>&#148;) and registered and material unregistered Copyrights owned or controlled by the Company or any of its Subsidiaries or used or held for use by the Company or any of its Subsidiaries in the Company Business (&#147;<B>Company
Copyrights</B>&#148;), (ii)&nbsp;licenses, sublicenses or other Contracts under which the Company or any of its Subsidiaries is granted rights by others in the Company Intellectual Property (&#147;<B>Company
<FONT STYLE="white-space:nowrap">Licenses-In</FONT></B>&#148;) (other than commercial off the shelf software or materials transfer agreements), and (iii)&nbsp;licenses, sublicenses or other Contracts under which the Company or any of its
Subsidiaries has granted rights to others in the Company Intellectual Property, other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses and sublicenses provided to distributors and users of Company Products in the Ordinary Course
of Business (&#147;<B>Company <FONT STYLE="white-space:nowrap">Licenses-Out</FONT></B>&#148;). <I>Schedule</I><I></I><I>&nbsp;2.9(a)</I> sets forth (i)&nbsp;the jurisdictions in which each such item of Company Intellectual Property has been issued,
registered, otherwise arises or in which any such application for such issuance and registration has been filed, (ii)&nbsp;the registration or application date and serial or patent number, as applicable, and (iii)&nbsp;any pending oppositions to any
of the Company Marks (registered or applied for). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.9(b)</I> of the Company
Disclosure Schedule, with respect to the Company Intellectual Property (i)&nbsp;purported to be owned by the Company or any of its Subsidiaries, the Company or one of its Subsidiaries owns the entire right, title, and interest in and to such Company
Intellectual Property and (ii)&nbsp;purported to be licensed to the Company or any of its Subsidiaries by a third party (other than commercial off the shelf software or materials transfer agreements), such Company Intellectual Property is the
subject of an enforceable written license or other written Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Except as set forth in
<I>Section</I><I></I><I>&nbsp;2.9(c)</I> of the Company Disclosure Schedule, the Company Intellectual Property is free and clear of all Encumbrances, other than Encumbrances resulting from the express terms of a Company <FONT
STYLE="white-space:nowrap">License-In,</FONT> the express terms of a Company <FONT STYLE="white-space:nowrap">License-Out</FONT> or Permitted Encumbrances granted by the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> The Company Intellectual Property includes all of the material Intellectual Property used in the Ordinary Course of Business by
the Company and its Subsidiaries as currently conducted, and there are no other items of Intellectual Property that are material to the Ordinary Course of Business of the Company and development, manufacturing, marketing, commercialization and sale
of the Company Products, as currently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> To the Knowledge of the Company, the Company Patents are (i)&nbsp;being
diligently prosecuted or otherwise registered in the respective United States Patent&nbsp;&amp; Trademark Office and all similar offices and agencies anywhere in the world in which foreign counterparts are registered or issued, and (ii)&nbsp;have
been filed and maintained in accordance with applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> None of the Company
<FONT STYLE="white-space:nowrap">Licenses-Out</FONT> grant any third party exclusive rights to or under any Company Intellectual Property or grant any third party the right to sublicense any Company Intellectual Property without the Company&#146;s
written consent or notice to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> To the Knowledge of the Company, each of the Company Patents properly identifies
each and every inventor of the claims thereof as determined in accordance with the laws of the jurisdiction in which such Company Patent is issued or pending. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> No Company Patent is currently involved in any post grant review, <I>inter partes </I>review, interference, reissue, <FONT
STYLE="white-space:nowrap">re-examination</FONT> or opposition proceeding; to the Knowledge of the Company, there is no patent or patent application of any third party that potentially interferes with a Company Patent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> Except as set forth in <I>Section</I><I>&nbsp;2.9(i)</I> of the Company Disclosure Schedule, (i)&nbsp;there are no material Legal
Proceedings pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries alleging that the Company or any of its Subsidiaries is infringing, misappropriating or otherwise violating, or has infringed,
misappropriated or otherwise violated any Third Party Intellectual Property; (ii)&nbsp;there are no material Legal Proceedings pending or threatened by the Company or any of its Subsidiaries against any Person alleging infringement, misappropriation
or other violation of any Company Intellectual Property; (iii)&nbsp;to the Knowledge of the Company, the operation or conduct of the Company Business and development, manufacturing, marketing, commercialization and sale of the Company Products
(including the use of the Company Intellectual Property), as currently conducted and conducted in the past has not infringed, misappropriated or otherwise violated any Intellectual Property rights of any Person, and there has been no material Legal
Proceeding asserted or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries alleging the Company&#146;s infringement, misappropriation, or violation of any Intellectual Property rights of another Person and
(iv)&nbsp;to the Knowledge of the Company, no Person is currently infringing or otherwise violating any Company Intellectual Property. To the Knowledge of the Company, there is no substantial basis for any claim that the operation of the Company
Business and the development, manufacturing, marketing, commercialization and sale of the Company Products, as currently conducted, infringes, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
misappropriates, or otherwise violates, or will infringe, misappropriate or otherwise violate any Third Party Intellectual Property under the Laws of any jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.9(j)</I> of the Company Disclosure Schedule<I>,</I> none of the Company
or any of its Subsidiaries has any obligation to compensate any person for the use of any Company Intellectual Property including pursuant to Section&nbsp;134 to the Israeli Patents Law &#150; 1967; none of the Company or any of its Subsidiaries has
entered into any agreement to indemnify any other person against any claim of infringement or misappropriation of any Third Party Intellectual Property by the use of Company Intellectual Property, except in connection with commercial off the shelf
software or materials transfer agreements; there are no settlements, covenants not to sue, consents, or Orders or similar obligations that: (i)&nbsp;restrict the rights of the Company or any of its Subsidiaries to use any Company Intellectual
Property, (ii)&nbsp;restrict the Company Business or development, manufacturing, marketing, commercialization and sale of the Company Products, in order to accommodate any Third Party Intellectual Property, or (iii)&nbsp;permit third parties to use
any Company Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.9(k)</I> of the Company Disclosure
Schedule, all former and current consultants and contractors who have independently or jointly contributed to the conception, reduction to practice, creation or development of any Company Intellectual Property and all former and current employees of
the Company or any of its Subsidiaries have executed written instruments with the Company or one or more of its Subsidiaries that assign to the Company or its Subsidiary, all rights, title and interest in and to any and all of all such Intellectual
Property arising from such employment or contractual arrangement, including, without limitation, inventions, improvements, discoveries, writings and other works of authorship, and information relating to the Company Business or the Company Products
and any Intellectual Property relating thereto (the &#147;<B>Company Created IP</B>&#148;). No such third party has retained any ownership rights with respect to such Company Created IP. Except as listed in <I>Section</I><I></I><I>&nbsp;2.9(k)
</I>of the Company Disclosure Schedule, where a Company Patent is held by the Company or any of its Subsidiaries by assignment, the assignment has been duly recorded with the U.S. Patent and Trademark Office and all similar offices and agencies
anywhere in the world in which foreign counterparts are registered or issued. Each Person who has or has had any ownership rights in or to any Company Created IP, has assigned and has executed an agreement assigning its entire right, title, and
interest in and to such Company Created IP to Company or its Subsidiary. For clarity, Company Created IP is Company Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> The Company and its Subsidiaries have taken commercially reasonable security measures, consistent with customary practices in the
industry in which it operates, to protect and preserve the secrecy, confidentiality and value of all Trade Secrets, if any, and confidential and proprietary information, owned by the Company or any of its Subsidiaries or used or held for use by the
Company or any of its Subsidiaries in the Company Business and the development, manufacturing, marketing, commercialization and sale of the Company Products (the &#147;<B>Company Trade Secrets</B>&#148;), including, without limitation, causing each
former and current employee and consultant of the Company and its Subsidiaries and any other person with access to Company Trade Secrets to execute a binding written confidentiality agreement, copies or forms of which have been provided to Radiant
and pursuant to which such employees, contractors and consultants have agreed to hold all trade secrets and confidential and proprietary information of the Company and the Subsidiaries in confidence both during and after their employment or
engagement. To the Knowledge of the Company and its Subsidiaries (i)&nbsp;no Person is in breach of their respective confidentiality agreement, and (ii)&nbsp;there has not been any disclosure of or access to any material Company Trade Secret to any
Person in a manner that has resulted or is reasonably likely to result in the loss of Trade Secret in and to such information. All current and former employees and consultants of the Company and the Subsidiaries having access to confidential or
proprietary information of any of their respective customers or business partners have executed and delivered to the Company an agreement regarding the protection of such confidential or proprietary information, to the extent required by such
customers and business partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> To the Knowledge of the Company, no current or former employee, consultant or independent
contractor of the Company or any Subsidiary (i)&nbsp;is in violation of any term or covenant of any Contract relating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to employment, invention disclosure (including patent disclosure), invention assignment, <FONT STYLE="white-space:nowrap">non-disclosure</FONT> or any other Contract with any other party by
virtue of such employee&#146;s, consultant&#146;s or independent contractor&#146;s being employed by, or performing services for, the Company or any Subsidiary or using trade secrets or proprietary information of others without permission; or
(ii)&nbsp;has developed any technology, software or other copyrightable, patentable or otherwise proprietary work for the Company or any Subsidiary that is subject to any Contract under which such employee, consultant or independent contractor has
assigned or otherwise granted to any third party any rights (including Intellectual Property rights) in or to such technology, software or other copyrightable, patentable or otherwise proprietary work. No director, officer, employee, consultant, or
other representative of the Company or any of its Subsidiaries owns or, to the Knowledge of the Company, claims any rights in any Company Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> No (i)&nbsp;government funding, (ii)&nbsp;facilities of a university, college, other educational institution or research or
medical center, or (iii)&nbsp;funding from any Person (other than funds received in consideration for Company Share Capital) was used in the development of the Company Intellectual Property. To the Knowledge of the Company, no current or former
employee of the Company or any Subsidiary, who was involved in, or who contributed to, the creation or development of any Company Intellectual Property, has performed services for any government, university, college or other educational institution
or research or medical center during a period of time during which such employee was also performing services for the Company or any Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_23"></A>2.10 Material Contracts</B>. <I>Section</I><I></I><I>&nbsp;2.10</I> of the Company Disclosure Schedule
identifies the following Company Material Contracts in effect as of the date of this Agreement:<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> the Company Leased Real Property and the Company Ancillary Lease Documents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> any Contract for the purchase of materials, supplies, goods, services, equipment or other assets for annual payments by the
Company or any of its Subsidiaries of, or pursuant to which in the last year the Company or any of its Subsidiaries paid, in the aggregate, $2,000,000 or more; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> any Contract for the sale of materials, supplies, goods, services, equipment or other assets excluding Company Products for annual
payments to Company or any of its Subsidiaries of, or pursuant to which in the last year the Company or any of its Subsidiaries received, in the aggregate, $2,000,000 or more; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> any Contract that relates to any partnership, joint venture, strategic alliance or other similar Contract other than agreements
entered into with third parties for the incorporation of Subsidiaries, copies of which have been provided to Radiant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> any
Contract relating to Indebtedness for borrowed money or the deferred purchase price of property (whether incurred, assumed, guaranteed or secured by any asset), except for Contracts relating to Indebtedness in an amount not exceeding $5,000,000 in
the aggregate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> any Contract for the employment of any employee or engagement of any independent contractor (i)&nbsp;that
provides for base salary or fee in excess of $200,000 on an annual basis, or&nbsp;(ii) that provides for&nbsp;severance, retention bonus, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> or similar
type Contracts, other than Contracts that provide for severance, retention bonus, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> or similar type Contracts at or below the amount of $100,000 per
employee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> all collective bargaining agreements or agreements with any labor organization, union or association to which the
Company is a party, except for such agreements which generally apply to all employees in Israel or specific segments of the Israeli labor market through extension orders issued by the applicable Israeli Governmental Authority (the &#147;<B>Extension
Orders</B>&#148;); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> any Contract which by its terms limits in any material respect (i)&nbsp;the
localities in which all or any significant portion of the business and operations of the Company or its Subsidiaries or, following the consummation of the Contemplated Transactions, the business and operations of Surviving Company, Radiant or any
Affiliate of Radiant, is or would be conducted, or (ii)&nbsp;the scope of the business and operations of the Company and its Subsidiaries, taken as a whole, in each case that would be material to the Company and its Subsidiaries taken as a whole;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> any Contract of the Company or any of its Subsidiaries with any executive officer, or Key Employee containing noncompetition,
<FONT STYLE="white-space:nowrap">non-solicitation,</FONT> nondisclosure, assignment of inventions or confidentiality provisions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> any Contract in respect of any Company Intellectual Property (including the distribution, licensing, marketing, advertising or
sales thereof) that provides for annual payments of, or pursuant to which in the last year the Company or any of its Subsidiaries paid or received, in the aggregate, $2,000,000 or more; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> any Contract with any healthcare professional or any employee of any healthcare professional, including, but not limited to, any
Contract for advisory boards, pharmacy practice management, consulting services, electronic medical records or practice management that provides for annual payments of, or pursuant to which in the last year the Company or any of its Subsidiaries
paid, in the aggregate, $250,000 or more; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> any Contract containing any royalty, dividend or similar arrangement based on the
revenues or profits of the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> any Contract with any Governmental Authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> any power of attorney, other than powers of attorney provided by the Company or its Subsidiaries in the Ordinary Course of
Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> any agreement that gives rise to any material payment or benefit as a result of the performance of this Agreement
or any of the other Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> any Contract with (i)&nbsp;an executive officer or director of the Company or
any of its Material Subsidiaries or any of such executive officer&#146;s or director&#146;s immediate family members, (ii)&nbsp;an owner of more than five percent (5%) of the voting power of the outstanding capital stock of the Company or
(iii)&nbsp;to the Knowledge of the Company, any &#147;related person&#148; (within the meaning of Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act) of any such officer, director or owner (other than the
Company or its Subsidiaries); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(q)</B> any Contract relating to the acquisition or disposition of any material interest in, or any
material amount of, property or assets of the Company or any of its Subsidiaries (whether by merger, stock sale, asset sale or otherwise) or for the grant to any Person of any preferential rights to purchase any of their assets, other than in the
Ordinary Course of Business consistent with past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(r)</B> any Contract containing any provisions requiring any of the
Company or its Subsidiaries to indemnify any other party, other than commercial Contracts entered into in the Ordinary Course of Business consistent with past practices; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(s)</B> except to the extent a Contract is described in the clauses above, any Contract not entered into in the Ordinary Course of
Business in excess of $2,000,000; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(t)</B> any other agreement (or group of related agreements) the performance of which requires
aggregate payments from the Company or any of its Subsidiaries in excess of $2,000,000 or that is material to the Company or its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has delivered or made available to Radiant accurate and complete (except for
applicable redactions thereto) copies of all material written Company Contracts, including all amendments thereto. There are no Company Material Contracts that are not in written form. Neither the Company nor any Subsidiary of the Company has, nor
to the Knowledge of the Company, has any other party to a Company Material Contract (as defined below), breached, violated or defaulted under, or received notice that it has breached, violated or defaulted under, any of the terms or conditions of
any of the agreements, contracts or commitments to which the Company or its Subsidiaries is a party or by which it is bound of the type described in clauses (a)&nbsp;through (t) above or any Company Contract listed in
<I>Section</I><I></I><I>&nbsp;2.13(a)</I> or <I>Section</I><I></I><I>&nbsp;2.15</I> of the Company Disclosure Schedule (any such agreement, contract or commitment, a &#147;<B>Company Material Contract</B>&#148;) in such manner as would permit any
other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would reasonably be expected to be material. As to the Company and its Subsidiaries, as of the date of this Agreement, each
Company Material Contract is valid, binding, enforceable and in full force and effect, subject to: (i)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (ii)&nbsp;rules of Law governing specific
performance, injunctive relief and other equitable remedies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_24"></A>2.11 Absence of Undisclosed
Liabilities</B>. Neither the Company nor any Subsidiary of the Company has any liability, Indebtedness, obligation, expense, claim, deficiency, guaranty or endorsement of any kind, whether accrued, absolute, contingent, matured, unmatured or other
(whether or not required to be reflected in the financial statements in accordance with GAAP) (each a &#147;<B>Liability</B>&#148;), individually or in the aggregate, except for: (a)&nbsp;Liabilities identified as such in the &#147;liabilities&#148;
column of the Company Balance Sheet; (b)&nbsp;current Liabilities that have been incurred by the Company or its Subsidiaries since the date of the Company Balance Sheet in the Ordinary Course of Business, each of which is under $250,000 individually
or in the aggregate; (c)&nbsp;Liabilities for performance of obligations of the Company or any Subsidiary of the Company under Contracts (other than for breach thereof); and (d)&nbsp;Liabilities described in <I>Section</I><I></I><I>&nbsp;2.11</I> of
the Company Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_25"></A>2.12 Compliance with Laws; Regulatory Compliance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(a)</I> of the Company Disclosure Schedule, each of the Company and its
Subsidiaries and, to the Knowledge of the Company, every director, officer, employee, agent, and Representative thereof, is and has been for the past three (3)&nbsp;years in material compliance with all applicable Laws (including, but not limited
to, Health Care Laws and all trade laws, including import control and export laws, trade embargos and anti-boycott laws) and Orders. To the Knowledge of the Company and its Subsidiaries, (i)&nbsp;no investigation by any Governmental Authority with
respect to the Company or any of its Subsidiaries is active and pending, and (ii)&nbsp;no Governmental Authority has indicated in writing or, to the Knowledge of the Company, orally, an intention to conduct an investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a Company Material
Adverse Effect, each of the Company and its Subsidiaries and, to the Knowledge of the Company, their respective employees and agents, hold all Company Permits, including, but not limited to, all authorizations required under the FDCA, and the
regulations of the FDA promulgated thereunder as well as the Public Health Service Act of 1944, as amended (&#147;<B>PHSA</B>&#148;). Except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a
Company Material Adverse Effect, all such Company Permits are valid, and in full force and effect. Since January&nbsp;1, 2016, there has not occurred any violation of, default (with or without notice or lapse of time or both) under, or event giving
to others any right of termination, amendment or cancellation of, with or without notice or lapse of time or both, any Company Permit except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a
Company Material Adverse Effect. Each of the Company and each of its Subsidiaries is in compliance in all material respects with the requirements associated with all Company Permits. No event has occurred that would reasonably be expected to result
in the revocation, cancellation, <FONT STYLE="white-space:nowrap">non-renewal</FONT> or adverse modification of any Company Permit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(c)</I> of the Company
Disclosure Schedule, none of the Company or its Subsidiaries, any director, officer, employee nor, to the Knowledge of the Company, agent or Representative thereof, has committed any act, made any statement or failed to make any statement that would
reasonably be expected to provide a basis for the FDA to invoke its policy with respect to &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&#148; as set forth in 56 Fed. Reg. 46191 (Sept. 10, 1991) and any
amendments thereto, or a similar policy enforced by any other Company Regulatory Agency. None of the Company or its Subsidiaries, any director, officer, employee nor, to the Knowledge of the Company, agent or Representative thereof, has engaged in
any activity that would result in a material violation under applicable Health Care Laws. There is no civil, criminal, administrative or other proceeding, notice or demand pending, received or, to the Knowledge of the Company, threatened against the
Company or any of its Subsidiaries that relates to an alleged violation of any Health Care Law and none of the Company or any of its Subsidiaries is in receipt of written notice of any civil, criminal, administrative or other proceeding, notice or
demand pending that relates to an alleged violation of any Health Care Law. None of the Company or any of its Subsidiaries, any director, officer, employee nor, to the Knowledge of the Company, agent or Representative thereof, has engaged in any
activity that would result in a material violation of any Health Care Law. None of the Company or any of its Subsidiaries nor, to the Knowledge of the Company, any director, officer, employee, agent or Representative thereof, has been convicted of
any crime or engaged in any conduct for which debarment is mandated by 21 U.S.C. &#167; 335a(a) or any similar Law or authorized by 21 U.S.C. &#167; 335a(b) or any similar Law. There are no Orders or similar actions to which the Company or any of
its Subsidiaries, any director, officer, employee, or, to the Knowledge of the Company, agent or Representative thereof, are bound or which relate to Company Products, or alleged violation of any Health Care Law. The Company and its Subsidiaries are
currently not, nor have ever been, a party or subject to the terms of a corporate integrity agreement required by the Office of the Inspector General of the United States Department of Health and Human Services or similar agreement or consent order
of any other Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> None of the Company or any of its Subsidiaries nor, to the Knowledge of the Company, any
director, officer, employee, agent or Representative thereof, has been investigated for, charged with or convicted of a Medicare, Medicaid or federal or state health program related offense, or convicted of, charged with or, to the Knowledge of the
Company, investigated for a violation of federal or state Law related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, obstruction of an investigation of controlled substances, or has been debarred, excluded
or suspended from participation in a Federal Health Care Program (nor is any such debarment, exclusion or suspension pending), or been subject to any Order or consent decree of, or criminal or civil fine or penalty imposed by, any Governmental
Authority. To the Knowledge of the Company, the Company has not arranged or contracted with (by employment or otherwise) any individual or entity that has been convicted of or pled guilty or nolo contendere to any federal or state health
care-related criminal offense or is excluded from participation in a Federal Health Care Program for the provision of items or services for which payment may be made under such Federal Health Care Program. No exclusion, suspension, or debarment
claims, actions, proceedings or investigations relating to the Company is pending, or to the Knowledge of the Company, is threatened against neither the Company, nor any of the Company&#146;s respective officers, directors, equity holders, employees
or agents acting on its behalf or for its benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(e)</I> of the
Company Disclosure Schedule, each of the Company and its Subsidiaries is and has been in compliance in all material respects with all applicable statutes, rules, regulations, decrees, writs and Orders of the FDA and any other Company Regulatory
Agency with respect to the labeling, storing, testing, developing, manufacturing, packaging, distributing, marketing, advertising, promoting, and selling of the Company Products. To the Knowledge of the Company, all required <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> toxicology studies conducted by or on behalf of the Company or its Subsidiaries and Company-sponsored clinical trials (or clinical trials sponsored by the Company or any other Subsidiary) conducted or
being conducted with respect thereto, have been and are being conducted in compliance in all material respects with applicable licenses and Laws, including, without limitation, the applicable requirements of the FDCA and the FDA&#146;s current Good
Manufacturing Practice, as codified in the Quality System Regulation, Good Laboratory Practice and Good Clinical Practice. The results of any such studies, tests and trials, and all other material information related to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such studies, tests and trials, have been made available to Radiant. To the Knowledge of the Company, each clinical trial conducted by or on behalf of the Company or any of its Subsidiaries with
respect to Company Products has been and is being conducted in all material respects in accordance with its clinical trial protocol, and in compliance in all material respects with all applicable Laws, including Good Clinical Practice, informed
consent, Institutional Review Board requirements and all other applicable requirements contained in 21 CFR Parts 312, 812, 50, 54, 56 and 11 and where applicable the Israeli Public Health Regulations (Clinical Trials in Human Subjects), 1980 and the
Israeli Procedure for Clinical Trials in Humans, 2016. To the Knowledge of the Company, each of the Company and its Subsidiaries has filed all required notices (and made available to Radiant copies thereof) of design defects, product problems,
adverse events, injuries and deaths relating to clinical trials conducted by or on behalf of the Company or any of its Subsidiaries with respect to such Company Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(f)</I> of the Company Disclosure Schedule, all applications,
submissions, information and data utilized by the Company or any of its Subsidiaries as the basis for, or submitted by or on behalf of the Company or any of its Subsidiaries in connection with any and all requests for a Company Permit relating to
the Company or any of its Subsidiaries, when submitted to the FDA or any other Company Regulatory Agency, were, to the Knowledge of the Company, true, correct and complete in all material respects as of the date of submission, and any updates,
changes, corrections or modification to such applications, submissions, information and data required under applicable Laws have been submitted to the FDA or any other Company Regulatory Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(g)</I> of the Company Disclosure Schedule, (i)&nbsp;the Company and each
of its Subsidiaries is in compliance in all material respects with the written procedures, record-keeping and FDA reporting requirements for Reports of Corrections and Removals set forth in 21 C.F.R. Part 806; (ii) neither the Company nor any of its
Subsidiaries has voluntarily or involuntarily issued or caused to be issued, or is aware of any facts that would require the Company or any of its Subsidiaries to issue or cause to be issued, any recall notice, market withdrawal notice, safety or
Warning Letter, report or other notice or action disclosing an alleged defect or lack of safety or efficacy of any product; (iii)&nbsp;the Company and each of its Subsidiaries is in compliance in all material respects with the regulations for
Medical Device Reporting set forth in 21 C.F.R. Part 803, or equivalent requirements issued by any other Governmental Authority; (iv)&nbsp;each product in current commercial distribution in the United States is a Class&nbsp;II medical device as
defined under 21 U.S.C. &#167;&nbsp;360c(a)(1)(A), (B) and applicable rules and regulations thereunder and was first marketed under, and is currently covered by, a premarket notification owned and held exclusively by the Company or one of its
Subsidiaries and in compliance with 21 U.S.C. &#167; 360(k) and the applicable rules and regulations thereunder; and (v)&nbsp;the Company and each of its Subsidiaries has always promoted and continues to promote such products for uses that are
within the scope of each Permit, and the Company and each of its Subsidiaries have not engaged in any <FONT STYLE="white-space:nowrap">off-label</FONT> promotion, or promotion of Company Products without Permits, when such medical devices under FDCA
must only be marketed with Permits (e.g., 510(k) premarket notification). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> Except as set forth in
<I>Section</I><I></I><I>&nbsp;2.12(h)</I> of the Company Disclosure Schedule, none of the Company or its Subsidiaries nor, to the Knowledge of the Company, any of the Representatives, licensors, licensees, assignors or assignees thereof has received
any notice that the FDA or any other Company Regulatory Agency has initiated, or threatened to initiate, any action to suspend or place restrictions on any clinical trial, suspend or terminate any Investigational Device Exemption
(&#147;<B>IDE</B>&#148;) or comparable Clinical Trial Application sponsored by the Company or any of its Subsidiaries or otherwise restrict the <FONT STYLE="white-space:nowrap">pre-clinical</FONT> research related to or clinical study of any Company
Product or any medical device or component being developed by any licensee or assignee of the Company Intellectual Property based on such intellectual property, or to recall, suspend or otherwise restrict the development or manufacture of any
Company Product. To the Knowledge of the Company, none of the Company or any of its Subsidiaries or any supplier of components and materials to the Company is in receipt of written notice of, or is subject to, any adverse inspection, finding of
deficiency, finding of <FONT STYLE="white-space:nowrap">non-compliance,</FONT> 483 observation, investigation, civil or criminal proceeding, hearing, suit, demand, claim, complaint, inquiry, proceeding, penalty, Untitled Letter, Warning Letter,
seizure, import alert, injunction, prosecution, or other compliance or enforcement action relating to any Company Products or to the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Business. To the Knowledge of the Company, there is no act, omission, event or circumstance that would reasonably be expected to give rise to any such action. All deficiencies and <FONT
STYLE="white-space:nowrap">non-conformities</FONT> discovered during internal audits and inspections have been corrected and resolved in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> To the extent the Company or its Subsidiaries collects, uses, or discloses Personal Information, the Company or its Subsidiaries,
as applicable, has in place publicly published privacy policies regarding the collection, use and disclosure of Personal Information in their possession, custody or control, or otherwise held or processed on their behalf. Except as set forth in
<I>Section</I><I></I><I>&nbsp;2.12(i) </I>of the Company Disclosure Schedule, the Company and its Subsidiaries are, and have been for the past three (3)&nbsp;years, in material compliance with the requirements of: (i)&nbsp;all applicable Data
Privacy and Security Laws; and (ii)&nbsp;all contractual obligations concerning the collection, use, and storage and disclosure of Personal Information. Neither the Company nor its Subsidiaries has been notified of any Legal Proceeding related to
data security or privacy or alleging a violation of any of its privacy policies or any Data Privacy and Security Law, nor, to the Knowledge of the Company, has any such claim been threatened. Except as set forth in
<I>Section</I><I></I><I>&nbsp;2.12(i)</I> of the Company Disclosure Schedule, the Company and its Subsidiaries have taken commercially reasonable measures designed to protect and maintain the confidentiality of all Personal Information collected by
or on behalf of the Company or its Subsidiaries and to maintain the security of its data storage practices for Personal Information, in each case, in accordance with all Data Privacy and Security Laws and consistent with commercially reasonable
industry practices applicable to such types of data gathered and maintained in the industry in which the Company or its Subsidiaries conduct their business. The Company and each of its Subsidiaries are not now, and have never been, subject to HIPAA
(as either a &#147;covered entity&#148; or &#147;business associate&#148;) and are not a party to any business associate agreement, as defined by HIPAA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.12(j)</I> of the Company Disclosure Schedule, the Company and each of its
Subsidiaries have maintained commercially reasonable administrative, physical and technical safeguards consistent with normal industry practice and in accordance with Data Privacy and Security Laws that are designed to (i)&nbsp;protect the
confidentiality, integrity and accessibility of IT Systems and information contained therein (including Intellectual Property, Personal Information, and other information subject to confidentiality obligations), and specifically, (ii)&nbsp;prevent
against loss and unauthorized access, use, modification, disclosure or other use of such information that would not, in each foregoing case, be consistent with the Company or its Subsidiaries&#146; published privacy policies or contract to which the
Company or any of its Subsidiaries is a party. With respect to the IT Systems, for the past three (3)&nbsp;years (i) none of the data (including Intellectual Property and Personal Information) that the Company or its Subsidiaries stores or processes
has been corrupted to a material extent, and (ii)&nbsp;to the Knowledge of the Company, none of the Personal Information that the Company or its Subsidiaries stores or processes has been subject to a security breach or incident requiring
notification under the applicable Data Privacy and Security Laws, including but not limited to, 45 C.F.R. Subpart D. The Company and its Subsidiaries have been, and are, in compliance with contractual obligations concerning the security and privacy
of IT Systems and information contained therein (including Intellectual Property, Personal Information, and other information subject to confidentiality obligations) in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.12(k)</I> of the Company Disclosure Schedule, there is no audit,
proceeding, claim or investigation currently pending against the Company or its Subsidiaries by any Governmental Authority in respect of Personal Information. The Company and its Subsidiaries have made available to Radiant true, correct and complete
copies of any and all material applications, approvals, licenses, written notices of inspectional observations, establishment inspection reports and any other documents received from the FDA or any other Company Regulatory Agency, including
documents that indicate or suggest lack of compliance with the regulatory requirements of the FDA or any other Company Regulatory Agency. The Company and its Subsidiaries have made available to Radiant for review all material correspondence to or
from the FDA or any other Company Regulatory Agency, minutes of meetings, written reports of phone conversations, visits or other contact with the FDA or any other Company Regulatory Agency, and all other documents concerning communications to or
from the FDA or any other Company Regulatory Agency, or prepared by the FDA or any other Company Regulatory Agency or which bear in any way on the Company&#146;s or any of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiaries&#146; material compliance with regulatory requirements of the FDA or any other Company Regulatory Agency, or on the likelihood or timing of approval or clearance of any Company
Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_26"></A>2.13 Taxes and Tax Returns</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Each of the Company and its Subsidiaries has timely (i)&nbsp;filed (taking into account any applicable extensions) all material
Tax Returns that were required to be filed on or prior to the date hereof, as detailed in <I>Section</I><I></I><I>&nbsp;2.13(a)</I> of the Company Disclosure Schedule, and all such Tax Returns were correct and complete in all material respects and
(ii)&nbsp;paid all Taxes, whether or not shown on such Tax Returns, other than Taxes which individually or the aggregate are not reasonably expected to be material. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> There are no liens for Taxes (other than statutory liens for current Taxes or other governmental charges, assessments or levies
that are not yet due and payable or liens for Taxes being contested in good faith by appropriate proceedings, and for which adequate reserves have been established in accordance with GAAP in the Company Financial Statements) on any assets of the
Company or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.13(c) </I>of the Company Disclosure
Schedule, neither the Company nor any of its Subsidiaries is a party to any currently pending Tax audits or other administrative proceedings or any currently pending court proceedings or any other material dispute or claim concerning any Tax
liability of the Company or any Subsidiary, in each case, for which written notice has been received. To the Knowledge of the Company, there are no material matters under discussion between the Company or any of its Subsidiaries and any Taxing
Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.13(d) </I>of the Company Disclosure Schedule, neither
the Company nor any of its Subsidiaries has filed for an extension of time within which to file any Tax Return which extension is currently in effect, other than customary extensions not to exceed six (6)&nbsp;months for which no approval is
required. Neither the Company nor any of its Subsidiaries has executed any outstanding waiver of any statute of limitations for, or extension of, the period for the assessment or collection of any Tax, in each case, which period has not yet expired.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> The Company and its Subsidiaries have complied in all material respects with all applicable legal requirements relating to
the payment and withholding of Taxes from payments made or deemed made to any employee, independent contractor, creditor, shareholder, lender or other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Neither the Company nor any of its Subsidiaries is a party to or is bound by any Tax sharing, allocation or indemnification
agreement (other than (i)&nbsp;any such agreement exclusively between or among the Company and/or its Subsidiaries and (ii)&nbsp;any other agreement (A)&nbsp;the primary purpose of which is not the allocation or payment of Tax liability and
(B)&nbsp;that was entered into in the Ordinary Course of Business). Neither the Company nor any of its Subsidiaries is or may be liable under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision
of the Tax Laws of any state, local or foreign jurisdiction) for Taxes of any Person other than the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> During the past two (2)&nbsp;years, neither the Company nor any of its Subsidiaries has distributed stock of another Person, or
has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Sections 355 or 361 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> None of the Company or its Subsidiaries has taken any action, or has any Knowledge of any fact or circumstance, that would
reasonably be expected to prevent the Merger, from qualifying as a reorganization within the meaning of Section&nbsp;368(a) of the Code. The Company is treated as an association taxable as a corporation for U.S. federal income tax purposes. The
Company is not, and has never been, a &#147;surrogate foreign corporation&#148; within the meaning of Section&nbsp;7874(a)(2)(B) of the Code, nor is it treated as a U.S. corporation pursuant to Section&nbsp;7874(b) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> All material related party transactions involving the Company are in compliance
with applicable transfer pricing laws and regulations, are at arm&#146;s length and are documented and reported with a proper transfer pricing study, in each case in accordance with applicable Tax Laws (including Section&nbsp;85A of the Israeli Tax
Ordinance and the regulations thereunder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> None of the Company or its Subsidiaries has a permanent establishment or other
taxable presence (as determined pursuant to an applicable tax treaty or applicable foreign Tax Law) in any country other than the country of its formation. Neither the Company nor any of the Subsidiaries is or has ever been subject to Tax in any
country other than their country of incorporation by virtue of being treated as a resident of that country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> No written claim
has been delivered to the Company or to any Subsidiary by a Taxing Authority, within the statutory limitation periods, in the jurisdiction where the Company or any Subsidiary does not file Tax Returns such that it is or may be subject to taxation by
that jurisdiction or required to file any Tax Return in that jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> The Company, and to the Knowledge of the Company,
the holders of Company Share Capital (concerning the Company Share Capital held by them) are not subject to restrictions or limitations pursuant to Part E2 of the Ordinance or a related tax ruling. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> The Company is duly registered for the purposes of Israeli value added Tax (&#147;<B>VAT</B>&#148;) and has complied in all
respects with all requirements concerning VAT under the requirements of Israel Value Added Tax Law of 1975 or regulations thereunder. No Subsidiaries are required to effect Israeli VAT registration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;2.13(n) </I>of the Company Disclosure Schedule, the Company has not
requested or received a ruling from the ITA or any Israeli Governmental Authority on behalf of itself or any of its employees or shareholders. The Company has not undertaken any transaction that required or will require special reporting in
accordance with Sections 131D, 131E and 131(g) of the Ordinance and the Israeli Income Tax Regulations (Tax Planning Requiring Reporting)(Temporary Provisions), 2006 regarding aggressive tax planning, or any equivalent transaction which should be
reported to any other Taxing Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.13(o)</I> of the Company
Disclosure Schedule, the Company is in compliance, in all material respects, with all terms and conditions of any tax exemptions, tax holiday or other tax reduction agreements, approvals or orders of any taxing authority. The Company has not been
granted or has claimed any tax incentive under the laws of the State of Israel, including grants or claims of &#147;approved enterprise&#148;, &#147;benefitted enterprise&#148; or &#147;preferred enterprise&#148; status. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> The Company is not and has never been a real property corporation (<I>Igud Mekarke&#146;in</I>) within the meaning Section&nbsp;1
of the Israeli Land Taxation Law (Appreciation and Acquisition), 5723-1963. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_27"></A>2.14 Employee Benefit
Programs</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <I>Section 2.14(a)</I> of the Company Disclosure Schedule sets forth a complete and accurate list of every
material Employee Program maintained by Company or any Subsidiary or with respect to which the Company or any Subsidiary has or may have any Liability (the &#147;<B>Company Employee Programs</B>&#148;), except for any Contract for the employment of
any employee or engagement of any independent contractor that provides (i)&nbsp;base salary or fee at or below the amount of $200,000 on an annual basis, and&nbsp;(ii) any severance, retention bonus, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control</FONT></FONT> or similar type payment at or below the amount of $100,000 per employee. The Company does not have any ERISA Affiliate that maintains an Employee Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> True, complete and correct copies of the following documents, with respect to each Company Employee Program, where applicable,
have previously been provided to Radiant: (i)&nbsp;all documents embodying or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
governing such Company Employee Program and any funding medium for the Company Employee Program; (ii)&nbsp;the most recent IRS determination or opinion letter; (iii)&nbsp;the most recently filed
IRS Form 5500; (iv) the most recent actuarial valuation report; (v)&nbsp;the most recent summary plan description (or other descriptions provided to employees) and all modifications thereto; and (vi)&nbsp;all
<FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence to and from any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Each Company
Employee Program that is intended to qualify under Section&nbsp;401(a) of the Code has received a favorable determination or approval letter from the IRS with respect to such qualification, or may rely on an opinion letter issued by the IRS with
respect to a prototype plan adopted in accordance with the requirements for such reliance. To the Knowledge of the Company, no event or omission has occurred with respect to the operation of any Company Employee Program that would reasonably be
expected to cause such Company Employee Program to lose its <FONT STYLE="white-space:nowrap">tax-qualification</FONT> or the <FONT STYLE="white-space:nowrap">tax-exempt</FONT> status of its accompanying trust under Code Sections 401(a) and 501(a),
respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.14(d)</I> of the Company Disclosure Schedule, to the
Knowledge of the Company, there is no material failure of any party to comply with any Laws applicable with respect to the Company Employee Programs. Except as would not, individually or in the aggregate, be material, with respect to any Company
Employee Program, there has been no (i) &#147;prohibited transaction,&#148; as defined in Section&nbsp;406 of ERISA or Code Section&nbsp;4975, which is not otherwise exempt, (ii)&nbsp;failure to operate and administer the Company Employee Programs
in accordance with their respective terms and in compliance with ERISA and other applicable Laws, or <FONT STYLE="white-space:nowrap">(iii)&nbsp;non-deductible</FONT> contribution. No litigation or governmental administrative proceeding (or
investigation) or other proceeding (other than those relating to routine claims for benefits) is pending or, to the Knowledge of the Company, threatened with respect to any such Company Employee Program. All payments and/or contributions required to
have been made with respect to all Company Employee Programs, for all periods prior to the Closing Date, either have been made or have been accrued in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Neither the Company nor any ERISA Affiliate of the Company has maintained an Employee Program subject to Title IV of ERISA,
including a Multiemployer Plan, in the six (6)&nbsp;years prior to the Closing Date. None of the Company Employee Programs provides or represents an obligation to provide health care or any other <FONT STYLE="white-space:nowrap">non-pension</FONT>
benefits to any employees after their employment is terminated (other than as required by part 6 of subtitle B of title I of ERISA or state continuation Laws). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Except as provided on <I>Section</I><I></I><I>&nbsp;2.14(f) </I>of the Company Disclosure Schedule, none of the Company or any of
its Subsidiaries is a party to any (i)&nbsp;agreement with any shareholder, director, employee or other service provider of the Company or any of its Subsidiaries (A)&nbsp;the benefits of which are contingent, or the terms of which are materially
altered, upon the occurrence of a transaction involving the Company or any of its Subsidiaries of the nature of any of the Contemplated Transactions (either alone or in conjunction with any other event), including, without limitation, the increase
in any payments, the forgiveness of any Indebtedness, the obligation to fund future benefits under any Company Employee Program or the requirement to pay any tax gross up payments, (B)&nbsp;providing any guaranteed period of employment or
compensation guarantee, or (C)&nbsp;providing severance benefits; or (ii)&nbsp;agreement or plan binding the Company or any of its Subsidiaries, including any stock option plan, stock appreciation right plan, restricted stock plan, stock purchase
plan, or severance benefit plan, any of the benefits of which shall be increased, or the vesting of the benefits of which shall be accelerated, by the occurrence of any of the Contemplated Transactions (either alone or in conjunction with any other
event) or the value of any of the benefits of which shall be calculated on the basis of any of the Contemplated Transactions. There is no contract, agreement, plan or arrangement covering any individual that, by itself or collectively, would give
rise to any parachute payment subject to Section&nbsp;280G of the Code, nor has Company made any such payment, and the consummation of the transactions contemplated herein shall not, individually or together with any other event or occurrence,
obligate Company or any other entity to make any parachute payment that would be subject to Section&nbsp;280G of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>
Each Company Employee Program that is a &#147;nonqualified deferred compensation plan&#148; within the meaning of Section&nbsp;409A of the Code is in documentary compliance and has been operated and maintained in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compliance with Section&nbsp;409A of the Code in all material respects. Neither the Company nor any Subsidiary is under any obligation to gross up any Taxes under Section&nbsp;409A of the Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> For purposes of this <I>Section</I><I></I><I>&nbsp;2.14</I>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> An entity &#147;maintains&#148; an Employee Program if such entity sponsors, contributes to, or provides benefits under or through
such Employee Program, or has any obligation (by agreement or under applicable Laws) to contribute to or provide benefits under or through such Employee Program, or if such Employee Program provides benefits to or otherwise covers current or former
employees or other service providers of such entity (or their spouses, dependents, or beneficiaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> An entity is an
&#147;<B>ERISA Affiliate</B>&#148; of Company if it would have ever been considered a single employer with Company under ERISA Section&nbsp;4001(b) or Section&nbsp;414 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> Each of the Company share incentive plans that are intended to qualify as a capital gains route plan under
Section&nbsp;102(b)(2) or 102(b)(3) of the Ordinance (a &#147;<B>102 Plan</B>&#148;) has received a favorable determination or approval letter from, or is otherwise approved by, or deemed approved by passage of time without objection by, the ITA.
Except as set forth in <I>Section</I><I></I><I>&nbsp;2.14(h)</I> of the Company Disclosure Schedule, all Company 102 Options and Company 102 Shares which were issued under any 102 Plan were and are currently in compliance with the applicable
requirements of Section&nbsp;102 (including the relevant <FONT STYLE="white-space:nowrap">sub-section</FONT> of Section&nbsp;102) and the written requirements and guidance of the ITA, including the filing of the necessary documents with the ITA, the
grant thereof only following the lapse of the required 30 day period from the filing of the 102 Plan with the ITA, the receipt of the required written consents from the option holders, the appointment of an authorized trustee, and the due deposit of
such Company 102 Options and Company 102 Shares with such trustee pursuant to the terms of Section&nbsp;102 of the Ordinance, and applicable regulations and rules and the guidance published by the ITA on July&nbsp;24, 2012 and clarification dated
November&nbsp;6, 2012, as applicable. The Company has complied with the requirements of Section&nbsp;3(i) of the Ordinance with respect to grants to independent Israeli contractors or &#147;Controlling Shareholders&#148; (as defined in the
Ordinance). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_28"></A>2.15 Labor and Employment Matters</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.15(a)</I> of the Company Disclosure Schedule, neither the Company (other
than with respect to Extension Orders) nor any of its Subsidiaries is a party to, or otherwise bound by, any collective bargaining agreement, contract, or other written agreement with a labor union or labor organization. To the Knowledge of the
Company, neither the Company (other than with respect to Extension Orders) nor any of its Subsidiaries is subject to, and during the past four (4)&nbsp;years there has not been, any charge, demand, petition, organizational campaign, or
representation proceeding seeking to compel, require, or demand it to bargain with any labor union or labor organization, including any threatened to be brought or filed, with the Israeli National Labor Relations Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.15(b)</I> of the Company Disclosure Schedule and except as would not,
individually or in the aggregate, be material, (i)&nbsp;to the Knowledge of the Company, the Company or any of its Subsidiaries are in compliance in all material respects, and has been for the past four (4)&nbsp;years, with all applicable Laws
respecting labor, employment, fair employment practices, work safety and health, terms and conditions of employment, immigration, and wages and hours and equal pay, (ii)&nbsp;neither the Company or any of its Subsidiaries is delinquent in any
payments to any employee or to any independent contractors, consultants, temporary employees, leased employees or other individual agents who personally provide services to the Company during most of such individual agent&#146;s working time,
employed or used with respect to the operation of the Company Business and classified by the Company or any of its Subsidiaries as other than an employee or compensated other than through wages paid by the Company or any of its Subsidiaries through
its respective payroll department (&#147;<B>Company Contingent Workers</B>&#148;), for any compensation due with respect to any services performed for it to the date of this Agreement or amounts required to be reimbursed to such employees or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company Contingent Workers; (iii)&nbsp;there are, and for the past four (4)&nbsp;years there have been, no outstanding grievances, complaints or charges with respect to employment or labor
matters pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries in any judicial, regulatory or administrative forum, under any private dispute resolution procedure, including, without limitation, any
claim relating to unfair labor practices, employment discrimination, harassment, retaliation, unpaid wages, or equal pay; (iv)&nbsp;none of the employment policies or practices of the Company or any of its Subsidiaries is currently being, or has
been in the past four (4)&nbsp;years, audited or investigated, or to the Knowledge of the Company, subject to imminent audit or investigation by any Governmental Authority; (v)&nbsp;none of the Company or any of its Subsidiaries is, or within the
last four (4)&nbsp;years has been, subject to any Order by any Governmental Authority or private settlement contract in respect of any labor or employment matters; (vi)&nbsp;to the extent that any Company Contingent Workers are employed, to the
Knowledge of the Company, each of the Company or any of its Subsidiaries has properly classified and treated them in accordance with applicable Laws and for purposes of all employee benefit plans and perquisites; (vii)&nbsp;the Company and its
Subsidiaries have properly classified their respective U.S. employees as exempt or <FONT STYLE="white-space:nowrap">non-exempt</FONT> under the Fair Labor Standards Act, as amended, and its state law equivalents, including the California Labor Code,
and all other relevant Laws; and (viii)&nbsp;there are no pending or, to the Knowledge of the Company, threatened or reasonably anticipated claims or actions against the Company or its Subsidiaries under any workers&#146; compensation policy or
long-term disability policy. None of the Company or any of its Subsidiaries has experienced a &#147;plant closing,&#148; &#147;business closing,&#148; or &#147;mass layoff&#148; as defined in the federal Worker Adjustment and Retraining Notification
Act of 1988 or similar state, local and foreign laws relating to plant closings, relocations, mass layoffs or employment losses (the &#147;<B>WARN Act</B>&#148;), and, during the ninety <FONT STYLE="white-space:nowrap">(90)-day</FONT> period
preceding the date of this Agreement, no employee has suffered an &#147;employment loss,&#148; as defined in the WARN Act, with respect to the Company or any of its Subsidiaries. Except for Extension Orders the Company nor any of its Subsidiaries is
a party to, or otherwise bound by, any consent decree with, or citation by, any Governmental Authority relating to employees or employment practices. All employees are employed on an <FONT STYLE="white-space:nowrap">at-will</FONT> basis (insofar as
such employment practice is legally recognized under applicable Law) unless otherwise set forth in <I>Section</I><I></I><I>&nbsp;2.15(b) </I>of the Company Disclosure Schedule. The Company and its Subsidiaries are in compliance with the requirements
of the Immigration Reform Control Act of 1986 and have a completed and accurate copy of U.S. Citizenship and Immigration Services Form <FONT STYLE="white-space:nowrap">I-9</FONT> for each employee of the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <I>Section 2.15(c) </I>of the Company Disclosure Schedule contains a complete and accurate list of all employees of the Company
and its Subsidiaries as of the date of this Agreement, setting forth for each employee his or her position or title, the annual base salary, date of hire, business location, bonus, retention, and other incentive or contingent compensation amounts to
be due and payable to such employee at the Closing and, with respect to employees of the Company who work in Israel (&#147;<B>Israeli Employees</B>&#148;), a description of social benefits to which the Israeli Employee is currently entitled,
including, if applicable, managers insurance, pension funds and education funds (<I>kranot hishtalmut</I>). <I>Section</I><I></I><I>&nbsp;2.15(c) </I>of the Company Disclosure Schedule also contains a complete and accurate list of all current
Company Contingent Workers, showing for each Company Contingent Worker such individual&#146;s role in the Company Business, and fee or compensation arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;2.15(d)</I> of the Company Disclosure Schedule, to the Knowledge of the
Company, during the year prior to the date hereof (i)&nbsp;no allegations of discrimination, harassment, or hostile work environment based on sex have been made against (A)&nbsp;any officer or director of the Company, (B)&nbsp;any employee of the
Company or its Subsidiaries at the level of Vice President or above, or (C)&nbsp;any employee of the Company who, directly or indirectly, supervises at least three (3)&nbsp;other employees; and (ii)&nbsp;the Company has not entered into any
settlement related to allegations of discrimination, harassment, or hostile work environment by an employee, director, officer, or Company Contingent Worker. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Without limiting the generality of any other representation herein, and except as set forth <I>in
Section</I><I></I><I>&nbsp;2.15(e)</I> of the Company Disclosure Schedule, with respect to each Israeli Employee: (i)&nbsp;the employment of such Israeli Employee is terminable by the Company upon no more than 30 days prior written notice under the
termination notice provisions included in the applicable employment Contract with such Israeli Employee or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable Law; (ii)&nbsp;all obligations of the Company to provide statutory severance pay to such Israeli Employee are in accordance with Section&nbsp;14 of the Israeli Severance Pay Law
(5723-1963) (the &#147;<B>Severance Pay Law</B>&#148;) and are fully funded (except for funding to be made in the ordinary course for the working month during which this Agreement was executed, or the Closing occurs, as applicable) or are accrued on
the Company Financial Statements, and all Israeli Employees have been subject to the provisions of Section&nbsp;14 of the Severance Pay Law with respect to their entire salary, as defined under the Severance Pay Law from the date of commencement of
their employment with the Company, and the Company has been in full compliance with the requirements of a Section&nbsp;14 Arrangement with respect to severance pay with respect to the full amount of such salary for which severance pay is due under
the Severance Pay Law; (iii)&nbsp;no Israeli Employee&#146;s employment by the Company, which requires any special license, permit or other authorization for the engagement or for the termination of such employment by any Governmental Authority is
carried out without such special license, permit or other authorization; (iv)&nbsp;there are no unwritten policies, practices or customs of the Company that entitle any Israeli Employee to benefits in addition to what such Israeli Employee is
entitled to by applicable Law or under the terms of such Israeli Employee&#146;s employment contract (including unwritten customs or practices concerning bonuses, the payment of statutory severance pay even when not required under applicable Law,
etc.); (v) all amounts that the Company or a Subsidiary of it that is an Israeli entity is legally or contractually required either (A)&nbsp;to deduct from such Israeli Employee&#146;s salary or to transfer to such Israeli Employee&#146;s pension or
provident, life insurance, incapacity insurance, advance study fund (<I>Keren Hishtalmut</I>) or other similar funds or (B)&nbsp;to withhold from such Israeli Employee&#146;s salary and benefits and to pay to any Israeli Governmental Authority as
required by applicable Israeli Tax Law, have, in each case, been duly deducted, transferred, withheld and paid, and the Company has no outstanding obligation to make any such deduction, transfer, withholding or payment (except for deduction,
transfer, withholding and payments to be made in the ordinary course after the date of this Agreement or after the Closing, as applicable, for the working month during which this Agreement was executed, or the Closing occurs, as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_29"></A>2.16 Environmental Matters</B>. Except as has not, would not and would not reasonably be expected to,
individually or in the aggregate, have a Company Material Adverse Effect: (a)&nbsp;the Company and its Subsidiaries are in compliance with all Environmental Laws applicable to their operations and use of the Company Leased Real Property;
(b)&nbsp;none of the Company or any of its Subsidiaries has generated, transported, treated, stored, or disposed of any Hazardous Material, except in material compliance with all applicable Environmental Laws, and there has been no Release or threat
of Release of any Hazardous Material by the Company or its Subsidiaries at or on the Company Leased Real Property that requires reporting, investigation or remediation by the Company or its Subsidiaries pursuant to any Environmental Law;
(c)&nbsp;none of the Company or any of its Subsidiaries has (i)&nbsp;received written notice under the citizen suit provisions of any Environmental Law or (ii)&nbsp;been subject to or, to the Knowledge of the Company, threatened with any
governmental or citizen enforcement action with respect to any Environmental Law; and (d)&nbsp;to the Knowledge of the Company, there are no underground storage tanks, landfills, current or former waste disposal areas or polychlorinated biphenyls at
or on the Company Leased Real Property that require reporting, investigation, cleanup, remediation or any other type of response action by the Company or its Subsidiaries pursuant to any Environmental Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_30"></A>2.17 Insurance</B>. <I>Section</I><I></I><I>&nbsp;2.17 </I>of the Company Disclosure Schedule lists each
insurance policy maintained by or on behalf of the Company and its Material Subsidiaries with respect to its and their properties, assets and business, together with a claims history for the past year.<SUP STYLE="font-size:85%; vertical-align:top">
</SUP>All of such insurance policies are in full force and effect, all premiums due and payable with respect to such insurance policies have been paid to date, and neither the Company nor any of its Subsidiaries has ever been (a)&nbsp;in default
with respect to its Liabilities under any such insurance policies or (b)&nbsp;denied insurance coverage. Except as set forth on <I>Section</I><I></I><I>&nbsp;2.17 </I>of the Company Disclosure Schedule, the Company does not have and has had no
self-insurance or <FONT STYLE="white-space:nowrap">co-insurance</FONT> program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_31"></A>2.18 Government
Programs</B>. No agreements, loans, funding arrangements or assistance programs are outstanding in favor of the Company or any of its Subsidiaries from any Governmental Authority, and, to the Knowledge of the Company, no basis exists for any
Governmental Authority to seek payment or repayment from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company or any of its Subsidiaries of any amount or benefit received, or to seek performance of any obligation of the Company or any of its Subsidiaries, under any such program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_32"></A>2.19 Transactions with Affiliates</B>. <I>Section</I><I></I><I>&nbsp;2.19</I> of the Company Disclosure
Schedule describes any material transactions or relationships since January&nbsp;1, 2016, between, on one hand, the Company or any of its Material Subsidiaries and, on the other hand, any (a)&nbsp;executive officer or director of the Company or any
of its Material Subsidiaries or any of such executive officer&#146;s or director&#146;s immediate family members, (b)&nbsp;owner of more than five percent (5%) of the voting power of the outstanding capital stock of the Company, (c)&nbsp;any
investment funds that are affiliated with such executive officer or director or (d)&nbsp;to the Knowledge of the Company, any &#147;related person&#148; (within the meaning of Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under
the Securities Act) of any such officer, director or owner (other than the Company or its Subsidiaries) in each of the case of (a), (b) or (c)&nbsp;that is of the type that would be required to be disclosed under Item 404 of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. The Company or its Material Subsidiaries are not indebted to any director, officer or employee of the Company (except for amounts due as salaries and bonuses, other amounts due under
employment agreements, retention agreements or employee benefit plans and amounts payable in reimbursement of expenses), and no such director, officer or employee is indebted to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_33"></A>2.20 Legal Proceedings; Orders</B>. Except as set forth on <I>Section</I><I></I><I>&nbsp;2.20</I> of the
Company Disclosure Schedule, there is not pending any material Legal Proceeding, and (to the Knowledge of the Company) no Person has threatened to commence any Legal Proceeding: (a)&nbsp;that involves the Company or any Subsidiary of the Company,
any director or officer of the Company (in his or her capacity as such) or any of the material assets owned or used by the Company and/or any Subsidiary; or (b)&nbsp;that challenges, or that may have the effect of preventing, delaying, making
illegal or otherwise interfering with, the Merger or any of the other Contemplated Transactions, in each case, except for any such Legal Proceedings that would not have, or reasonably be expected to have, a Company Material Adverse Effect. Other
than with respect to the applicable Extension Orders, there is no Order to which the Company or any Subsidiary of the Company, or any of the material assets owned or used by the Company or any Subsidiary of the Company, is subject. To the Knowledge
of the Company, no officer or other Key Employee of the Company or any Subsidiary of the Company is subject to any Order that prohibits such officer or other employee from engaging in or continuing any conduct, activity or practice relating to the
Company Business or to any material assets owned or used by the Company or any Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_34"></A>2.21 Anticorruption and Anti-Bribery Laws</B>. Neither the Company nor any of its Subsidiaries (including
any of their respective employees, officers or directors) or, to the Knowledge of the Company, any third party acting on behalf of the Company or any of its Subsidiaries, has taken or failed to take during the past three (3)&nbsp;years any action
that would cause it to be in violation of the Foreign Corrupt Practices Act of 1977, as amended, Title 5 of the Israeli Penalty Law (Bribery Transactions), the Israeli Prohibition on Money Laundering Law, 2000, the Israeli Public Service Law (Gifts)
&#150; 1979, or any other applicable <FONT STYLE="white-space:nowrap">anti-corruption</FONT> or anti-kickback law or regulation, including without limitation: (a)&nbsp;the making of any offer or promise to pay, payment of, or authorization of
payment of, directly or indirectly, money or anything of value to any foreign government official (including appointed or elected officials, government employees, political parties, party officials, candidates for political office, and any officer,
director or employee of any government entity), for the purpose of corruptly influencing an act or decision, inducing the doing or omission of any act in violation of a lawful duty, or securing an improper advantage, or the receipt of a corrupt
payment or of anything of value under such circumstances; (b)&nbsp;use of any corporate funds for any illegal contributions, gifts, entertainment or other unlawful expenses relating to political activity; (c)&nbsp;establishment or maintenance of any
unlawful fund of corporate monies or other properties; or (d)&nbsp;making of any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment of any nature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_35"></A>2.22 Warranty and Related Matters</B><B>; Product Liability</B>. The Company has made available to Radiant
correct and complete copies of the Company&#146;s standard written warranty or warranties for sales in the last three (3)&nbsp;years for any and all the Company Products. Except as set forth on <I>Section</I><I></I><I>&nbsp;2.22 </I>of the Company
Disclosure Schedule, neither the Company nor any of its Subsidiaries has received any Warranty Claims. Except </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as disclosed on <I>Section</I><I></I><I>&nbsp;2.22 </I>of the Company Disclosure Schedule, and any Warranty Claims in the Ordinary Course of Business, the Company Products conform in all material
respects to applicable product specifications, warranties and contractual commitments, and there are no material Product Liability Claims with respect to any Company Product. To the Knowledge of the Company, there is no reasonable basis for any
present or future material Product Liability Claim against any of the Company or its Subsidiaries which could give rise to any material liability. No product prepared or manufactured by the Company or its Subsidiaries is or has been subject to any
voluntary or involuntary market withdrawal or product recall during the past three (3)&nbsp;years and, to the Knowledge of the Company, no facts or circumstances exist that would reasonably be expected to result in a recall of products already
manufactured by the Company or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_36"></A>2.23 Inapplicability of Anti-takeover Statutes</B>. No
takeover statute or similar Law applies or purports to apply to the Merger, this Agreement, or any of the other Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_37"></A>2.24 Vote Required</B>. The affirmative vote (or action by written consent) of (a)&nbsp;the holders of a
majority of the Company Ordinary Shares and Company Preferred Shares, voting together as a single class (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Company Ordinary Shares basis), and (b)&nbsp;the holders of at least 67% of the
outstanding shares of the Company Preferred Shares (other than the outstanding <FONT STYLE="white-space:nowrap">non-voting</FONT> shares of the Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Shares), voting together as a single class
(on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Company Ordinary Shares basis), and (c)&nbsp;the holders of majority of each class of Preferred Shares (other than the outstanding <FONT STYLE="white-space:nowrap">non-voting</FONT>
shares of the Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Shares), in each case as outstanding on the record date for the Company Shareholder Meeting and entitled to vote thereon (the &#147;<B>Company Shareholder
Approval</B>&#148;), is necessary to adopt or approve this Agreement, and approve the Merger, the Contemplated Transactions and the other matters set forth in <I>Section</I><I></I><I>&nbsp;5.2(a)</I> of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_38"></A>2.25 No Financial Advisor</B>. Except as set forth in <I>Section</I><I></I><I>&nbsp;2.25</I> of the Company
Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder&#146;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated
Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_39"></A>2.26 Financing Consent Letters</B>. The Company has delivered to Radiant and Merger Sub executed copies of
the Financing Consent Letters. The Financing Consent Letters, in the form so delivered to Radiant and Merger Sub, are in full force and effect and are legal, valid and binding obligations of the Company. The only conditions precedent or other
contingencies related to the obligations of the parties to the Financing Consent Letters to provide the consents set forth therein are those expressly set forth in the Financing Consent Letters. As of the date of this Agreement, the Company has no
reason to believe that it will be unable to satisfy on a timely basis any term or condition of the Financing Consent Letters required to be satisfied by the Company and within its control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_40"></A>2.27 No Other Representations or Warranties; Disclaimer of Other Representations and Warranties</B>. The
Company acknowledges and agrees that, except for the representations and warranties expressly set forth in this Agreement and the Radiant Disclosure Schedule (a)&nbsp;each of Radiant and Merger Sub is not making and has not made any representations
or warranties relating to itself or its business or otherwise in connection with the transactions contemplated by this Agreement, including the Merger, and any such other representations and warranties are hereby expressly disclaimed, and none of
the Company or its Representatives is relying on any representation or warranty of Radiant or Merger Sub except for those expressly set forth in this Agreement and the Radiant Disclosure Schedule and (b)&nbsp;any estimates, projections, predictions,
data, financial information, memoranda, presentations or any other materials or information provided or addressed to the Company or any of its Representatives are not and shall not be deemed to be or include representations or warranties unless any
such materials or information are the subject of any express representation or warranty set forth in this Agreement or the Radiant Disclosure Schedule. Notwithstanding the foregoing, nothing herein shall be deemed to apply to or limit in any way,
the Company&#146;s rights and remedies in the case of fraud. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_41"></A>Section&nbsp;3. REPRESENTATIONS AND WARRANTIES OF RADIANT
AND MERGER SUB </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Radiant and Merger Sub represent and warrant to the Company as follows, except (i)&nbsp;as set forth in the written disclosure
schedule delivered by Radiant to the Company (the &#147;<B>Radiant Disclosure Schedule</B>&#148;) and (ii)&nbsp;as otherwise disclosed or identified in the Radiant SEC Reports filed with the SEC and publicly available prior to the date hereof,
without giving effect to any amendment to any such Radiant SEC report filed on or after the date hereof (other than any forward-looking disclosures contained in the &#147;Forward Looking Statements&#148; and &#147;Risk Factors&#148; sections of such
Radiant SEC Reports and any other disclosures included therein to the extent they are primarily predictive, cautionary or forward looking in nature). The Radiant Disclosure Schedule shall be arranged in parts and subparts corresponding to the
numbered and lettered sections and subsections contained in this <I>Section</I><I></I><I>&nbsp;3</I>. The disclosures in any part or subpart of the Radiant Disclosure Schedule shall qualify other Sections and subsections in this
<I>Section</I><I></I><I>&nbsp;3</I> only to the extent it is reasonably apparent from the face of the disclosure that such disclosure is applicable to such other Sections and subsections herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_42"></A>3.1 Organization</B>. Radiant is a corporation, duly organized, validly existing and in good corporate
standing under the Laws of the State of Delaware and each of Radiant&#146;s Subsidiaries is a corporation or legal entity validly existing and, if applicable, in good standing under the Laws of the jurisdiction of its organization. Radiant and each
of its Subsidiaries have all requisite corporate power and authority to own, lease and operate all of its properties and assets and to carry on its business as it is now being conducted. Radiant and each of its Subsidiaries are duly licensed or
qualified to do business and, to the extent applicable, is in corporate good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned, leased, or operated by it
makes such licensing or qualification necessary, except where the failure to be so licensed or qualified and, to the extent applicable, in corporate good standing would not, either individually or in the aggregate, reasonably be expected to have a
Radiant Material Adverse Effect. Merger Sub is a private company duly incorporated and validly existing under the Laws of Israel and is not a &#147;defaulting company&#148; as defined under the ICL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_43"></A><B>3.2 Capitalization</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> As of the date of this Agreement, the authorized capital stock of Radiant consists of 300,000,000 shares of Radiant Common Stock
and 10,000,000 shares of Radiant Preferred Stock. As of March&nbsp;11, 2019, there were 40,767,012 shares of Radiant Common Stock issued and outstanding and no shares of Radiant Preferred Stock issued and outstanding. As of the date of this
Agreement, there are no shares of Radiant Common Stock and no shares of Radiant Preferred Stock held in the treasury of Radiant. Radiant has no Radiant Common Stock or Radiant Preferred Stock reserved for issuance other than as described above and
in <I>Section</I><I></I><I>&nbsp;3.2(b)</I> and <I>Section</I><I></I><I>&nbsp;3.2(d)</I>. The outstanding shares of Radiant Common Stock have been duly authorized, validly issued, fully paid and nonassessable, and were not issued in violation of the
material terms of any agreement or understanding binding upon Radiant at the time at which they were issued and were issued in compliance with the Radiant Charter and Radiant Bylaws in effect upon such issuance and in accordance with all applicable
Laws. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.2(a) </I>of the Radiant Disclosure Schedule, Radiant does not have and is not bound by any outstanding subscriptions, options, warrants, calls, commitments, rights agreements, or
agreements of any character calling for Radiant to issue, deliver, or sell, or cause to be issued, delivered, or sold any shares of Radiant Common Stock or any other equity security of Radiant or any Subsidiary of Radiant or any securities
convertible into, exchangeable for, or representing the right to subscribe for, purchase, or otherwise receive any shares of Radiant Common Stock or any other equity security of Radiant or any Subsidiary of Radiant or obligating Radiant or any such
Subsidiary to grant, extend, or enter into any such subscriptions, options, warrants, calls, commitments, rights agreements, or any other similar agreements. There are no registration rights, repurchase or redemption rights, anti-dilution rights,
voting agreements, voting trusts, preemptive rights or contractual restrictions on transfer relating to any capital stock of Radiant. Other than the Radiant Charter and Radiant Bylaws and as set forth in <I>Section</I><I></I><I>&nbsp;3.2(a) </I>of
the Radiant Disclosure Schedule, Radiant is not a party to or bound by or subject to any shareholder agreement or other agreement governing the relationships, rights and obligations of Radiant&#146;s shareholders and is not subject to a shareholder
rights plan or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar plan. As of March&nbsp;11, 2019, there were 6,323,754 shares of Radiant Common Stock authorized for issuance under the Radiant Stock Option Plans, of which: (i) 3,975,649 shares of
Radiant Common Stock are issuable upon exercise of all outstanding Radiant Stock Options, subject to adjustment on the terms set forth in the Radiant Stock Option Plans, (ii) 2,078,105 shares of Radiant Common Stock remain available for issuance
under the Radiant Stock Option Plans, and (iii) 270,000 shares of Radiant Common Stock are issuable pursuant to restricted stock awards. Since March&nbsp;11, 2019, Radiant has not issued any shares of its capital stock or other equity securities, or
securities convertible into or exchangeable for such capital stock or other equity securities, other than those shares of capital stock reserved for issuance described in this <I>Section</I><I></I><I>&nbsp;3.2(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <I>Section 3.2(a)</I> of the Radiant Disclosure Schedule sets forth a true, correct and complete list, as of the date of this
Agreement, of (i)&nbsp;the name of the holder of each Radiant Stock Option, (ii)&nbsp;the date each Radiant Stock Option was granted, (iii)&nbsp;the number and type of securities subject to each such Radiant Stock Option and the Radiant Stock Option
Plan pursuant to which such option was issued, (iv)&nbsp;the expiration date of each such Radiant Stock Option, (v)&nbsp;number of vested Radiant Stock Options, (vi)&nbsp;the price at which each such Radiant Stock Option (or each component thereof,
if applicable) may be exercised, (vii)&nbsp;the number of shares of Radiant Common Stock issuable upon the exercise of such, or upon the conversion of all securities issuable upon the exercise of such, Radiant Stock Options and (viii)&nbsp;the
vesting schedule of each Radiant Stock Option. To the Knowledge of Radiant, each grant of a Radiant Stock Option was duly authorized by all necessary corporate action, including, as applicable, approval by the Board of Directors of Radiant (or a
duly constituted and authorized committee thereof) and any required shareholder approval by the necessary number of votes or written consents, and to the Knowledge of Radiant the award agreement governing such grant (if any) was executed and
delivered by each party thereto. Except as disclosed in <I>Section</I><I></I><I>&nbsp;3.2(a)</I> of the Radiant Disclosure Schedule, Radiant does not have any outstanding restricted stock or restricted stock units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> As of the date of this Agreement, there are no shares of Radiant&#146;s or any of its Subsidiaries&#146; capital stock outstanding
subject to any vesting schedule or subject to a repurchase option or risk of forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> As of March&nbsp;11, 2019, there
were 272,211 shares of Radiant Common Stock and no shares of Radiant Preferred Stock issuable upon exercise of all outstanding Radiant Warrants. <I>Section</I><I></I><I>&nbsp;3.2(d) </I>of the Radiant Disclosure Schedule sets forth a true, correct
and complete list, as of March&nbsp;11, 2019, of (i)&nbsp;the name of the holder of each Radiant Warrant, (ii)&nbsp;the date each Radiant Warrant was issued, (iii)&nbsp;the number and type of securities subject to each Radiant Warrant, (iv)&nbsp;the
price at which each Radiant Warrant (or each component thereof, if applicable) may be exercised, (v)&nbsp;the number of shares of Radiant Common Stock and Radiant Preferred Stock issuable upon the exercise of such Radiant Warrant and
(vi)&nbsp;whether any consent of the holders of Radiant Warrants shall be required to exercise or cancel such Radiant Warrants prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <I>Section 3.2(e)</I> of the Radiant Disclosure Schedule lists each Subsidiary of Radiant, as of the date of this Agreement and
indicates for each such Subsidiary as of such date (i)&nbsp;the percentage and type of equity securities owned or controlled, directly or indirectly, by Radiant and (ii)&nbsp;the jurisdiction of incorporation or organization. No Subsidiary of
Radiant has or is bound by any outstanding subscriptions, options, warrants, calls, commitments, rights agreements, or agreements of any character calling for it to issue, deliver, or sell, or cause to be issued, delivered, or sold any of its equity
securities or any securities convertible into, exchangeable for, or representing the right to subscribe for, purchase or otherwise receive any such equity security or obligating such Subsidiary to grant, extend or enter into any such subscriptions,
options, warrants, calls, commitments, rights agreements, or other similar agreements. There are no outstanding contractual obligations of any Subsidiary of Radiant to repurchase, redeem, or otherwise acquire any of its capital stock or other equity
interests. All of the shares of capital stock of each of the Subsidiaries of Radiant (i)&nbsp;have been duly authorized and are validly issued, fully paid (to the extent required under the applicable governing documents) and nonassessable,
(ii)&nbsp;are owned by Radiant free and clear of any claim, lien, Encumbrance (other than Permitted Encumbrances), or agreement with respect thereto, (iii)&nbsp;were not issued in violation of the material terms of any agreement or understanding
binding upon Radiant or any of its Subsidiaries at the time at which they were issued and (iv)&nbsp;were issued in compliance with the applicable governing documents and all applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> The Radiant Common Stock to be issued in the Merger will, when issued in
accordance with the provisions of this Agreement, have been duly authorized, and be validly issued, fully paid and nonassessable. Merger Sub was formed solely for the purpose of engaging in the Contemplated Transactions. All of the issued and
outstanding share capital of Merger Sub, which consists of 1,000,000 ordinary shares, with a nominal value of NIS 0.01, is validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and is owned, beneficially and of
record, by Radiant, free and clear of any claim, lien, Encumbrance, or agreement with respect thereto. Except for obligations and liabilities incurred in connection with its incorporation and the Contemplated Transactions, Merger Sub has not, and
will not have, incurred, directly or indirectly, any obligations or liabilities or engaged in any business activities of any type or kind whatsoever or entered into any agreements or arrangements with any Person. As of the date of this Agreement,
the copy of the Articles of Association of Merger Sub which has previously been made available to the Company is a true, correct and complete copy of such Articles of Association as currently in effect and Merger Sub is not in violation of any
provision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_44"></A><B>3.3 Authority</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Each of Radiant and Merger Sub has full corporate power and authority to execute and deliver this Agreement and to consummate the
transactions contemplated hereunder and to perform its obligations hereunder. The Board of Directors of Radiant (i)&nbsp;has determined that the Merger is advisable, fair and in the best interests of Radiant and its shareholders, (ii)&nbsp;has
approved this Agreement, the Merger and the Contemplated Transactions and has deemed this Agreement advisable, fair and in the best interests of Radiant and its shareholders, (iii)&nbsp;has approved and determined to recommend the approval and
adoption of this Agreement and the approval of the Merger to the shareholders of Radiant, and (iv)&nbsp;has duly authorized the execution and delivery of this Agreement and the Ancillary Agreements to which it is a party and the consummation of the
transactions contemplated hereby and thereby. Except as explicitly provided in this Agreement, no other proceedings on the part of Radiant are necessary to approve and authorize the execution and delivery of this Agreement and the Ancillary
Agreements to which it is a party and the consummation of the Merger and the Contemplated Transactions, other than the Radiant Shareholder Approval and the adoption of this Agreement by Radiant in its capacity as the sole shareholder of Merger Sub.
This Agreement and each Ancillary Agreement to which it is a party has been duly executed and delivered by Radiant, and, assuming the due authorization, execution and delivery by the Company, this Agreement and the Ancillary Agreements constitute a
valid and binding obligation of Radiant, enforceable against Radiant in accordance with their respective terms, subject to: (1)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (2)&nbsp;rules of Law
governing specific performance, injunctive relief and other equitable remedies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Board of Directors of Merger Sub
(i)&nbsp;has determined that the Merger is advisable, fair and in the best interests of Merger Sub and its sole shareholder, (ii)&nbsp;has approved this Agreement, the Merger, and the Contemplated Transactions and has deemed this Agreement
advisable, fair and in the best interests of Merger Sub and its sole shareholder, (iii)&nbsp;has determined that, considering the financial conditions of the merging companies, no reasonable concern exists that the Surviving Company (as defined
below) will be unable to fulfill the obligations of the Company or Merger Sub, as applicable, to its creditors, and (iv)&nbsp;has determined to recommend that the sole shareholder of Merger Sub vote to approve the Merger and such other actions as
contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_45"></A><B>3.4 <FONT STYLE="white-space:nowrap">Non-Contravention;</FONT>
Consents</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The execution, delivery and performance by Radiant of this Agreement and the Ancillary Agreements and the
performance by Radiant of the transactions contemplated by this Agreement and the Ancillary Agreements do not and will not: (i)&nbsp;violate or result in a violation of, conflict with or constitute or result in a material default (whether after the
giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any Radiant Material Contract, permit, license or authorization to which Radiant is a party or by which its assets are bound,
(ii)&nbsp;violate or result in a violation of, conflict with or constitute or result in a default (whether after the giving of notice, lapse of time or both) under, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or accelerate any obligation under, any provision of Radiant&#146;s or its Subsidiaries&#146; organizational documents; or (iii)&nbsp;subject to obtaining the Radiant Shareholder Approval and
compliance with the requirements set forth in <I>Section</I><I></I><I>&nbsp;3.4(b), </I>violate or result in a violation of, or constitute a default by Radiant (whether after the giving of notice, lapse of time or both) under, any provision of any
Law or any order of, or any restriction imposed by, any court or Governmental Authority applicable to Radiant or any of its Subsidiaries, <U>provided</U>, <U>however</U> that in the cases of clauses (i)&nbsp;and (iii) of this
<I>Section</I><I></I><I>&nbsp;3.4(a)</I>, except for any such conflicts, violations, defaults, terminations, cancellations, accelerations or losses that, individually or in the aggregate, are not material. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> No material consent, approval, license, permit, order or authorization of, or registration, declaration, notice or filing with any
Governmental Authority is required by or with respect to Radiant or any of its Subsidiaries in connection with the execution and delivery of this Agreement by Radiant or the consummation by Radiant of the Contemplated Transactions, except for:
(i)&nbsp;obtaining the Radiant Shareholder Approval; (ii)&nbsp;the filings and notifications required by the ICL; (iii)&nbsp;receipt of a Certificate of Merger from the Companies Registrar in accordance with the ICL; (iv)&nbsp;such consents,
approvals, orders, authorizations, registrations, declarations, notices and filings as may be required under applicable state securities laws and the laws of any foreign country and (v)&nbsp;such other consents, licenses, permits, orders,
authorizations, filings, approvals and registrations which, if not obtained or made, have not had, and would not reasonably be expected to result in a Radiant Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_46"></A><B>3.5 SEC Filings; Financial Statements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Radiant has filed or furnished, as applicable, on a timely basis all forms, statements, certifications, reports and documents
required to be filed or furnished by it with the SEC under the Exchange Act or the Securities Act since September&nbsp;1, 2017 (the forms, statements, reports and documents filed or furnished since September&nbsp;1, 2017 and those filed or furnished
subsequent to the date of this Agreement, including any amendments thereto, the &#147;<B>Radiant SEC Reports</B>&#148;). Each of the Radiant SEC Reports, at the time of its filing or being furnished complied in all material respects with the
applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, and any rules and regulations promulgated thereunder applicable to the Radiant SEC Reports, or, if not yet filed or furnished, will comply in all material
respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, and any rules and regulations promulgated thereunder applicable to the Radiant SEC Reports. As of their respective dates (or, if amended
prior to the date of this Agreement, as of the date of such amendment), the Radiant SEC Reports did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements made therein, in light of the circumstances in which they were made, not misleading, and any Radiant SEC Reports filed or furnished with the SEC subsequent to the date of this Agreement will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances in which they were made, not misleading. As used in this <I>Section</I><I></I><I>&nbsp;3.5(a)</I>,
the term &#147;file&#148; and variations thereof shall be broadly construed to include any manner in which a document or information is furnished, supplied or otherwise made available to the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> As of the date of this Agreement, Radiant has timely responded to all comment letters of the staff of the SEC relating to the
Radiant SEC Reports, and the SEC has not advised Radiant that any final reports are inadequate, insufficient or otherwise <FONT STYLE="white-space:nowrap">non-responsive.</FONT> Radiant has made available to the Company true, correct and complete
copies of all comment letters, written inquiries and enforcement correspondence between the SEC, on the one hand, and Radiant and any of its Subsidiaries, on the other hand, occurring since September&nbsp;1, 2017 and will, reasonably promptly
following receipt thereof, make available to the Company any such correspondence sent or received after the date of this Agreement. As of the date of this Agreement, none of the Radiant SEC Reports is the subject of ongoing SEC review or outstanding
SEC comment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Each of the consolidated financial statements (including, in each case, any notes or schedules thereto) included
in or incorporated by reference into the Radiant SEC Reports (the &#147;<B>Radiant Financial</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>Statements</B>&#148;) fairly present, in all material respects, the consolidated financial position of Radiant and its consolidated Subsidiaries as of its date, or, in the case of the Radiant
SEC Reports filed after the date of this Agreement, will fairly present, in all material respects, the consolidated financial position of Radiant and its consolidated Subsidiaries as of its date and each of the consolidated statements of income,
changes in shareholders&#146; equity (deficit) and cash flows included in or incorporated by reference into the Radiant SEC Reports (including any related notes and schedules) fairly presents in all material respects, the results of operations,
retained earnings (loss) and changes in financial position, as the case may be, of such companies for the periods set forth therein (except as indicated in the notes thereto, and in the case of unaudited statements, as may be permitted by the rules
of the SEC, and subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments that will not be material in amount or effect), in each case in accordance with GAAP consistently applied during the periods involved, except as may
be noted therein, or in the case of Radiant SEC Reports filed after the date of this Agreement, will fairly present, in all material respects, the results of operations, retained earnings (loss) and changes in financial position, as the case may be,
of such companies for the periods set forth therein (except as indicated in the notes thereto, and in the case of unaudited statements, as may be permitted by the rules of the SEC, and subject to normal
<FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments that will not be material in amount or effect), in each case in accordance with GAAP consistently applied during the periods involved, except as may be noted therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Radiant has designed and maintains a system of internal control over financial reporting (as defined in Rules <FONT
STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(f)</FONT> of the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of financial reporting, and, to the Knowledge of Radiant,
such system is effective in providing such assurance. Radiant (i)&nbsp;maintains disclosure controls and procedures (as defined in Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> of the
Exchange Act) designed to ensure that information required to be disclosed by Radiant in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC&#146;s
rules and forms, and such disclosure controls and procedures are effective (ii)&nbsp;has, to the extent required by Law, disclosed, based on the most recent evaluation of its chief executive officer and its principal financial officer prior to the
date of this Agreement, to Radiant&#146;s auditors and the Audit Committee of the Board of Directors of Radiant (and made summaries of such disclosures available to the Company) (A)&nbsp;(y) any significant deficiencies in the design or operation of
internal control over financial reporting that would adversely affect in any material respect Radiant&#146;s ability to record, process, summarize and report financial information and (z)&nbsp;any material weakness in internal control over financial
reporting, and (B)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in Radiant&#146;s internal controls over financial reporting. Each of Radiant and its Subsidiaries have materially
complied with or substantially addressed such deficiencies, material weaknesses or fraud. Radiant has delivered or made available to the Company complete and correct copies of all material correspondence between the NASDAQ market and Radiant in the
past twelve (12)&nbsp;months and any correspondence with respect to unresolved matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Each of the principal executive
officer of Radiant and the principal financial officer of Radiant (or each former principal executive officer of Radiant and each former principal financial officer of Radiant, as applicable) has made all certifications required by Rule <FONT
STYLE="white-space:nowrap">13a-14</FONT> or <FONT STYLE="white-space:nowrap">15d-14</FONT> under the Exchange Act or Sections 302 and 906 of the Sarbanes-Oxley Act and the rules and regulations of the SEC promulgated thereunder with respect to the
Radiant SEC Reports, and the statements contained in such certifications were true and correct on the date such certifications were made. For purposes of this <I>Section</I><I></I><I>&nbsp;3.5(e)</I>, &#147;principal executive officer&#148; and
&#147;principal financial officer&#148; has the meanings given to such terms in the Sarbanes-Oxley Act. None of Radiant or any of its Subsidiaries has outstanding, or has arranged any outstanding, &#147;extensions of credit&#148; to directors or
executive officers in violation of Section&nbsp;402 of the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Neither Radiant or any of its Subsidiaries
nor, to the Knowledge of Radiant, any director, officer, employee, or internal or external auditor of Radiant or any of its Subsidiaries has received or otherwise had or obtained constructive knowledge of any substantive material complaint,
allegation, assertion or claim, whether written or oral, that Radiant or any of its Subsidiaries has engaged in questionable accounting or auditing practices. Since September&nbsp;1, 2017, there have been no formal internal investigations regarding
financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, principal financial officer or general counsel of Radiant,
the Board of Directors of Radiant or any committee thereof, other than ordinary course audits or reviews of accounting policies or internal controls required by the Sarbanes-Oxley Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Radiant has never been and is not an &#147;ineligible issuer,&#148; as defined in Rule 405 of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> From the time of Radiant&#146;s initial public offering through the date hereof, the Company has been and is an &#147;emerging
growth company,&#148; as defined in Rule 405 of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> Radiant is eligible for use of a Form <FONT
STYLE="white-space:nowrap">S-3</FONT> for the registration of any Radiant Common Stock to be issued pursuant to the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Radiant is, and since September&nbsp;1, 2017 has been, in compliance in all material respects with (i)&nbsp;the applicable listing
and corporate governance rules and regulations of the NASDAQ market, and (ii)&nbsp;
the applicable provisions of the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_47"></A><B>3.6 Absence of Changes</B>. Since December&nbsp;31,
2018, Radiant and each of its Subsidiaries have conducted their respective businesses in all material respects in the Ordinary Course of Business. During the period after December&nbsp;31, 2018 and before the date of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> there has not been any change, event, circumstance or condition to the Knowledge of Radiant that, individually or in the
aggregate, has had, or would reasonably be expected to have, a Radiant Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> there has been no split,
combination or reclassification of any of the outstanding shares of Radiant&#146;s capital stock, and Radiant has not declared or paid any dividends on or made any other distributions (in either case, in stock or property) on or in respect of the
outstanding shares of Radiant&#146;s capital stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> none of Radiant or its Subsidiaries has allotted, reserved, set aside or
issued, authorized or proposed the allotment, reservation, setting aside or issuance of, or purchased or redeemed or proposed the purchase or redemption of, any shares in its capital stock or any class of securities convertible or exchangeable into,
or rights, warrants or options to acquire, any such shares or other convertible or exchangeable securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> except as
required as a result of a change in applicable Laws or GAAP, there has not been any material change in any method of accounting or accounting practice by Radiant or any of its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> neither Radiant nor any of its Subsidiaries has, (i)&nbsp;acquired or sold, pledged, leased, encumbered or otherwise disposed of
any material property or assets or agreed to do any of the foregoing, outside of the sale of inventory in the Ordinary Course of Business or (ii)&nbsp;incurred or committed to incur capital expenditures in excess of $100,000, in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> there has been no transfer (by way of a license or otherwise) of, or agreement to transfer to, any Person&#146;s rights to any
Radiant Intellectual Property, other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses and sublicenses provided to distributors and users of Radiant Products in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> there has been no notice delivered to Radiant or any of its Subsidiaries of any claim of ownership by a third party of any Radiant
Intellectual Property owned or developed by Radiant or any of its Subsidiaries, or of infringement by Radiant or any of its Subsidiaries of any Third Party Intellectual Property; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> there has not been any: (i)&nbsp;grant of any severance,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, or termination pay to any employee or other service provider of Radiant or its Subsidiaries or any Contract entered or amended,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
providing for the grant of any severance, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, or termination pay to any employee or other
service provider of Radiant or its Subsidiaries, in each case, other than as required by law; (ii)&nbsp;entry into any employment, deferred compensation, severance, equity, pension, post-retirement or other similar plan or agreement (or any
amendment to any such existing agreement) with any new or current employee or other service provider of Radiant or its Subsidiaries; (iii)&nbsp;increase in the compensation, bonus or other benefits (including accelerated equity vesting) payable or
to become payable to any employee or other service provider of Radiant or its Subsidiaries, except, with respect to (ii)&nbsp;and (iii) of this subsection (h), in the Ordinary Course of Business consistent with past practice, or as required by any
preexisting plan or arrangement set forth in <I>Section</I><I></I><I>&nbsp;3.6 </I>of the Radiant Disclosure Schedule; or (iv)&nbsp;termination or resignation of any of the officers or key employees of Radiant or any of its Subsidiaries; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> there has not been any agreement to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_48"></A>3.7 Title to Assets</B>. Except with respect to Radiant Intellectual Property, which is covered in
<I>Section</I><I></I><I>&nbsp;3.9</I>, each of Radiant and its Subsidiaries owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or assets and equipment used or
held for use in its business or operations or purported to be owned by it. All of said <FONT STYLE="white-space:nowrap">non-leased</FONT> properties and assets are owned by Radiant or a Radiant Subsidiary free and clear of any Encumbrances, except
for: (i)&nbsp;any lien for current Taxes not yet due and payable or for Taxes that are being contested in good faith and for which adequate reserves have been made on Radiant&#146;s audited consolidated balance sheet at December&nbsp;31, 2018; (ii)
minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets subject thereto or materially impair the operations of Radiant and its Subsidiaries,
taken as a whole and (iii)&nbsp;Encumbrances described in <I>Section</I><I></I><I>&nbsp;3.7</I> of the Radiant Disclosure Schedule. Merger Sub has not granted any Encumbrance that qualifies as a floating charge under the ICL and that restricts the
right of Merger Sub to create or grant security interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_49"></A>3.8 Properties</B>.
<I>Section</I><I></I><I>&nbsp;3.8</I> of the Radiant Disclosure Schedule sets forth a list of Radiant Leased Real Property. True and complete copies of all leases relating to Radiant Leased Real Property have been made available to the Company. With
respect to each property listed on <I>Section</I><I></I><I>&nbsp;3.8</I> of the Radiant Disclosure Schedule: (i)&nbsp;Radiant has a valid and enforceable leasehold interest to the leasehold estate in the Radiant Leased Real Property granted to
Radiant pursuant to each pertinent lease, subject to applicable bankruptcy, insolvency, moratorium or other similar Laws relating to creditors&#146; rights and general principles of equity; (ii)&nbsp;each of said leases has been duly authorized and
executed by Radiant and is in full force and effect; (iii)&nbsp;Radiant is not in material default under any of said leases, nor, to the Knowledge of Radiant, has any event occurred which, with notice or the passage of time, or both, would give rise
to such a material default by Radiant; and (iv)&nbsp;Radiant has not assigned subleased, transferred, conveyed, mortgaged, deeded in trust or encumbered any interest in any such lease. Neither Radiant nor any of its Subsidiaries owns or has ever
owned any real property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_50"></A>3.9 Intellectual Property.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <I>Section 3.9(a)</I> of the Radiant Disclosure Schedule contains a complete and accurate list of all (i)&nbsp;issued Patents or
pending patent applications owned or controlled (i.e., exclusively licensed) by Radiant or any of its Subsidiaries or patents used or held for use by Radiant or any of its Subsidiaries in Radiant Business (&#147;<B>Radiant Patents</B>&#148;), all
registered trademarks, tradenames, and service mark registrations and applications to register any trademarks (including domain names) therefor, including material unregistered trademarks, tradenames, and service marks (&#147;<B>Radiant
Marks</B>&#148;) and registered and material unregistered Copyrights owned or controlled by Radiant or any of its Subsidiaries or copyrights used or held for use by Radiant or any of its Subsidiaries in the Radiant Business (&#147;<B>Radiant
Copyrights</B>&#148;), (ii) licenses, sublicenses or other Contracts under which Radiant or any of its Subsidiaries is granted rights by others in the Radiant Intellectual Property (&#147;<B>Radiant
<FONT STYLE="white-space:nowrap">Licenses-In</FONT></B>&#148;) (other than commercial off the shelf software or materials transfer agreements), and (iii)&nbsp;licenses, sublicenses or other Contracts under which Radiant or any of its Subsidiaries
has granted rights to others in the Radiant Intellectual Property, other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses and sublicenses provided to distributors and users of Radiant Products in the Ordinary Course of Business
(&#147;<B>Radiant <FONT STYLE="white-space:nowrap">Licenses-Out</FONT></B>&#148;). <I>Schedule</I><I></I><I>&nbsp;3.9(a)</I> sets forth (i)&nbsp;the jurisdictions in which each such item of Radiant Intellectual Property has been issued, registered,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise arises or in which any such application for such issuance and registration has been filed, (ii)&nbsp;the registration or application date and serial or patent number, as applicable, and
(iii)&nbsp;any pending oppositions to any of the Radiant Marks (registered or applied for). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> With respect to Radiant
Intellectual Property (i)&nbsp;purported to be owned by Radiant or any of its Subsidiaries, Radiant or one of its Subsidiaries own the entire right, title, and interest in and to such Radiant Intellectual Property and (ii)&nbsp;purported to be
licensed to Radiant or any of its Subsidiaries by a third party (other than commercial off the shelf software or materials transfer agreements), such Radiant Intellectual Property is the subject of an enforceable written license or other written
Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;3.9(c) </I>of the Radiant Disclosure Schedule, the Radiant
Intellectual Property is free and clear of all Encumbrances, other than Encumbrances resulting from the express terms of a Radiant <FONT STYLE="white-space:nowrap">License-In,</FONT> the express terms of a Radiant
<FONT STYLE="white-space:nowrap">License-Out,</FONT> , or Permitted Encumbrances granted by Radiant or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> The Radiant Intellectual Property includes all of the material Intellectual Property used in the Ordinary Course of Business by
Radiant and its Subsidiaries as currently conducted, and there are no other items of Intellectual Property that are material to the Ordinary Course of Business of Radiant and development, manufacturing, marketing, commercialization and sale of the
Radiant Products, as currently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> To the Knowledge of Radiant, the Radiant Patents are (i)&nbsp;being diligently
prosecuted or otherwise registered in the respective United States Patent&nbsp;&amp; Trademark Office and all similar offices and agencies anywhere in the world in which foreign counterparts are registered or issued and (ii)&nbsp;have been filed and
maintained in accordance with applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> None of the Radiant <FONT STYLE="white-space:nowrap">Licenses-Out</FONT> grant
any third party exclusive rights to or under any Radiant Intellectual Property or grant any third party the right to sublicense any Radiant Intellectual Property without Radiant&#146;s written consent or notice to Radiant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Except for those Patents listed in <I>Section</I><I></I><I>&nbsp;3.9(g) </I>of the Radiant Disclosure Schedule, to the Knowledge
of Radiant, each of the Radiant Patents, properly identifies each and every inventor of the claims thereof as determined in accordance with the laws of the jurisdiction in which such Radiant Patent is issued or pending. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> No Radiant Patent is currently involved in any post grant review, <I>inter partes </I>review, interference, reissue, <FONT
STYLE="white-space:nowrap">re-examination</FONT> or opposition proceeding; to the Knowledge of Radiant, there is no patent or patent application of any third party that potentially interferes with a Radiant Patent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;3.9(i)</I> of the Radiant Disclosure Schedule (i)&nbsp;there are no material
Legal Proceedings pending or, to the Knowledge of Radiant, threatened against Radiant or any of its Subsidiaries alleging that Radiant or any of its Subsidiaries is infringing, misappropriating or otherwise violating, or has infringed,
misappropriated or otherwise violated any Third Party Intellectual Property; (ii)&nbsp;there are no material Legal Proceedings pending or threatened by Radiant or any of its Subsidiaries against any Person alleging infringement, misappropriation or
other violation of any Radiant Intellectual Property; (iii)&nbsp;to the Knowledge of Radiant, the operation or conduct of the Radiant Business and development, manufacturing, marketing, commercialization and sale of the Radiant Products (including
the use of the Radiant Intellectual Property), as currently conducted and conducted in the past has not infringed, misappropriated or otherwise violated any Intellectual Property rights of any Person, and there has been no material Legal Proceeding
asserted or, to the Knowledge of Radiant, threatened against Radiant or any of its Subsidiaries alleging Radiant&#146;s infringement, misappropriation, or violation of any Intellectual Property rights of another Person, and (iv)&nbsp;to the
Knowledge of Radiant, no Person is currently infringing or otherwise violating any Radiant Intellectual Property. To the Knowledge of Radiant, there is no substantial basis for any claim that the operation of the Radiant Business and the
development, manufacturing, marketing, commercialization and sale of the Radiant Products, as currently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conducted, infringes, misappropriates, or otherwise violates, or will infringe, misappropriate or otherwise violate any Third Party Intellectual Property under the Laws of any jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Other than as set forth in <I>Section</I><I></I><I>&nbsp;3.9(j)</I> of the Radiant Disclosure Schedule, none of Radiant or any of
its Subsidiaries has any obligation to compensate any person for the use of any Radiant Intellectual Property; none of Radiant or any of its Subsidiaries has entered into any agreement to indemnify any other person against any claim of infringement
or misappropriation of any Third Party Intellectual Property by the use of Radiant Intellectual Property, except in connection with commercial off the shelf software or materials transfer agreements; there are no settlements, covenants not to sue,
consents, or Orders or similar obligations that: (i)&nbsp;restrict the rights of Radiant or any of its Subsidiaries to use any Radiant Intellectual Property, (ii)&nbsp;restrict the Radiant Business or development, manufacturing, marketing,
commercialization and sale of the Radiant Products, in order to accommodate a Third Party Intellectual Property, or (iii)&nbsp;permit third parties to use any Radiant Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;3.9(j) </I>of the Radiant Disclosure Schedule, all former and current
consultants and contractors who have independently or jointly contributed to the conception, reduction to practice, creation or development of any Radiant Intellectual Property and all former and current employees of Radiant or any of its
Subsidiaries have executed written instruments with Radiant or one or more of its Subsidiaries that assign to Radiant or its Subsidiary, all rights, title and interest in and to any and all of all such Intellectual Property arising from such
employment or contractual arrangement, including, without limitation, inventions, improvements, discoveries, writings and other works of authorship, and information relating to the Radiant Business or the Radiant Products and any Intellectual
Property relating thereto (the &#147;<B>Radiant Created IP</B>&#148;). No such third party has retained any ownership rights with respect to such Radiant Created IP. Except as listed in <I>Section</I><I></I><I>&nbsp;3.9(j) </I>of the Radiant
Disclosure Schedule, where a Radiant Patent is held by Radiant or any of its Subsidiaries by assignment, the assignment has been duly recorded with the U.S. Patent and Trademark Office and all similar offices and agencies anywhere in the world in
which foreign counterparts are registered or issued. Each Person who has or has had any rights in or to any Radiant Created IP, has assigned and has executed an agreement assigning its entire right, title, and interest in and to such Radiant Created
IP to Radiant or its Subsidiary. For clarity, Radiant Created IP is Radiant Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> Radiant and its
Subsidiaries have taken commercially reasonable security measures, consistent with customary practices in the industry in which it operates, to protect and preserve the secrecy, confidentiality and value of all Trade Secrets, if any, and
confidential and proprietary information, owned by Radiant or any of its Subsidiaries or used or held for use by Radiant or any of its Subsidiaries in the Radiant Business and the development, manufacturing, marketing, commercialization and sale of
the Radiant Products (the &#147;<B>Radiant Trade Secrets</B>&#148;), including, without limitation, causing each former and current employee and consultant of Radiant and its Subsidiaries and any other person with access to Radiant Trade Secrets to
execute a binding written confidentiality agreement, copies or forms of which have been provided to the Company and pursuant to which such employees, contractors and consultants have agreed to hold all trade secrets and confidential and proprietary
information of Radiant and the Subsidiaries in confidence both during and after their employment or engagement. To the Knowledge of Radiant and its Subsidiaries (i)&nbsp;no Person is in breach of their respective confidentiality agreement, and
(ii)&nbsp;there has not been any disclosure of or access to any material Radiant Trade Secret to any Person in a manner that has resulted or is reasonably likely to result in the loss of Trade Secret in and to such information. All current and
former employees and consultants of Radiant and the Subsidiaries having access to confidential or proprietary information of any of their respective customers or business partners have executed and delivered to Radiant an agreement regarding the
protection of such confidential or proprietary information, to the extent required by such customers and business partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(m)</B>
To the Knowledge of Radiant, no current or former employee, consultant or independent contractor of Radiant or any Subsidiary (i)&nbsp;is in violation of any term or covenant of any Contract relating to employment, invention disclosure (including
patent disclosure), invention assignment, <FONT STYLE="white-space:nowrap">non-disclosure</FONT> or any other Contract with any other party by virtue of such employee&#146;s, consultant&#146;s or independent contractor&#146;s being
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employed by, or performing services for, Radiant or any Subsidiary or using trade secrets or proprietary information of others without permission; or (ii)&nbsp;has developed any technology,
software or other copyrightable, patentable or otherwise proprietary work for Radiant or any Subsidiary that is subject to any Contract under which such employee, consultant or independent contractor has assigned or otherwise granted to any third
party any rights (including Intellectual Property rights) in or to such technology, software or other copyrightable, patentable or otherwise proprietary work. No director, officer, employee, consultant, or other representative of Radiant or any of
its Subsidiaries owns or, to the Knowledge of Radiant, claims any rights in any Radiant Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> Except as
provided in <I>Section</I><I></I><I>&nbsp;3.9(n)</I> of the Radiant Disclosure Schedule, no (i)&nbsp;government funding, (ii)&nbsp;facilities of a university, college, other educational institution or research or medical center, or
(iii)&nbsp;funding from any Person (other than funds received in consideration for shares of Radiant Common Stock) was used in the development of the Radiant Intellectual Property. To the Knowledge of Radiant, no current or former employee of
Radiant or any Subsidiary, who was involved in, or who contributed to, the creation or development of any Radiant Intellectual Property, has performed services for any government, university, college or other educational institution or research or
medical center during a period of time during which such employee was also performing services for Radiant or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_51">
</A>3.10 Material Contracts</B>. <I>Section</I><I></I><I>&nbsp;3.10</I> of the Radiant Disclosure Schedule identifies the following Radiant Material Contracts in effect as of the date of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> the Radiant Leases and the Radiant Ancillary Lease Documents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> any Contract for the purchase of materials, supplies, goods, services, equipment or other assets for annual payments by Radiant or
any of its Subsidiaries of, or pursuant to which in the last year Radiant or any of its Subsidiaries paid, in the aggregate, $500,000 or more; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> any Contract for the sale of materials, supplies, goods, services, equipment or other assets, excluding Radiant Products, for
annual payments to Radiant or any of its Subsidiaries of, or pursuant to which in the last year Radiant or any of its Subsidiaries received, in the aggregate, $150,000 or more; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> any Contract that relates to any partnership, joint venture, strategic alliance or other similar Contract other than agreements
entered into with third parties for the incorporation of Subsidiaries, copies of which have been provided to the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> any
Contract relating to Indebtedness for borrowed money or the deferred purchase price of property (whether incurred, assumed, guaranteed or secured by any asset), except for Contracts relating to Indebtedness in an amount not exceeding $100,000 in the
aggregate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> any Contract for the employment of any employee or engagement of any independent contractor (i)&nbsp;that provides
for base salary in excess of $100,000 on an annual basis, or (ii)&nbsp;that provides for severance, retention bonus, change in control or similar types of Contracts, other than Contracts that provide for severance, retention bonus, change in control
or similar type Contracts at or below the amount of $100,000 per employee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> all collective bargaining agreements or agreements
with any labor organization, union or association to which Radiant is a party; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> any Contract which by its terms limits in any
material respect (i)&nbsp;the localities in which all or any significant portion of the business and operations of Radiant or its Subsidiaries or, following the consummation of the Contemplated Transactions, the business and operations of Surviving
Company, Radiant or any Affiliate of Radiant, is or would be conducted, or (ii)&nbsp;the scope of the business and operations of Radiant and its Subsidiaries, taken as a whole, in each case that would be material to Radiant and its Subsidiaries
taken as a whole; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> any Contract with any officer, Radiant Key Employee or other employee of Radiant
who develops or has developed any intellectual property of or for Radiant, or Radiant Contingent Worker of any of Radiant or its Subsidiaries containing noncompetition, <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> nondisclosure,
assignment of inventions or confidentiality provisions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> any Contract in respect of any Radiant Intellectual Property
(including the distribution, licensing, marketing, advertising or sales thereof) that provides for annual payments of, or pursuant to which in the last year Radiant or any of its Subsidiaries paid or received, in the aggregate, $250,000 or more;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> any Contract with any healthcare professional or any employee of any healthcare professional, including, but not limited to,
any Contract for advisory boards, pharmacy practice management, consulting services, electronic medical records or practice management that provides for annual payments of, or pursuant to which in the last year Radiant or any of its Subsidiaries
paid, in the aggregate, $100,000 or more; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> any Contract containing any royalty, dividend or similar arrangement based on the
revenues or profits of Radiant or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> any Contract with any Governmental Authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> any power of attorney, other than powers of attorney provided by Radiant and its Subsidiaries in the Ordinary Course of Business;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> any agreement that gives rise to any material payment or benefit as a result of the performance of this Agreement or any of
the other Contemplated Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> any Contract with (i)&nbsp;an executive officer or director of Radiant or any of its
Subsidiaries or any of such executive officer&#146;s or director&#146;s immediate family members or (ii)&nbsp;an owner of more than five percent (5%) of the voting power of the outstanding capital stock of Radiant or (iii)&nbsp;to the Knowledge of
Radiant, any &#147;related person&#148; (within the meaning of Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act) of any such officer, director or owner (other than Radiant or its Subsidiaries); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(q)</B> any Contract relating to the acquisition or disposition of any material interest in, or any material amount of, property or assets
of Radiant or any of its Subsidiaries (whether by merger, stock sale, asset sale or otherwise) or for the grant to any Person of any preferential rights to purchase any of their assets, other than in the Ordinary Course of Business consistent with
past practice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(r)</B> any Contract containing any provisions requiring any of Radiant or its Subsidiaries to indemnify any other
party, other than commercial Contracts entered into the Ordinary Course of Business consistent with past practices; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(s)</B> except to
the extent a Contract is described in the clauses above, any Contract not entered into in the Ordinary Course of Business in excess of $500,000; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(t)</B> any other agreement (or group of related agreements) the performance of which requires aggregate payments from Radiant or any of
its Subsidiaries in excess of $500,000 or that is material to Radiant or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Radiant has delivered or made available to the
Company accurate and complete (except for applicable redactions thereto) copies of all material written Radiant Contracts, including all amendments thereto. There are no Radiant Material Contracts that are not in written form. Neither Radiant nor
any Subsidiary of Radiant has, nor to the Knowledge of Radiant, has any other party to a Radiant Material Contract (as defined below), breached, violated or defaulted under, or received notice that it has breached, violated or defaulted under, any
of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the terms or conditions of any of the agreements, contracts or commitments to which Radiant or its Subsidiaries is a party or by which it is bound of the type described in clauses
(a)&nbsp;through (t)&nbsp;above or any Radiant Contract listed in <I>Section</I><I></I><I>&nbsp;3.13(i)</I> or <I>Section</I><I></I><I>&nbsp;3.15</I> of the Radiant Disclosure Schedule (any such agreement, contract or commitment, a &#147;<B>Radiant
Material Contract</B>&#148;) in such manner as would permit any other party to cancel or terminate any such Radiant Material Contract, or would permit any other party to seek damages which would reasonably be expected to be material. As to Radiant
and its Subsidiaries, as of the date of this Agreement, each Radiant Material Contract is valid, binding, enforceable and in full force and effect, subject to: (i)&nbsp;Laws of general application relating to bankruptcy, insolvency and the relief of
debtors; and (ii)&nbsp;
rules of Law governing specific performance, injunctive relief and other equitable remedies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_52"></A>3.11
Absence of Undisclosed Liabilities</B>. As of the date of this Agreement, neither Radiant nor any Subsidiary of Radiant has any Liability, individually or in the aggregate, except for: (a)&nbsp;Liabilities identified in the financial statements
(including any related notes) contained or incorporated by reference in the Radiant SEC Reports; (b)&nbsp;normal and recurring current Liabilities that have been incurred by Radiant since the date of the most recent balance sheet included in the
Radiant SEC Reports consolidated balance sheet in the Ordinary Course of Business, which are under $50,000 in the aggregate; and (c)&nbsp;Liabilities described in <I>Section</I><I></I><I>&nbsp;3.13 </I>of the Radiant Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_53"></A>3.12 Compliance with Laws; Regulatory Compliance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;3.12(a) </I>of the Radiant Disclosure Schedule, each of Radiant and its
Subsidiaries, and, to the Knowledge of Radiant, every director, officer, employee, agent, and Representative thereof, is and has been for the past three (3)&nbsp;years in material compliance with all applicable Laws (including, but not limited to,
FDCA, Health Care Laws, and all trade laws, including import control and export laws, trade embargos and anti-boycott laws) and Orders. To the Knowledge of Radiant and its Subsidiaries, (i)&nbsp;no investigation by any Governmental Authority with
respect to Radiant or any of its Subsidiaries is active and pending, and (ii)&nbsp;no Governmental Authority has indicated in writing or, to the Knowledge of Radiant, orally, an intention to conduct an investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a Radiant Material
Adverse Effect, each of Radiant and its Subsidiaries and, to the Knowledge of Radiant, their respective employees and agents, hold all Radiant Permits, including, but not limited to, all authorizations required under the FDCA, and the regulations of
the FDA promulgated thereunder as well as the PHSA. Except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a Radiant Material Adverse Effect, all such Radiant Permits are valid, and in full force
and effect. Since January&nbsp;1, 2015, there has not occurred any violation of, default (with or without notice or lapse of time or both) under, or event giving to others any right of termination, amendment or cancellation of, with or without
notice or lapse of time or both, any Radiant Permit except as has not, would not and would not reasonably be expected to, individually or in the aggregate, have a Radiant Material Adverse Effect. Each of Radiant and each of its Subsidiaries is in
compliance in all material respects with the requirements associated with all Radiant Permits. No event has occurred that would reasonably be expected to result in the revocation, cancellation, <FONT STYLE="white-space:nowrap">non-renewal</FONT> or
adverse modification of any Radiant Permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> None of Radiant or its Subsidiaries, any director, officer, employee, nor, to the
Knowledge of Radiant, any agent or Representative thereof, has committed any act, made any statement or failed to make any statement that would reasonably be expected to provide a basis for the FDA to invoke its policy with respect to &#147;Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&#148; as set forth in 56 Fed. Reg. 46191 (Sept. 10, 1991) and any amendments thereto, or a similar policy enforced by any other Radiant Regulatory Agency. None of Radiant or its
Subsidiaries, any director, officer, employee, nor, to the Knowledge of Radiant, any agent or Representative thereof, has engaged in any activity that would result in a material violation under applicable FDCA or Health Care Laws. There is no civil,
criminal, administrative or other proceeding, notice or demand pending, received or, to the Knowledge of Radiant, threatened against Radiant or any of its Subsidiaries </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that relates to an alleged violation of FDCA or any Health Care Law and none of Radiant or any of its Subsidiaries is in receipt of written notice of any civil, criminal, administrative or other
proceeding, notice or demand pending that relates to an alleged violation of FDCA or any Health Care Law. None of Radiant or its Subsidiaries, any director, officer, employee nor, to the Knowledge of Radiant, agent or Representative thereof, has
engaged in any activity that would result in a material violation of any FDCA or Health Care Law. None of Radiant or any of its Subsidiaries nor, to the Knowledge of Radiant, any director, officer, employee, agent or Representative thereof, has been
convicted of any crime or engaged in any conduct for which debarment is mandated by 21 U.S.C. &#167; 335a(a) or any similar Law or authorized by 21 U.S.C. &#167; 335a(b) or any similar Law. There are no Orders or similar actions to which Radiant or
any of its Subsidiaries any director, officer, employee, or, to the Knowledge of Radiant, agent or Representative thereof, are bound or which relate to Radiant Products, or alleged violation of any FDCA or Health Care Law. Radiant and its
Subsidiaries are currently not, nor have ever been, a party or subject to the terms of a corporate integrity agreement required by the Office of the Inspector General of the United States Department of Health and Human Services or similar agreement
or consent order of any other Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> None of Radiant or any of its Subsidiaries nor, to the Knowledge of
Radiant, any director, officer, employee, agent or Representative thereof, has been investigated for, charged with or convicted of a Medicare, Medicaid or federal or state health program related offense, or convicted of, charged with or, to the
Knowledge of Radiant, investigated for a violation of federal or state Law related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, obstruction of an investigation of controlled substances, or has been
debarred, excluded or suspended from participation in a Federal Health Care Program (nor is any such debarment, exclusion or suspension pending), or been subject to any Order or consent decree of, or criminal or civil fine or penalty imposed by, any
Governmental Authority. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.12(d)</I> of the Radiant Disclosure Schedule, to the Knowledge of Radiant, Radiant has not arranged or contracted with (by employment or otherwise) any individual or
entity has been convicted of or pled guilty or nolo contendere to any federal or state health care-related criminal offense or is excluded from participation in a Federal Health Care Program for the provision of items or services for which payment
may be made under such Federal Health Care Program. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.12(d)</I> of the Radiant Disclosure Schedule, no exclusion, suspension, or debarment claims, actions, proceedings or investigations relating
to Radiant is pending or, to the Knowledge of Radiant, is threatened against neither Radiant, nor any of Radiant&#146;s respective officers, directors, equity holders, employees or agents acting on its behalf or for its benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Each of Radiant and each of its Subsidiaries is and has been in compliance in all material respects with all applicable statutes,
rules, regulations, decrees, writs and Orders of the FDA and any other Radiant Regulatory Agency with respect to the labeling, storing, testing, developing, manufacturing, packaging, distributing, marketing, advertising, promoting, and selling of
the Radiant Products. To the Knowledge of Radiant, each of Radiant and its Subsidiaries has filed all required notices in accordance with FDCA and any other Laws, and made available to the Company copies thereof, of design defects, product problems,
adverse events, injuries and deaths relating to Radiant Products. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.12(e) </I>of the Radiant Disclosure Schedule, to the Knowledge of Radiant, all required
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies conducted by or on behalf of Radiant or its Subsidiaries and Radiant-sponsored clinical trials (or clinical trials sponsored by Radiant or any other Subsidiary) conducted or being
conducted with respect thereto, have been and are being conducted in compliance in all material respects with applicable licenses and Laws, including, without limitation, the applicable requirements of the FDCA and the FDA&#146;s current Good
Manufacturing Practice as codified in the Quality System Regulation, Good Laboratory Practice and Good Clinical Practice. The results of any such studies, tests and trials, and all other material information related to such studies, tests and
trials, have been made available to Company. To the Knowledge of Radiant, each clinical trial conducted by or on behalf of Radiant or any of its Subsidiaries with respect to Radiant Products has been and is being conducted in all material respects
in accordance with its clinical trial protocol, and in compliance in all material respects with all applicable Laws, including Good Clinical Practice, informed consent, Institutional Review Board requirements and all other applicable requirements
contained in 21 CFR Parts 312, 812, 50, 54, 56 and 11. To the Knowledge of Radiant, each of Radiant and its Subsidiaries has filed all required notices (and made available to the Company copies </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereof) of design defects, product problems, adverse events, injuries and deaths relating to clinical trials conducted by or on behalf of Radiant or any of its Subsidiaries with respect to such
Radiant Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> All applications, submissions, information and data utilized by Radiant or any of its Subsidiaries as the
basis for, or submitted by or on behalf of Radiant or any of its Subsidiaries in connection with any and all requests for a Radiant Permit relating to Radiant or any of its Subsidiaries, when submitted to the FDA or any other Radiant Regulatory
Agency, were, to the Knowledge of Radiant, true, correct and complete in all material respects as of the date of submission, and any updates, changes, corrections or modification to such applications, submissions, information and data required under
applicable Laws have been submitted to the FDA or any other Radiant Regulatory Agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> (i) Radiant and each of its
Subsidiaries is in compliance in all material respects with the written procedures, record-keeping and FDA reporting requirements for Reports of Corrections and Removals set forth in 21 C.F.R. Part 806; (ii) neither Radiant nor any of its
Subsidiaries has voluntarily or involuntarily issued or caused to be issued, or is aware of any facts that would require Radiant or any of its Subsidiaries to issue or cause to be issued, any recall notice, market withdrawal notice, safety or
Warning Letter, report or other notice or action disclosing an alleged defect or lack of safety or efficacy of any product; (iii)&nbsp;Radiant and each of its Subsidiaries is in compliance in all material respects with the regulations for Medical
Device Reporting set forth in 21 C.F.R. Part 803, or equivalent requirements issued by any other Governmental Authority; (iv)&nbsp;each product in current commercial distribution in the United States is a Class&nbsp;II medical device as defined
under 21 U.S.C. &#167;&nbsp;360c(a)(1)(A), (B) and applicable rules and regulations thereunder and was first marketed under, and is currently covered by, a premarket notification owned and held exclusively by Radiant or one of its Subsidiaries and
in compliance with 21 U.S.C. &#167; 360(k) and the applicable rules and regulations thereunder; and (v)&nbsp;Radiant and each of its Subsidiaries has always promoted and continues to promote such products for uses that are within the scope of each
Permit, and Radiant and each of its Subsidiaries have not engaged in any <FONT STYLE="white-space:nowrap">off-label</FONT> promotion, or promotion of Radiant Products without Permits, when such medical devices under FDCA must only be marketed with
Permits (e.g., 510(k) premarket notification). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> None of Radiant or its Subsidiaries nor, to the Knowledge of Radiant, any of
the Representatives, licensors, licensees, assignors or assignees thereof has received any notice that the FDA or any other Radiant Regulatory Agency has initiated, or threatened to initiate, any action to suspend or place restrictions on any
clinical trial, suspend or terminate any IDE or comparable Clinical Trial Application sponsored by Radiant or any of its Subsidiaries or otherwise restrict the <FONT STYLE="white-space:nowrap">pre-clinical</FONT> research related to or clinical
study of any Radiant Product or any medical device or component being developed by any licensee or assignee of the Radiant Intellectual Property based on such intellectual property, or to recall, suspend or otherwise restrict the development or
manufacture of any Radiant Product. To the Knowledge of Radiant, none of Radiant or any of its Subsidiaries or any supplier of components and materials to Radiant is in receipt of written notice of, or is subject to, any adverse inspection, finding
of deficiency, finding of <FONT STYLE="white-space:nowrap">non-compliance,</FONT> 483 observation, investigation, civil or criminal proceeding, hearing, suit, demand, claim, complaint, inquiry, proceeding, penalty, Untitled Letter, Warning Letter,
seizure, import alert, injunction, prosecution, or other compliance or enforcement action relating to any Radiant Products or to the Radiant Business. To the Knowledge of Radiant, there is no act, omission, event or circumstance that would
reasonably be expected to give rise to any such action. All deficiencies and <FONT STYLE="white-space:nowrap">non-conformities</FONT> discovered during internal audits and inspections have been corrected and resolved in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> To the extent Radiant or its Subsidiaries collects, uses, or discloses Personal Information, Radiant and/or its Subsidiaries, as
applicable, has in place publicly published privacy policies regarding the collection, use and disclosure of Personal Information in their possession, custody or control, or otherwise held or processed on their behalf. Radiant and its Subsidiaries
are, and have been for the past three (3)&nbsp;years, in material compliance with the requirements of: (i)&nbsp;all applicable Data Privacy and Security Laws; and (ii)&nbsp;all contractual obligations concerning the collection, use, storage and
disclosure of Personal Information. Neither Radiant nor its Subsidiaries has been notified of any Legal Proceeding related to data security or privacy or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
alleging a violation of any of its privacy policies or any Data Privacy and Security Law, nor, to the Knowledge of Radiant, has any such claim been threatened. Radiant and its Subsidiaries have
taken commercially reasonable measures designed to protect and maintain the confidentiality of all Personal Information collected by or on behalf of Radiant or its Subsidiaries and to maintain the security of its data storage practices for Personal
Information, in each case, in accordance with all Data Privacy and Security Laws and consistent with commercially reasonable industry practices applicable to such types of data gathered and maintained in the industry in which Radiant or its
Subsidiaries conduct their business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> Radiant and each of its Subsidiaries have maintained commercially reasonable
administrative, physical and technical safeguards consistent with normal industry practice and in accordance with Data Privacy and Security Laws that are designed to (i)&nbsp;protect the confidentiality, integrity and accessibility of IT Systems and
information contained therein (including Intellectual Property, Personal Information, and other information subject to confidentiality obligations), and specifically, (ii)&nbsp;prevent against loss and unauthorized access, use, modification,
disclosure or other use of such information that would not, in each foregoing case, be consistent with Radiant or its Subsidiaries&#146; published privacy policies or contract to which Radiant or any of its Subsidiaries is a party. With respect to
the IT Systems, for the past three (3)&nbsp;years (i) none of the data (including Intellectual Property and Personal Information) that Radiant or its Subsidiaries stores or processes has been corrupted to a material extent, and (ii)&nbsp;to the
Knowledge of Radiant, none of the Personal Information, that Radiant or its Subsidiaries stores or processes has been subject to a security breach or incident regarding Personal Information requiring notification under the applicable Data Privacy
and Security Laws, including but not limited to, 45 C.F.R. Subpart D. Radiant and its Subsidiaries have been, and are, in compliance with contractual obligations concerning the security and privacy of IT Systems and information contained therein
(including Intellectual Property, Personal Information, and other information subject to confidentiality obligations) in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> Any database owned or used Radiant or its Subsidiaries that is required to be registered under any Data Privacy and Security Law,
if any, has been duly registered and maintained, and there has been no unauthorized or illegal use of or access to any of the data or information in any of such databases. There is no audit, proceeding, claim or investigation currently pending
against Radiant or its Subsidiaries by any Governmental Authority in respect of Personal Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> Radiant and its
Subsidiaries have made available to the Company true, correct and complete copies of any and all material applications, approvals, licenses, written notices of inspectional observations, establishment inspection reports and any other documents
received from the FDA or any other Radiant Regulatory Agency, including documents that indicate or suggest lack of compliance with the regulatory requirements of the FDA or any other Radiant Regulatory Agency. Radiant and its Subsidiaries have made
available to the Company for review all correspondence to or from the FDA or any other Radiant Regulatory Agency, minutes of meetings, written reports of phone conversations, visits or other contact with the FDA or any other Radiant Regulatory
Agency, and all other documents concerning communications to or from the FDA or any other Radiant Regulatory Agency, or prepared by the FDA or any other Radiant Regulatory Agency or which bear in any way on Radiant&#146;s or any of its
Subsidiaries&#146; material compliance with regulatory requirements of the FDA or any other Radiant Regulatory Agency, or on the likelihood or timing of approval or clearance of any Radiant Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_54"></A>3.13 Taxes and Tax Returns</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Each of Radiant and its Subsidiaries has timely (i)&nbsp;filed (taking into account any applicable extensions) all material Tax
Returns that were required to be filed on or prior to the date hereof and all such Tax Returns were correct and complete in all material respects and (ii)&nbsp;paid all Taxes, whether or not shown on such Tax Returns, other than Taxes which
individually or the aggregate are not reasonably expected to be material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> There are no liens for Taxes (other than statutory
liens for current Taxes or other governmental charges, assessments or levies that are not yet due and payable or liens for Taxes being contested in good faith by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
appropriate proceedings and for which adequate reserves have been established in accordance with GAAP in the Radiant Financial Statements) on any assets of Radiant or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Neither Radiant nor any of its Subsidiaries is a party to any currently pending Tax audits or other administrative proceedings or
any currently pending court proceedings or any other material dispute or claim concerning any Tax liability of Radiant or any Subsidiary, in each case, for which written notice has been received. To the Knowledge of Radiant, there are no material
matters under discussion between Radiant or any of its Subsidiaries and any Taxing Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Neither Radiant nor any of its
Subsidiaries has filed for an extension of time within which to file any Tax Return which extension is currently in effect, other than customary extensions not to exceed six (6)&nbsp;months for which no approval is required. Neither Radiant nor any
of its Subsidiaries has executed any outstanding waiver of any statute of limitations for, or extension of, the period for the assessment or collection of any Tax, in each case, which period has not yet expired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Radiant and its Subsidiaries have complied in all material respects with all applicable legal requirements relating to the payment
and withholding of Taxes from payments made or deemed made to any employee, independent contractor, creditor, shareholder, lender or other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Neither Radiant nor any of its Subsidiaries is a party to or is bound by any Tax sharing, allocation or indemnification agreement
(other than (i)&nbsp;any such agreement exclusively between or among the Radiant and/or its Subsidiaries and (ii)&nbsp;any other agreement (A)&nbsp;the primary purpose of which is not the allocation or payment of Tax liability and (B)&nbsp;that was
entered into in the Ordinary Course of Business). Neither Radiant nor any of its Subsidiaries is or may be liable under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of the Tax Laws of
any state, local or foreign jurisdiction) for Taxes of any Person other than Radiant and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> During the past
two (2)&nbsp;years, neither Radiant nor any of its Subsidiaries has distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by
Sections 355 or 361 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> None of Radiant or its Subsidiaries has taken any action, or has any Knowledge of any fact
or circumstance, that would reasonably be expected to prevent the Merger from qualifying as a reorganization within the meaning of Section&nbsp;368(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> All material related party transactions involving Radiant and its Subsidiaries are in compliance with applicable transfer pricing
laws and regulations, are at arm&#146;s length and are documented and reported with a proper transfer pricing study, in each case in accordance with applicable Tax Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> None of Radiant or its Subsidiaries has a permanent establishment or other taxable presence (as determined pursuant to an
applicable tax treaty or applicable Tax Law) in any country other than the country of its formation. Neither the Radiant nor any of its Subsidiaries is or has ever been subject to Tax in any country other than their country of incorporation by
virtue of being treated as a resident of that country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> No written claim has been delivered to Radiant or to any of its
Subsidiaries by a Taxing Authority, within the statutory limitation periods, in the jurisdiction where Radiant or any Subsidiary does not file Tax Returns such that it is or may be subject to taxation by that jurisdiction or required to file any Tax
Return in that jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_55"></A>3.14 Employee Benefit Programs</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <I>Section 3.14(a)</I> of the Radiant Disclosure Schedule sets forth a complete and accurate list of every material Employee
Program maintained by Radiant or any Subsidiary or with respect to which Radiant or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any Subsidiary has or may have any Liability (the &#147;<B>Radiant Employee Programs</B>&#148;), except for any Contract for the employment of any employee or engagement of any independent
contractor that provides (i)&nbsp;base salary or fee at or below the amount of $100,000 on an annual basis, and&nbsp;(ii) any severance, retention bonus,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> or similar type payment at or below the amount of $100,000 per employee. Radiant does not have any ERISA Affiliate that maintains a Radiant Employee
Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> True, complete and correct copies of the following documents, with respect to each Radiant Employee Program, where
applicable, have previously been provided to the Company: (i)&nbsp;all documents embodying or governing such Radiant Employee Program and any funding medium for the Radiant Employee Program; (ii)&nbsp;the most recent IRS determination or opinion
letter; (iii)&nbsp;the most recently filed IRS Form 5500; (iv) the most recent actuarial valuation report; (v)&nbsp;the most recent summary plan description (or other descriptions provided to employees) and all modifications thereto; and
(vi)&nbsp;all <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence to and from any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Each
Radiant Employee Program that is intended to qualify under Section&nbsp;401(a) of the Code has received a favorable determination or approval letter from the IRS with respect to such qualification, or may rely on an opinion letter issued by the IRS
with respect to a prototype plan adopted in accordance with the requirements for such reliance. To the Knowledge of Radiant, no event or omission has occurred with respect to the operation of any Radiant Employee Program that would reasonably be
expected to cause such Radiant Employee Program to lose its <FONT STYLE="white-space:nowrap">tax-qualification</FONT> or the <FONT STYLE="white-space:nowrap">tax-exempt</FONT> status of its accompanying trust under Code Sections 401(a) and 501(a),
respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> To the Knowledge of Radiant, there is no material failure of any party to comply with any Laws applicable with
respect to the Radiant Employee Programs. Except as would not, individually or in the aggregate, be material, with respect to any Radiant Employee Program, there has been no (i)&nbsp;&#147;prohibited transaction,&#148; as defined in Section&nbsp;406
of ERISA or Code Section&nbsp;4975, which is not otherwise exempt, (ii)&nbsp;failure to operate and administer the Radiant Employee Programs in accordance with their respective terms and in compliance with ERISA and other applicable Laws, or <FONT
STYLE="white-space:nowrap">(iii)&nbsp;non-deductible</FONT> contribution. No litigation or governmental administrative proceeding (or investigation) or other proceeding (other than those relating to routine claims for benefits) is pending or, to the
Knowledge of Radiant, threatened with respect to any such Radiant Employee Program. All payments and/or contributions required to have been made with respect to all Radiant Employee Programs, for all periods prior to the Closing Date, either have
been made or have been accrued in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Neither Radiant nor any ERISA Affiliate of Radiant has maintained a
Radiant Employee Program subject to Title IV of ERISA, including a Multiemployer Plan, in the six (6)&nbsp;years prior to the Closing Date. None of the Radiant Employee Programs provides or represents an obligation to provide health care or any
other <FONT STYLE="white-space:nowrap">non-pension</FONT> benefits to any employees after their employment is terminated (other than as required by part 6 of subtitle B of title I of ERISA or state continuation Laws). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Except as provided on <I>Section</I><I></I><I>&nbsp;3.14(f)</I> of the Radiant Disclosure Schedule, none of Radiant or any of its
Subsidiaries is a party to any (i)&nbsp;agreement with any shareholder, director, employee or other service provider of Radiant or any of its Subsidiaries (A)&nbsp;the benefits of which are contingent, or the terms of which are materially altered,
upon the occurrence of a transaction involving Radiant or any of its Subsidiaries of the nature of any of the Contemplated Transactions (either alone or in conjunction with any other event), including, without limitation, the increase in any
payments, the forgiveness of any Indebtedness, the obligation to fund future benefits under any Radiant Employee Program or the requirement to pay any tax gross up payments, (B)&nbsp;providing any guaranteed period of employment or compensation
guarantee, or (C)&nbsp;providing severance benefits; or (ii)&nbsp;agreement or plan binding Radiant or any of its Subsidiaries, including any stock option plan, stock appreciation right plan, restricted stock plan, stock purchase plan, or severance
benefit plan, any of the benefits of which shall be increased, or the vesting of the benefits of which shall be accelerated, by the occurrence of any of the Contemplated Transactions (either alone or in conjunction with any other event) or the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
value of any of the benefits of which shall be calculated on the basis of any of the Contemplated Transactions. There is no contract, agreement, plan or arrangement covering any individual that,
by itself or collectively, would give rise to any parachute payment subject to Section&nbsp;280G of the Code, nor has Radiant made any such payment, and the consummation of the transactions contemplated herein shall not, individually or together
with any other event or occurrence, obligate Radiant or any other entity to make any parachute payment that would be subject to Section&nbsp;280G of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Each Radiant Employee Program that is a &#147;nonqualified deferred compensation plan&#148; within the meaning of
Section&nbsp;409A of the Code is in documentary compliance and has been operated and maintained in compliance with Section&nbsp;409A of the Code in all material respects. Neither Radiant nor any Subsidiary is under any obligation to gross up any
Taxes under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> There is no current offering period under and pursuant to the terms of the 2017
Radiant Employee Stock Purchase Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> For purposes of this <I>Section</I><I></I><I>&nbsp;3.14</I>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> An entity &#147;<B>maintains</B>&#148; a Radiant Employee Program if such entity sponsors, contributes to, or provides benefits
under or through such Radiant Employee Program, or has any obligation (by agreement or under applicable Laws) to contribute to or provide benefits under or through such Radiant Employee Program, or if such Radiant Employee Program provides benefits
to or otherwise covers current or former employees or other service providers of such entity (or their spouses, dependents, or beneficiaries). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> An entity is an &#147;<B>ERISA Affiliate</B>&#148; of Radiant if it would have ever been considered a single employer with
Radiant under ERISA Section&nbsp;4001(b) or Section&nbsp;414 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_56"></A>3.15 Labor and Employment
Matters</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Neither Radiant nor any of its Subsidiaries is a party to, or otherwise bound by, any collective bargaining
agreement, contract, or other written agreement with a labor union or labor organization. To the Knowledge of Radiant, neither Radiant nor any of its Subsidiaries is subject to, and during the past four (4)&nbsp;years there has not been, any charge,
demand, petition, organizational campaign, or representation proceeding seeking to compel, require, or demand it to bargain with any labor union or labor organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;3.15(b)</I> of Radiant&#146;s Disclosure Schedule and except as would not,
individually or in the aggregate, be material, (i)&nbsp;Radiant and its Subsidiaries are in compliance in all material respects, and has been for the past four (4)&nbsp;years, with all applicable Laws respecting labor, employment, fair employment
practices, work safety and health, terms and conditions of employment, immigration and wages and hours and equal pay; (ii)&nbsp;neither Radiant nor any of its Subsidiaries is delinquent in any payments to any employee or to any independent
contractors, consultants, temporary employees, leased employees or individual agents who personally provide service to Radiant during most of such individual agent&#146;s working time, employed or used with respect to the operation of the Radiant
Business and classified by Radiant or any of its Subsidiaries as other than an employee or compensated other than through wages paid by Radiant or any of its Subsidiaries through its respective payroll department (&#147;<B>Radiant Contingent
Workers</B>&#148;), for any compensation due with respect to any services performed for it to the date of this Agreement or amounts required to be reimbursed to such employees or Radiant Contingent Workers; (iii)&nbsp;there are, and for the past
four (4)&nbsp;years there have been no outstanding grievances, complaints or charges with respect to employment or labor matters pending or, to the Knowledge of Radiant, threatened against Radiant or any of its Subsidiaries in any judicial,
regulatory or administrative forum, under any private dispute resolution procedure, including, without limitation, any claim relating to unfair labor practices, employment discrimination, harassment, retaliation, unpaid wages, or equal pay;
(iv)&nbsp;none of the employment policies or practices of Radiant or any of its Subsidiaries is currently being, or has been in the past four (4)&nbsp;years, audited or investigated, or to the Knowledge of Radiant, subject to imminent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
audit or investigation by any Governmental Authority; (v)&nbsp;neither Radiant nor any of its Subsidiaries is, or within the last four (4)&nbsp;years has been, subject to any Order by any
Governmental Authority or private settlement contract in respect of any labor or employment matters; (vi)&nbsp;to the extent that any Radiant Contingent Workers are employed, to the Knowledge of Radiant, Radiant and each of its Subsidiaries has
properly classified and treated them in accordance with applicable Laws and for purposes of all employee benefit plans and perquisites; (vii)&nbsp;Radiant and its Subsidiaries have properly classified their respective employees as exempt or <FONT
STYLE="white-space:nowrap">non-exempt</FONT> under the Fair Labor Standards Act, as amended, and, its state law equivalents, including the California Labor Code, and all other relevant Laws; and (viii)&nbsp;there are no pending or, to the Knowledge
of Radiant, threatened or reasonably anticipated claims or actions against Radiant or its Subsidiaries under any workers&#146; compensation policy or long-term disability policy. None of Radiant or any of its Subsidiaries has experienced a
&#147;plant closing,&#148; &#147;business closing,&#148; or &#147;mass layoff&#148; as defined in the federal Worker Adjustment and Retraining Notification Act of 1988 or similar state, local and foreign laws relating to plant closings, relocations,
mass layoffs or employment losses (the &#147;<B>WARN Act</B>&#148;), and, during the ninety <FONT STYLE="white-space:nowrap">(90)-day</FONT> period preceding the date of this Agreement, no employee has suffered an &#147;employment loss,&#148; as
defined in the WARN Act, with respect to Radiant or any of its Subsidiaries. Neither Radiant nor any of its Subsidiaries is a party to, or otherwise bound by, any consent decree, with or citation by, any Governmental Authority relating to employees
or employment practices. All employees are employed on an <FONT STYLE="white-space:nowrap">at-will</FONT> basis (insofar as such employment practice is legally recognized under applicable Law) unless otherwise set forth in
<I>Section</I><I></I><I>&nbsp;3.15(b)</I> of the Radiant Disclosure Schedule. Radiant and its Subsidiaries are in compliance with the requirements of the Immigration Reform Control Act of 1986 and have a completed and accurate copy of U.S.
Citizenship and Immigration Services Form <FONT STYLE="white-space:nowrap">I-9</FONT> for each employee of Radiant and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <I>Section 3.15(c)(i)</I> of the Radiant Disclosure Schedule contains a complete and accurate list of all employees of Radiant and
its Subsidiaries as of the date of this Agreement, setting forth for each employee his or her position or title, whether classified as exempt or <FONT STYLE="white-space:nowrap">non-exempt</FONT> for wage and hour purposes, annual base salary, date
of hire, business location, and the total amount of bonus, retention, severance, and other amounts to be paid to such employee at the Closing or otherwise in connection with the Contemplated Transactions.
<I>Section</I><I></I><I>&nbsp;3.15(c)(ii)</I> of the Radiant Disclosure Schedule also contains a complete and accurate list of all Radiant Contingent Workers showing for each Radiant Contingent Worker such individual&#146;s role in the Radiant
Business, fee or compensation arrangements and location. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> To the Knowledge of Radiant or its Subsidiaries, during the year
prior to the date hereof (i)&nbsp;no allegations of discrimination, harassment, or hostile work environment based on sex have been made against (A)&nbsp;any officer or director of Radiant or its Subsidiaries, (B)&nbsp;any employee of Radiant or its
Subsidiaries at the level of Vice President or above, or (C)&nbsp;any employee of Radiant or its Subsidiaries who, directly or indirectly, supervises at least three (3)&nbsp;other employees; and (ii)&nbsp;Radiant and its Subsidiaries have not
entered into any settlement related to allegations of discrimination, harassment, or hostile work environment by an employee, director, officer, or Radiant Contingent Worker. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_57"></A>3.16 Environmental Matters</B>. Except as has not, would not and would not reasonably be expected to,
individually or in the aggregate, have a Radiant Material Adverse Effect: (a)&nbsp;Radiant and its Subsidiaries are in compliance with all Environmental Laws applicable to their operations and use of the Radiant Leased Real Property; (b)&nbsp;none
of Radiant or any of its Subsidiaries has generated, transported, treated, stored, or disposed of any Hazardous Material, except in material compliance with all applicable Environmental Laws, and there has been no Release or threat of Release of any
Hazardous Material by Radiant or its Subsidiaries at or on the Radiant Leased Real Property that requires reporting, investigation or remediation by Radiant or its Subsidiaries pursuant to any Environmental Law; (c)&nbsp;none of Radiant or any of
its Subsidiaries has (i)&nbsp;received written notice under the citizen suit provisions of any Environmental Law or (ii)&nbsp;been subject to or, to the Knowledge of Radiant, threatened with any governmental or citizen enforcement action with
respect to any Environmental Law; and (d)&nbsp;to the Knowledge of Radiant, there are no underground storage tanks, landfills, current or former waste disposal areas or polychlorinated biphenyls at or on the Radiant Leased Real Property that require
reporting, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investigation, cleanup, remediation or any other type of response action by Radiant or its Subsidiaries pursuant to any Environmental Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_58"></A>3.17 Insurance</B>. <I>Section</I><I></I><I>&nbsp;3.17 </I>of the Radiant Disclosure Schedule lists each
insurance policy maintained by or on behalf of Radiant and its Subsidiaries with respect to its and their properties, assets and business, together with a claims history for the past two (2)&nbsp;years. All of such insurance policies are in full
force and effect, all premiums due and payable with respect to such insurance policies have been paid to date, and neither Radiant nor any of its Subsidiaries has ever been (a)&nbsp;in default with respect to its Liabilities under any such insurance
policies or (b)&nbsp;denied insurance coverage. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.17 </I>of the Radiant Disclosure Schedule, Radiant does not have and has had no self-insurance or
<FONT STYLE="white-space:nowrap">co-insurance</FONT> program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_59"></A>3.18 Government Programs</B>. No
agreements, loans, funding arrangements or assistance programs are outstanding in favor of Radiant or any of its Subsidiaries from any Governmental Authority, and, to the Knowledge of Radiant, no basis exists for any Governmental Authority to seek
payment or repayment from Radiant or any of its Subsidiaries of any amount or benefit received, or to seek performance of any obligation of Radiant or any of its Subsidiaries, under any such program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_60"></A>3.19 Transactions with Affiliates</B>. Except as set forth in the Radiant SEC Reports since the date of
Radiant&#146;s last proxy statement filed on April&nbsp;26, 2018 with the SEC, no event has occurred that would be required to be reported by Radiant pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the
SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_61"></A>3.20 Legal Proceedings; Orders</B>. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.20
</I>of the Radiant Disclosure Schedule, there is not pending any material Legal Proceeding and (to the Knowledge of Radiant) no Person has threatened to commence any Legal Proceeding: (a)&nbsp;that involves Radiant, any Subsidiary of Radiant or any
director or officer of Radiant (in his or her capacity as such) or any of the material assets owned or used by Radiant and/or any Subsidiary; or (b)&nbsp;that challenges, or that may have the effect of preventing, delaying, making illegal or
otherwise interfering with, the Merger or any of the other Contemplated Transactions, in each case, except for (i)&nbsp;any shareholder litigation or other claims arising from allegations of breach of fiduciary duty relating to this Agreement
following the date hereof or (ii)&nbsp;any such Legal Proceedings that would not have, or reasonably be expected to have, a Radiant Material Adverse Effect. There is no Order to which Radiant or any Subsidiary of Radiant, or any of the material
assets owned or used by Radiant or any Subsidiary of Radiant, is subject. To the Knowledge of Radiant, no officer or other key employee of Radiant or any Subsidiary of Radiant is subject to any Order that prohibits such officer or other employee
from engaging in or continuing any conduct, activity or practice relating to the Radiant Business or to any material assets owned or used by Radiant or any Subsidiary of Radiant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_62"></A>3.21 Anticorruption and Anti-Bribery Laws</B>. Neither Radiant nor any of its Subsidiaries (including any of
their respective employees, officers or directors) or, to the Knowledge of Radiant, any third party acting on behalf of Radiant or any of its Subsidiaries, has taken or failed to take during the past three (3)&nbsp;years any action that would cause
it to be in violation of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-corruption or anti-kickback law or regulation, including without limitation: (a)&nbsp;the making of any offer or promise to pay, payment of,
or authorization of payment of, directly or indirectly, money or anything of value to any foreign government official (including appointed or elected officials, government employees, political parties, party officials, candidates for political
office, and any officer, director or employee of any government entity), for the purpose of corruptly influencing an act or decision, inducing the doing or omission of any act in violation of a lawful duty, or securing an improper advantage, or the
receipt of a corrupt payment or of anything of value under such circumstances; (b)&nbsp;use of any corporate funds for any illegal contributions, gifts, entertainment or other unlawful expenses relating to political activity; (c)&nbsp;establishment
or maintenance of any unlawful fund of corporate monies or other properties; or (d)&nbsp;making of any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment of any nature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_63"></A>3.22 Warranty and Related Matters; Product Liability</B>. Radiant has made available to the Company correct
and complete copies of Radiant&#146;s standard written warranty or warranties for sales in the last two </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(2)&nbsp;years for any and all of Radiant Products. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.22 </I>of the Radiant Disclosure Schedule, neither Radiant nor any of its Subsidiaries
has received any Warranty Claims. Except as disclosed on <I>Section</I><I></I><I>&nbsp;3.22 </I>of the Radiant Disclosure Schedule, the Radiant Products conform in all material respects to applicable product specifications, warranties and
contractual commitments, and there are no Product Liability Claims with respect to any Radiant Product. To the Knowledge of Radiant, there is no reasonable basis for any present or future Product Liability Claim against any of Radiant or its
Subsidiaries which could give rise to any material liability. No product prepared or manufactured by Radiant or its Subsidiaries is or has been subject to any voluntary or involuntary market withdrawal or product recall during the past two
(2)&nbsp;years and, to the Knowledge of Radiant, no facts or circumstances exist that would reasonably be expected to result in a recall of products already manufactured by Radiant or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_64"></A>3.23 Antitrust</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Neither Radiant nor Merger Sub (or any affiliated entity, as would be deemed &#147;affiliated&#148; for the purposes of the
Economic Competition Law, 5748-1988 and the regulations, rules, decrees and guidelines promulgated thereunder (the &#147;<B>Economic</B> <B>Competition Law</B>&#148;)) has any operations or business activities or &#147;sales turnover&#148; as
defined in Section&nbsp;17(a)(2) of the Competition Law and the regulations promulgated thereunder in the State of Israel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>
Neither Radiant nor Merger Sub (or any affiliated entity) has shares, options or other rights in any Israeli company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Neither
Radiant nor Merger Sub (or any affiliated entity) has a &#147;a place of business&#148; in Israel, as such term is defined in the Guidelines of the General Director of the Israeli Competition Authority for Reporting and Evaluating Mergers Pursuant
to the Competition Law. Particularly, neither Radiant nor Merger Sub (or any affiliated entity)&nbsp;has a sales office, agency, representative, factory, industry, agents, or distributors in Israel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_65"></A>3.24 Inapplicability of Anti-takeover Statutes</B>. The Boards of Directors of Radiant and Merger Sub have
taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section&nbsp;203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and
the Radiant Voting Agreements and to the consummation of the Merger and the other Contemplated Transactions. No other state takeover statute or similar Law applies or purports to apply to the Merger, this Agreement, the Radiant Voting Agreements or
any of the other Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_66"></A>3.25 Vote Required</B>. The affirmative vote of
(a)&nbsp;the holders of the shares of Radiant Common Stock having voting power representing a majority of the outstanding shares of Radiant Common Stock and (b)&nbsp;the holders of a majority of the votes properly cast at the Radiant Shareholder
Meeting are the only votes of the holders of any class or series of Radiant&#146;s capital stock necessary to approve the Radiant Shareholder Proposals (the &#147;<B>Radiant Shareholder Approval</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_67"></A>3.26 No Financial Advisor</B>. Except as set forth in <I>Section</I><I></I><I>&nbsp;3.26 </I>of the Radiant
Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder&#146;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated
Transactions based upon arrangements made by or on behalf of Radiant or any Subsidiary of Radiant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_68"></A>3.27
No Other Representations or Warranties; Disclaimer of Other Representations and Warranties</B>. Each of Radiant and Merger Sub acknowledges and agrees that, except for the representations and warranties expressly set forth in this Agreement and the
Company Disclosure Schedule (a)&nbsp;the Company is not making and has not made any representations or warranties relating to itself or its business or otherwise in connection with the transactions contemplated by this Agreement, including the
Merger and any such other representations and warranties are hereby expressly disclaimed, and none of Radiant, Merger Sub or their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective Representatives is relying on any representation or warranty of the Company except for those expressly set forth in this Agreement and the Company Disclosure Schedule and (b)&nbsp;any
estimates, projections, predictions, data, financial information, memoranda, presentations or any other materials or information provided or addressed to Radiant, Merger Sub or any of their Representatives are not and shall not be deemed to be or
include representations or warranties unless any such materials or information are the subject of any express representation or warranty set forth in this Agreement or the Company Disclosure Schedule. Notwithstanding the foregoing, nothing herein
shall be deemed to apply to or limit in any way, Radiant&#146;s rights and remedies in the case of fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_69"></A>Section&nbsp;4. CERTAIN COVENANTS OF THE PARTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_70"></A>4.1 Access and Investigation</B>. Subject to the terms of the Confidentiality Agreement which the Parties
agree will continue in full force following the date of this Agreement, during the period commencing on the date of this Agreement and ending at the earlier of the date of termination of this Agreement and the Effective Time (the &#147;<B><FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Period</B>&#148;), upon reasonable notice, each Party shall, and shall use commercially reasonable efforts to cause such Party&#146;s Representatives to: (a)&nbsp;provide the other Party and such other
Party&#146;s Representatives with reasonable access during normal business hours to such Party&#146;s Representatives, personnel and assets and to all existing books, records, Tax Returns, work papers and other documents and information relating to
such Party and its Subsidiaries and (b)&nbsp;provide the other Party and such other Party&#146;s Representatives with such copies of the existing books, records, Tax Returns, work papers, product data, and other documents and information relating to
such Party and its Subsidiaries, and with such additional financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably request; and (c)&nbsp;permit the other Party&#146;s officers
and other employees to meet, upon reasonable notice and during normal business hours, with the chief financial officer and other officers and managers of such Party responsible for such Party&#146;s financial statements and the internal controls of
such Party to discuss such matters as the other Party may deem necessary or appropriate in order to enable the other Party to satisfy its obligations under the Sarbanes-Oxley Act and the rules and regulations relating thereto. Without limiting the
generality of the foregoing, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, each party shall promptly make available to the other Party copies of:<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>(a)&nbsp;any written
materials or communications sent by or on behalf of a Party to all of its shareholders; (b)&nbsp;any notice, report or other document filed with or otherwise furnished, submitted or sent to any Governmental Authority on behalf of a Party in
connection with the Merger or any of the Contemplated Transactions; (c)&nbsp;any <FONT STYLE="white-space:nowrap">non-privileged</FONT> notice, pleading or settlement communication sent by or on behalf of, or sent to, a Party relating to any pending
or threatened material Legal Proceeding involving or affecting such Party; and (d)&nbsp;any notice, report or other document received by a Party from the FDA or any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any investigation conducted by either Radiant or the Company pursuant to this <I>Section</I><I></I><I>&nbsp;4.1</I> shall be conducted in such
manner as to not interfere unreasonably with the conduct of the business of the other Party. Notwithstanding the foregoing, any Party may restrict the foregoing access (a)&nbsp;to the extent that any Law applicable to such Party requires such Party
to restrict or prohibit access to any such properties or information or (b)&nbsp;as may be necessary to preserve the attorney-client privilege under any circumstances in which such privilege may be jeopardized by such disclosure or access
<U>provided</U>, that in each such case, such Party shall use commercially reasonable efforts to cooperate with the other Parties and such Party&#146;s Representatives to enter into appropriate confidentiality, joint defense or similar documents or
arrangements so that such Party and such Party&#146;s Representatives may have access to such information without jeopardizing such privilege. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_71"></A>4.2 Operation of Radiant&#146;s Business</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;4.2</I> of the Radiant Disclosure Schedule, as expressly contemplated by this
Agreement, as required by applicable Law or unless the Company shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period:
(i)&nbsp;Radiant and each Subsidiary of Radiant shall conduct its business and operations in the Ordinary Course of Business and (ii)&nbsp;Radiant and each Subsidiary of Radiant shall use commercially reasonable efforts to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preserve intact its current business organization, use commercially reasonable efforts to keep available the services of its current key employees, officers and other employees and maintain its
relations and goodwill with all suppliers, customers, landlords, creditors, licensors, licensees, employees, regulators and other Persons having business relationships with Radiant or its Subsidiaries. Radiant covenants and agrees to use
commercially reasonable efforts to maintain all rights to Radiant Intellectual Property and to not let any rights to Radiant Intellectual Property lapse or terminate, except in the Ordinary Course of Business or by operation of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, Radiant shall promptly notify the Company in writing, of
any event, condition, fact or circumstance that could reasonably be expected to prevent satisfaction of any of the conditions set forth in <I>Section</I><I></I><I>&nbsp;6</I>, <I>Section</I><I></I><I>&nbsp;7</I> and
<I>Section</I><I></I><I>&nbsp;8</I> on or before the Drop Dead Date. No notification given to the Company pursuant to this <I>Section</I><I></I><I>&nbsp;4.2(b)</I> shall change, limit or otherwise affect any of the representations, warranties,
covenants or obligations of Radiant contained in this Agreement or the Radiant Disclosure Schedule for purposes of <I>Section</I><I></I><I>&nbsp;8.1</I><I> </I>or any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_72"></A>4.3 Operation of the Company&#146;s Business</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in <I>Section</I><I></I><I>&nbsp;4.3(a)</I> of the Company Disclosure Schedule, as expressly contemplated by
this Agreement, as required by applicable Law or unless Radiant shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period:
(i)&nbsp;the Company and each Subsidiary of the Company shall conduct its business and operations (A)&nbsp;in the Ordinary Course of Business and (B)&nbsp;in material compliance with all applicable Laws; (ii)&nbsp;the Company and each Subsidiary of
the Company shall use commercially reasonable efforts to preserve intact its current business organization, use commercially reasonable efforts to keep available the services of its current key employees, officers and other employees and maintain
its relations and goodwill with all suppliers, customers, landlords, creditors, licensors, licensees, employees, regulators and other Persons having business relationships with the Company or its Subsidiaries; and (iii)&nbsp;the Company shall
promptly notify Radiant of any Legal Proceeding against, relating to, involving or otherwise affecting this Agreement or the Contemplated Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, the Company shall promptly notify Radiant in writing, of
any event, condition, fact or circumstance that could reasonably be expected to prevent satisfaction of any of the conditions set forth in <I>Section</I><I></I><I>&nbsp;6</I>, <I>Section</I><I></I><I>&nbsp;7</I> and
<I>Section</I><I></I><I>&nbsp;8</I> on or before the Drop Dead Date. No notification given to Radiant pursuant to this <I>Section</I><I></I><I>&nbsp;4.3(b)</I> shall change, limit or otherwise affect any of the representations, warranties, covenants
or obligations of the Company contained in this Agreement or the Company Disclosure Schedule for purposes of <I>Section</I><I></I><I>&nbsp;7.1</I> or any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_73"></A>4.4 Negative Obligations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except (i)&nbsp;as expressly contemplated by this Agreement, including with respect to the Radiant Post-Closing Financing and the
Radiant Shareholder Proposals, (ii)&nbsp;as set forth in <I>Section</I><I></I><I>&nbsp;4.4(a)</I> of the Radiant Disclosure Schedule, (iii)&nbsp;as required by applicable Law, or (iv)&nbsp;with the prior written consent of the Company (which consent
shall not be unreasonably withheld, delayed or conditioned), at all times during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, neither Radiant nor Merger Sub shall, or shall cause or permit any Subsidiary of Radiant or Merger Sub
to, do any of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> issue, reserve for issuance, set aside or authorize any shares in the capital stock of Radiant
or any of its Subsidiaries or any class of securities convertible or exchangeable into, or rights, warrants or options (subject to <I>Section</I><I></I><I>&nbsp;5.5</I>) to acquire, any such shares of capital stock or such convertible or
exchangeable securities, except for issuing shares of Radiant Common Stock upon exercise of Radiant Stock Options outstanding under Radiant Stock Option Plans as of the date hereof or shares of Radiant Common Stock upon exercise of a Radiant Warrant
outstanding as on the date hereof, in each case in accordance with the terms and conditions of the Radiant Plans, award agreement and/or warranty as applicable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> declare, accrue, set aside or pay any dividend or make any other distribution
in respect of any shares of capital stock; or repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except for shares of Radiant Common Stock from terminated employees of Radiant at actual cost); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> amend the charter, certificate of incorporation, bylaws, articles of association or other charter or organizational documents of
Radiant, Merger Sub or any Subsidiary of Radiant, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> except for contractual commitments in place at the time of this Agreement and disclosed in
<I>Section</I><I></I><I>&nbsp;4.4(a)(iv)</I> of the Radiant Disclosure Schedule, and other than as contemplated by the Contemplated Transactions, sell, issue or grant, authorize the issuance, sale, or grant, amend or modify or agree to amend or
modify the terms of (including by changing any option expiration date, exercise period or vesting schedule) or make any commitments to do any of the foregoing: (A)&nbsp;any capital stock or other security (except for Radiant Common Stock issued upon
the valid exercise of outstanding Radiant Stock Options); (B) any option, warrant, right or other award to acquire any capital stock or any other security; or (C)&nbsp;any instrument convertible into, exercisable or exchangeable for any capital
stock or other security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> form any Subsidiary or acquire any equity interest or other interest in any other Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> lend money to any Person; incur or guarantee any Indebtedness for borrowed money; issue or sell any debt securities or options,
warrants, calls or other rights to acquire any debt securities; guarantee any debt securities of others; or make any capital expenditure, or commitment therefor in excess of $500,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(vii)</B> adjust or otherwise accelerate the vesting, exercisability or payment of, any Radiant Stock Options or Radiant restricted stock
awards outstanding under Radiant Stock Option Plans as of the date hereof, and, other than as required by Law or any Radiant Employee Program: (A)&nbsp;adopt, establish or enter into or terminate any Radiant Employee Program; (B)&nbsp;cause or
permit any Radiant Employee Program to be amended, terminated or rights thereunder to be accelerated, other than as required by Law; (C)&nbsp;hire any new employee or consultant or terminate any key employee (in each case, other than employees or
consultants with a base salary or fee in an amount not exceeding $100,000 on an annual basis), or (D)&nbsp;grant, make or pay any severance, bonus or profit-sharing or similar payment (including any special or transaction payments) to, or increase
the amount of the wages, salary, commissions, fringe benefits or other compensation, remuneration or benefits (including accelerated equity vesting) payable to, any of its directors, employees or consultants; in each case, except in the Ordinary
Course of Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(viii)</B> acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material
assets, properties or rights, or grant any Encumbrance with respect to such assets, properties or rights; in each case, except in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ix)</B> make, change or revoke any material Tax election; file any material amendment to any Tax Return; adopt or change any material
accounting method in respect of Taxes; change any material annual Tax accounting period; settle or compromise any claim, notice, audit report or assessment in respect of material Taxes (other than the Withholding Tax Ruling and the Options Tax
Ruling); apply for or enter into any ruling from any Tax authority with respect to Taxes; or surrender any right to claim a material Tax refund; in each case, except in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(x)</B> enter into, amend or terminate any Radiant Material Contract other than in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xi)</B> settle any lawsuit, claim, action, suit, proceeding, investigation or other Legal Proceeding, whether civil, criminal,
administrative or investigative, other than (A)&nbsp;for routine collection of bills or (B)&nbsp;for a breach of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xii)</B> adopt a plan of complete or partial liquidation or authorize or undertake a
dissolution, merger, consolidation, restructuring, recapitalization or other reorganization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xiii)</B> apply for, negotiate or
obtain a Governmental Grant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xiv)</B> enter into a new line of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xv)</B> take any action to delist, deregister or any other action the effect of which would reasonably be expected to result in Radiant
ceasing to be a reporting company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xvi)</B> terminate or cancel any insurance coverage policy maintained by Radiant or any of its
Subsidiaries that is not promptly replaced by a comparable amount of insurance coverage; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xvii)</B> agree to take, take or permit any
Subsidiary of Radiant to take or agree to take, any of the actions specified in clauses <I>(i)</I>&nbsp;through <I>(xv) </I>of this <I>Section</I><I></I><I>&nbsp;4.4(a)</I>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xviii)</B> fail to timely tender any fees or make any required prosecution or maintenance payments relating to any Radiant Intellectual
Property or allow any material rights to Radiant Intellectual Property to lapse or terminate, except in the Ordinary Course of Business or by operation of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except (i)&nbsp;as expressly contemplated by this Agreement, including with respect to the Radiant Post-Closing Financing,
(ii)&nbsp;as set forth in <I>Section</I><I></I><I>&nbsp;4.4(b)</I> of the Company Disclosure Schedule, (iii)&nbsp;as required by applicable Law, or (iv)&nbsp;with the prior written consent of Radiant (which consent shall not be unreasonably
withheld, delayed or conditioned), at all times during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, the Company shall not, nor shall it cause or permit any Subsidiary of the Company to, do any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> issue, reserve for issuance, set aside or authorize any shares in the capital stock of the Company or any of its Subsidiaries or
any class of securities convertible or exchangeable into, or rights, warrants or options to acquire, any such shares of capital stock or such convertible or exchangeable securities except for issuing shares of Company Ordinary Shares upon exercise
of Company Options outstanding under the Company Option Plan as of the date hereof or shares of the Company upon exercise of a Company Warrant; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of capital stock; or
repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except for shares of Company Ordinary Shares from terminated employees of the Company at actual cost); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> except as set forth in <I>Section</I><I></I><I>&nbsp;4.4(b)(iii)</I> of the Company Disclosure Schedule, amend the Company
Charter or other charter or organizational documents of the Company, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or
similar transaction; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> except for contractual commitments in place at the time of this Agreement and disclosed in
<I>Section</I><I></I><I>&nbsp;4.4(b)(iv)</I> of the Company Disclosure Schedule, and other than as contemplated by the Contemplated Transactions, sell, issue or grant, authorize the issuance, sale, or grant, amend or modify or agree to amend or
modify the terms of (including by changing any option expiration date, exercise period or vesting schedule) or make any commitments to do any of the foregoing, other than as contemplated by the Contemplated Transactions: (A)&nbsp;any capital stock
or other security (except for outstanding Company Share Capital issued upon the valid exercise of Company Options and/or Company Warrants,); (B) any option, warrant or right to acquire any capital stock or any other security; or (C)&nbsp;any
instrument convertible into, exercisable or exchangeable for any capital stock or other security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> form any Subsidiary or
acquire any equity interest or other interest in any other Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> lend money to any Person; incur or guarantee any Indebtedness for borrowed
money; issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities; guarantee any debt securities of others; or make any capital expenditure or commitment therefor in excess of $500,000, in each case,
other than pursuant to commitments and similar arrangements which are in existence as of the date hereof; provided that the Company may incur additional indebtedness of up to $4,000,000 under its existing credit facility with Madryn Health Partners,
LP and its affiliates; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(vii)</B> other than as required by Law or any Company Employee Program: (A)&nbsp;terminate any key employee
(other than employees with a base salary in an amount not exceeding $100,000 on an annual basis); or (B)&nbsp;grant, make or pay bonus or profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, fringe benefits
or other compensation, remuneration or benefits (including accelerated equity vesting) payable to, any of its directors, employees or consultants (in each case, other than normal merit increases or annual bonuses to employees made in the Ordinary
Course of Business);<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(viii)</B> make, change or revoke any material Tax
election; file any material amendment to any Tax Return; adopt or change any material accounting method in respect of Taxes; change any material annual Tax accounting period; settle or compromise any claim, notice, audit report or assessment in
respect of material Taxes; apply for or enter into any ruling from any Tax authority with respect to Taxes (other than the Options Tax Ruling and the Withholding Tax Ruling); or surrender any right to claim a material Tax refund; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ix)</B> enter into, amend or terminate any Company Material Contract other than in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(x)</B> commence, threaten, litigate and/or settle a lawsuit, claim, action, suit, proceeding, investigation or other Legal Proceeding,
whether civil, criminal, administrative or investigative, other than (A)&nbsp;for routine collection of bills, (B)&nbsp;for a breach of this Agreement or (C)&nbsp;in connection with Legal Proceedings disclosed in
<I>Schedule</I><I></I><I>&nbsp;2.20</I>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xi)</B> adopt a plan of complete or partial liquidation or authorize or undertake a
dissolution, merger, consolidation, restructuring, recapitalization or other reorganization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xii)</B> enter into a new line of
business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xiii)</B> modify, terminate or cancel any insurance coverage policy maintained by the Company or any of its Subsidiaries
that is not promptly replaced by a comparable amount of insurance coverage; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xiv)</B> fail to make any material payment with respect
to any of the Company&#146;s accounts payable or Indebtedness in a timely manner in accordance with the terms thereof and consistent with past practices; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(xv)</B> agree to take, take or permit any Subsidiary of the Company to take or agree to take, any of the actions specified in clauses
(i)&nbsp;through <I>(xiv)</I> of this <I>Section</I><I></I><I>&nbsp;4.4(b)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_74"></A>4.5 <FONT
STYLE="white-space:nowrap">Non-Solicitation</FONT> by Radiant</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as expressly permitted by this
<I>Section</I><I></I><I>&nbsp;4.5</I>, without the prior written consent of the Company, none of Radiant, its Subsidiaries or any Representative of Radiant or any of its Subsidiaries shall directly or indirectly (i)&nbsp;initiate, solicit, propose,
seek or knowingly encourage, facilitate or support any inquiries, indications of interest, proposals or offers that constitute or may reasonably be expected to lead to, a Radiant Acquisition Proposal (as defined below), (ii) engage in, continue,
facilitate or otherwise participate in any discussions or negotiations regarding, or furnish any nonpublic information or data to any Person in connection with, any inquiries, indications of interest, proposals or offers that constitute, or may
reasonably be expected to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
lead to, a Radiant Acquisition Proposal, (iii)&nbsp;enter into any letter of intent, indication of interest, agreement in principle or other similar type of agreement relating to a Radiant
Acquisition Proposal, or enter into any agreement or agreement in principle requiring Radiant to abandon, terminate or fail to consummate the transactions contemplated hereby or resolve, propose or agree to do any of the foregoing,
(iv)&nbsp;approve, endorse or recommend any Radiant Acquisition Proposal, or (v)&nbsp;fail to include in the Proxy Statement the Radiant Recommendation; <U>provided</U><I>, </I><U>however</U>, that (x)&nbsp;Radiant and its Representatives may
ascertain facts from the Person making an unsolicited Radiant Acquisition Proposal for the sole purpose of the Board of Directors of Radiant informing itself about the terms of such Radiant Acquisition Proposal and the Person that made it and
(y)&nbsp;prior to the approval of the Radiant Shareholder Proposals at the Radiant Shareholder Meeting, Radiant may take the following actions in response to an unsolicited bona fide written Radiant Acquisition Proposal received from a third party
after the date of this Agreement that the Board of Directors of Radiant has determined, in good faith, after consultation with its outside counsel and independent financial advisors, constitutes, or would reasonably be expected to lead to, a Radiant
Superior Offer: (A)&nbsp;furnish nonpublic information regarding Radiant to the third party making the Radiant Acquisition Proposal (a &#147;<B>Radiant Qualified Bidder</B>&#148;); and (B)&nbsp;engage in discussions or negotiations with the Radiant
Qualified Bidder and its representatives with respect to such Radiant Acquisition Proposal; <U>provided</U> that (1)&nbsp;Radiant receives from the Radiant Qualified Bidder an executed Acceptable Confidentiality Agreement (a copy of such
confidentiality agreement shall promptly, and in any event within twenty-four (24)&nbsp;hours, be provided to Company for informational purposes only), (2) Radiant promptly, and in any event within twenty-four (24)&nbsp;hours, supplies to Company
any such nonpublic information or access to any such nonpublic information to the extent it has not been previously provided or made available to Company, (3)&nbsp;neither Radiant nor any Subsidiary or Representative of Radiant or any Subsidiary has
breached this <I>Section</I><I></I><I>&nbsp;4.5</I>, and (4)&nbsp;the Board of Directors of Radiant determines in good faith, after consultation with its outside legal counsel and financial advisors, that failure to take such actions would
reasonably be expected to be inconsistent with the fiduciary duties of the Board of Directors of Radiant under applicable Laws. Without limiting the generality of the foregoing, Radiant acknowledges and agrees that any violation of any of the
restrictions set forth in the preceding sentence by any Representative of Radiant or any of its Subsidiaries, whether or not such Representative is purporting to act on behalf of Radiant or any of its Subsidiaries, shall be deemed to constitute a
breach of this <I>Section</I><I></I><I>&nbsp;4.5(a)</I> by Radiant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> For purposes of this Agreement, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> &#147;<B>Radiant Acquisition Proposal</B>&#148; means any proposal, indication of interest or offer for (A)&nbsp;a merger
(including a reverse merger), tender offer, recapitalization, reorganization, liquidation, dissolution, business combination, share exchange, arrangement or consolidation, or any similar transaction involving Radiant or its Subsidiaries, (B)&nbsp;a
sale, lease, exchange, mortgage, pledge, transfer or other acquisition of assets representing twenty five percent (25%) or more of the consolidated revenues, net income or assets of Radiant and its Subsidiaries, taken as a whole, in one or a series
of related transactions, or (C)&nbsp;a purchase, tender offer or other acquisition (including by way of merger, consolidation, share exchange, arrangement, consolidation or otherwise) of beneficial ownership (the term &#147;beneficial
ownership&#148; for purposes of this Agreement having the meaning assigned thereto in Section&nbsp;13(d) of the Exchange Act and the rules and regulations thereunder) of securities representing twenty five percent (25%) or more of the voting power
of Radiant (including securities of Radiant currently beneficially owned by such Person); provided, however, that the term &#147;Radiant Acquisition Proposal&#148; shall not include (1)&nbsp;the Merger or the other transactions contemplated by this
Agreement or (2)&nbsp;or the Radiant Post-Closing Financing; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> &#147;<B>Radiant Superior Offer</B>&#148; shall mean an
unsolicited bona fide Radiant Acquisition Proposal (with all references to &#147;twenty five percent (25%)&#148;<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>in the definition of Radiant Acquisition Proposal being treated as references to
&#147;seventy-five percent (75%)&#148;<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>for these purposes) made by a third party that the Board of Directors of Radiant determines in good faith, after consultation with its outside legal counsel
and financial advisor, and after taking into account all financial, legal, regulatory, and other aspects of such Radiant Acquisition Proposal (including the financing terms and the ability of such third party to finance such Radiant Acquisition
Proposal), (A) is more favorable from a financial point of view to the Radiant Shareholders than as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided hereunder (including any changes to the terms of this Agreement proposed by the Company in response to such Radiant Superior Offer pursuant to and in accordance with
<I>Section</I><I></I><I>&nbsp;4.5(d)</I> or otherwise) and (B)&nbsp;is reasonably capable of being completed on the terms proposed without unreasonable delay. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Except as otherwise provided in <I>Section</I><I></I><I>&nbsp;4.5(d)</I>, neither the Board of Directors of Radiant nor any
committee of the Board of Directors of Radiant shall (i)&nbsp;fail to make, withhold, withdraw, amend, qualify, change or publicly propose to withhold, withdraw, amend, qualify or change in a manner adverse to the Company, the Radiant
Recommendation, (ii)&nbsp;knowingly make any public statement inconsistent with such recommendation, (iii)&nbsp;fail to recommend against acceptance of a tender offer within ten (10)&nbsp;Business Days after commencement, (iv)&nbsp;approve, adopt or
recommend or propose publicly to approve, adopt or recommend any Radiant Acquisition Proposal, (v)&nbsp;make any public statement inconsistent with its recommendation, (vi)&nbsp;fail to include the Radiant Recommendation in the Proxy Statement or
(vii)&nbsp;allow Radiant to execute or enter into any letter of intent, agreement in principle or other similar type of agreement relating to any Radiant Acquisition Proposal (any action described in this sentence being referred to as a
&#147;<B>Radiant Change of Recommendation</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Notwithstanding anything in this <I>Section</I><I></I><I>&nbsp;4.5
</I>to the contrary, if at any time prior to the approval of the Radiant Shareholder Proposals at the Radiant Shareholder Meeting, Radiant receives a Radiant Acquisition Proposal from a third party (which did not result from or arise out of or in
connection with a breach of this Agreement) that the Board of Directors of Radiant determines in good faith, after consultation with its outside legal counsel and financial advisors, constitutes a Radiant Superior Offer and the Board of Directors of
Radiant determines in good faith (after consultation with outside legal counsel and financial advisor) that failure to effect a Radiant Change of Recommendation would reasonably be expected to be inconsistent with the fiduciary duties of the Board
of Directors of Radiant under applicable Laws, the Board of Directors of Radiant may (i)&nbsp;effect a Radiant Change of Recommendation, and/or (ii)&nbsp;terminate this Agreement in accordance with <I>Section</I><I></I><I>&nbsp;9.1(i)</I> in order
to enter into a definitive agreement for a Radiant Superior Offer; <U>provided</U>, <U>however</U>, that such actions may only be taken (A)&nbsp;at a time that is after the fourth (4th) Business Day following Company&#146;s receipt of written notice
from Radiant that the Board of Directors of Radiant and/or a committee thereof is prepared to take such action (which notice will specify the identity of the Person making such Radiant Superior Offer and a summary of the material terms of the
applicable Radiant Superior Offer, including a copy of the proposed definitive agreement), and (B)&nbsp;at the end of such period, the Board of Directors of Radiant and/or a committee thereof determines in good faith, after taking into account all
amendments or revisions to this Agreement proposed by Company and after consultation with Radiant&#146;s outside legal counsel and financial advisors, that such Radiant Superior Offer remains a Radiant Superior Offer and (C)&nbsp;if requested by the
Company during such four (4)&nbsp;Business Day period, Radiant engages in good faith negotiations with the Company to consider amendments to this Agreement proposed by the Company that would result in the offer that was determined to constitute a
Radiant Superior Offer no longer constituting a Radiant Superior Offer. During any such four (4)&nbsp;Business Day period, the Company shall be entitled to deliver to Radiant one or more counterproposals to amend this Agreement so as to cause such
Radiant Superior Offer to no longer be a Radiant Superior Offer (it being understood that any change in the purchase price or form of consideration in such Radiant Superior Offer shall be deemed a material modification and shall trigger a new notice
and negotiation period as provided above, except that the four (4)&nbsp;Business Day notice period shall instead be equal to two (2)&nbsp;Business Days). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Notwithstanding anything to the contrary in this <I>Section</I><I></I><I>&nbsp;4.5</I>, if, at any time prior to the approval of
the Radiant Shareholder Proposals at the Radiant Shareholder Meeting, the Board of Directors of Radiant determines in good faith, after consultation with its outside legal counsel and financial advisors, that there has been a Radiant Intervening
Event, the Board of Directors of Radiant may effect a Radiant Change of Recommendation if (i)&nbsp;Radiant notifies the Company, in writing, four (4)&nbsp;Business Days before making a Radiant Change of Recommendation that the Board of Directors of
Radiant and/or a committee thereof intends to consider such action, which notice shall include a reasonably detailed description of the material facts and circumstances giving rise to the applicable Radiant Intervening Event, which notice shall not,
by itself, constitute a Radiant Change of Recommendation, (ii)&nbsp;if requested by the Company during such four (4)&nbsp;Business Day </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period, Radiant engages in good faith negotiations with the Company to amend this Agreement in such a manner that the underlying facts giving rise to, and the reasons for taking such action,
ceases to constitute a Radiant Intervening Event, and (iii)&nbsp;the Board of Directors of Radiant determines in good faith after taking into account all amendments or revisions to this Agreement proposed by the Company and, after consultation with
its outside legal counsel and financial advisors, that the failure to make a Radiant Change of Recommendation would reasonably be expected to be inconsistent with the fiduciary duties of the Board of Directors of Radiant under applicable Law.
Radiant acknowledges and hereby agrees that any Radiant Change of Recommendation effected (or proposed to be effected) in response to or in connection with any Radiant Acquisition Proposal may be made pursuant to
<I>Section</I><I></I><I>&nbsp;4.5(d)</I> only, and may not be made pursuant to this <I>Section</I><I></I><I>&nbsp;4.5(e)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>
Nothing contained in this Agreement shall prohibit Radiant or the Radiant Board of Directors from complying with Rules <FONT STYLE="white-space:nowrap">14d-9</FONT> and <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> promulgated under the Exchange
Act; <U>provided</U>, <U>however</U>, that any disclosure made by Radiant or the Radiant Board of Directors pursuant to Rules <FONT STYLE="white-space:nowrap">14d-9</FONT> and <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> shall be limited to a
statement that Radiant is unable to take a position with respect to the bidder&#146;s tender offer unless the Radiant Board of Directors determines in good faith, after consultation with its outside legal counsel, that such statement would result in
a breach of its fiduciary duties under applicable Law; <U>provided</U> further, that any such disclosures (other than a &#147;stop, look and listen&#148; communication or similar communication of the type contemplated by <FONT
STYLE="white-space:nowrap">Section&nbsp;14d-9(f)</FONT> under the Exchange Act) shall be deemed to be a Radiant Change of Recommendation unless the Radiant Board of Directors expressly publicly reaffirms the Radiant Recommendation (i)&nbsp;in such
communication or (ii)&nbsp;within five (5)&nbsp;
Business Days after being requested in writing to do so by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_75"></A><B>4.6 Notification of
Solicitation</B>. Radiant shall notify the Company no later than twenty-four (24)&nbsp;hours after receipt of any Radiant Acquisition Proposal and any such notice shall be made orally and in writing and shall indicate in reasonable detail the
material terms and conditions of such Radiant Acquisition Proposal, and the identity of the offeror. Radiant shall keep the Company informed, on a current basis, of the status and material developments (including any changes to the terms) of such
Radiant Acquisition Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_76"></A><B>4.7 Standstill</B>. Radiant shall, and shall cause each of its
Subsidiaries and their Representatives to, immediately cease and cause to be terminated any and all existing activities, discussions or negotiations with any Person conducted heretofore with respect to, or that may reasonably be expected to lead to,
a Radiant Acquisition Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_77"></A><B>4.8 Cooperation with Financing</B>. Prior to the Closing, Radiant shall
use its commercially reasonable efforts to provide, and shall cause its Subsidiaries to provide, and shall cause its representatives, directors, officers, employees, consultants and advisors, including its legal and accounting advisors (in each case
at the Company&#146;s sole expense with respect to any reasonable, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> and documented costs and expenses incurred by Radiant or its Subsidiaries in connection
therewith) to provide, such cooperation as is reasonably requested by the Company in connection with causing the conditions in the Financing Consent Letters to be satisfied, including: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> furnishing to the Company and the other parties to the Financing Consent Letters, all reasonable financial and other pertinent
information regarding Radiant and its Subsidiaries (including their businesses, operations and existing financial projections) as may be reasonably requested as promptly as reasonably practicable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> executing and delivering definitive financing documents, including guarantee and collateral documents, currency or interest
hedging arrangements and other certificates and documents as may be reasonably requested by the Company; provided that such documents shall only be effective at or after Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> facilitating the pledging of collateral and reasonable cooperation in connection with the payoff of existing indebtedness for
borrowed money of Radiant and its Subsidiaries and the release of related liens, provided further that such pledges, payoffs and releases shall only be effective at Closing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> executing and delivering a certificate of the chief financial officer of such
Party (solely on behalf of such Party and not in such person&#146;s individual capacity) with respect to the solvency of Radiant and its Subsidiaries; provided that such documents shall only be effective at Closing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> cooperating with requests for due diligence to the extent customary and reasonable and to the extent available to such Party and
its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> providing reasonable access to Radiant&#146;s and its Subsidiaries&#146;&#146; current assets, cash
management and accounting systems, and policies and procedures relating thereto, for the purpose of establishing collateral arrangements (including allowing access for field exams, collateral audits, asset appraisals, surveys, Phase I environmental
site assessments and engineering and property condition reports); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> at least three (3)&nbsp;Business Days prior to the
Closing Date, providing all documentation and other information about Radiant and each of its Subsidiaries as is reasonably requested in writing by the Party at least ten (10)&nbsp;Business Days prior to the Closing Date that is required to be
delivered pursuant to paragraph 8 of Exhibit B to the Financing Consent Letter relating to &#147;know your customer&#148; and anti-money laundering rules and regulations including the USA PATRIOT Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> Notwithstanding the foregoing, (x)&nbsp;nothing in this <I>Section</I><I></I><I>&nbsp;4.8</I> shall require any such cooperation
to the extent it would unreasonably interfere with the business or operations of Radiant and its Subsidiaries and (y)&nbsp;none of Radiant or any of its Subsidiaries shall be required to pay any commitment or other fee or incur any other liability
or obligation in connection with the Financing Consent Letters or be required to take any action that would subject it to actual or potential liability, to bear any cost or expense or to pay any commitment or other similar fee or make any other
payment or agree to provide any indemnity in connection with the Financing Consent Letters or any of the foregoing, in each case, that is effective prior to the Closing. For the avoidance of doubt, none of Radiant or its Subsidiaries or their
respective officers, directors or employees shall be required to execute or enter into or perform any agreement with respect to the Financing Consent Letters that is not contingent upon the Closing or that would be effective prior to the Closing.
The Company shall indemnify and hold harmless Radiant and its Subsidiaries and their respective directors, officers, employees, accountants, consultants, legal counsel and other agents (each, an &#147;<B>Indemnified Party</B>&#148;) from and against
any and all losses and reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses suffered or incurred by them in connection with the Financing Consent Letters and the performance of their
respective obligations under this <I>Section</I><I></I><I>&nbsp;4.8</I> and any information utilized in connection therewith (except to the extent directly resulting from the gross negligence, willful misconduct and/or fraud of such Indemnified
Party; provided, that Radiant and its respective Affiliates, and not the Company, shall be responsible for any general expenses incurred in connection with the transactions contemplated hereby to the extent such expenses are not exclusively related
to the performance of such Indemnified Party&#146;s obligations under this <I>Section</I><I></I><I>&nbsp;
4.8</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_78"></A><B>4.9 <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> by the Company</B><B></B>. Without
the prior written consent of Radiant, none of the Company, its Subsidiaries or any Representative of the Company or any of its Subsidiaries shall directly or indirectly (a)&nbsp;initiate, solicit, propose, seek or knowingly encourage, facilitate or
support any inquiries, indications of interest, proposals or offers that constitute or may reasonably be expected to lead to, a Company Alternative Transaction (as defined below), (b) engage in, continue, facilitate or otherwise participate in any
discussions or negotiations regarding, or furnish any nonpublic information or data to any Person in connection with, any inquiries, indications of interest, proposals or offers that constitute, or may reasonably be expected to lead to, a Company
Alternative Transaction, (c)&nbsp;enter into any letter of intent, indication of interest, agreement in principle or other similar type of agreement relating to a Company Alternative Transaction, or enter into any agreement or agreement in principle
requiring the Company to abandon, terminate or fail to consummate the transactions contemplated hereby or resolve, propose or agree to do any of the foregoing. For purposes of this <I>Section</I><I></I><I>&nbsp;4.9</I>, &#147;<B>Company Alternative
Transaction</B>&#148; means any transaction involving (a)&nbsp;the direct or indirect sale, license, disposition or acquisition of any material portion of the business or assets of the Company or any of its Subsidiaries, (b)&nbsp;the direct or
indirect issuance, grant, disposition or acquisition of (i)&nbsp;any shares of capital stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other equity security of the Company or any of its Subsidiaries, (ii)&nbsp;any option, call, warrant or right (whether or not immediately exercisable) to acquire any shares of capital stock or
other equity security of the Company or any of its Subsidiaries, or (iii)&nbsp;any security, instrument or obligation that is or may become convertible into or exchangeable for any shares of capital stock or other equity security of the Company or
any of its Subsidiaries, or (c)&nbsp;any merger, consolidation, dissolution, business combination, reorganization or similar transaction involving the Company or any of its Subsidiaries, in each case with respect to the foregoing clauses
(a)&nbsp;through (c), that could reasonably be expected to prevent or materially delay the consummation of the Merger on or before the Drop Dead Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_79"></A>Section&nbsp;5. ADDITIONAL AGREEMENTS OF THE PARTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_80"></A>5.1 Disclosure Documents; Merger Proposal; Registration. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> As promptly as practicable after the date of this Agreement, (i)&nbsp;Radiant shall prepare and file with the SEC a proxy
statement relating to the Radiant Shareholder Meeting to be held in connection with the Merger (together with any amendments thereof or supplements thereto, the &#147;<B>Proxy Statement</B>&#148;) and (ii)&nbsp;Radiant, in cooperation with the
Company, shall prepare and file with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the &#147;<B>Form <FONT STYLE="white-space:nowrap">S-4</FONT></B>&#148;), in which the Proxy Statement shall be included as a
part (the Proxy Statement and the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> collectively, the &#147;<B>Registration Statement</B>&#148;), in connection with the registration under the Securities Act of the shares of Radiant Common Stock to
be issued by virtue of the Merger. Each of Radiant and the Company shall use their commercially reasonable efforts to cause the Registration Statement to become effective as promptly as practicable, and shall take all or any action required under
any applicable federal, state, securities and other Laws in connection with the issuance of shares of Radiant Common Stock pursuant to the Merger. Each of Radiant, Merger Sub and the Company shall furnish all information concerning itself and their
Subsidiaries, as applicable, to the other parties as the other parties may reasonably request in connection with such actions and the preparation of the Registration Statement and Proxy Statement. Except with respect to any information regarding or
provided by the Company, Radiant covenants and agrees that the Registration Statement (and the letter to shareholders, notice of meeting and form of proxy included therewith), as of the date it is mailed to its shareholders and as of the date of the
Radiant Shareholder Meeting, will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under
which they were made, not misleading. The Company covenants and agrees that the information supplied by the Company or its Subsidiaries to Radiant for inclusion in the Registration Statement (including the Company Financial Statements) will not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make such information, in light of the circumstances under which they were made, not misleading. Radiant shall
use commercially reasonable efforts to cause the Proxy Statement to be mailed to its shareholders as promptly as practicable after the Registration Statement is declared effective by the SEC. If Radiant, Merger Sub or the Company become aware of any
event or information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Registration Statement or Proxy Statement, as the case may be, then such party, as the case may be, shall
promptly inform the other parties thereof and shall cooperate with such other parties in filing such amendment or supplement with the SEC and, if appropriate, in mailing such amendment or supplement to the Radiant Shareholders. Notwithstanding
anything to the contrary stated above, prior to filing and mailing, as applicable, the Registration Statement or Proxy Statement (or any amendment or supplement thereto) or responding to any comments of the SEC with respect thereto, Radiant shall
provide the Company a reasonable opportunity to review and comment on such document or response and shall discuss with the Company and consider in good faith comments reasonably proposed by the Company. Radiant will advise the Company, promptly
after Radiant receives notice thereof, of the time when the Registration Statement has become effective or any supplement or amendment has been filed, of the issuance of any stop order or the suspension of the qualification of Radiant Common Stock
for offering or sale in any jurisdiction, of the initiation or threat of any proceeding for any such purpose, or of any request by the SEC for the amendment or supplement of the Registration Statement or for additional information. The Company shall
reasonably cooperate with Radiant and provide Radiant, and use its reasonable best efforts to cause its Representatives to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provide, Radiant and its Representatives, advisors, accountants and attorneys, with all information regarding the Company that is required by legal requirement to be included in the Form <FONT
STYLE="white-space:nowrap">S-4</FONT> or reasonably requested from the Company to be included in the Form <FONT STYLE="white-space:nowrap">S-4</FONT> which information will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances, under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Subject to the ICL, as soon as reasonably practicable following the date of this Agreement, each of the Company and Merger Sub
shall (and Radiant shall cause Merger Sub to), as applicable, take the following actions within the timeframes set forth in this <I>Section</I><I></I><I>&nbsp;5.1(b)</I>: (i) as promptly as practicable following the date hereof, cause a merger
proposal (in the Hebrew language) reflecting the Merger, the Contemplated Transactions and this Agreement in a form complying with the ICL and reasonably acceptable to the Parties (the &#147;<B>Merger Proposal</B>&#148;) to be executed in accordance
with Section&nbsp;316 of the ICL; (ii)&nbsp;deliver the Merger Proposal to the Companies Registrar within three (3)&nbsp;days of the calling of the Company Shareholder Meeting; (iii)&nbsp;cause a copy of the Merger Proposal to be delivered to its
secured creditors, if any, no later than three days after the date on which the Merger Proposal is delivered to the Companies Registrar; (iv)&nbsp;(A) publish a notice to its creditors in a form acceptable to the Parties, stating that a Merger
Proposal was submitted to the Companies Registrar and that the creditors may review the Merger Proposal at the office of the Companies Registrar, the Company&#146;s registered offices or Merger Sub&#146;s registered offices, as applicable, and at
such other locations as the Company or Merger Sub, as applicable, may determine, in (x)&nbsp;two daily Hebrew newspapers circulated in Israel, on the day that the Merger Proposal is delivered to the Companies Registrar, and (y)&nbsp;in a popular
newspaper outside of Israel within three Business Days after the date on which the Merger Proposal is delivered to the Companies Registrar if required by applicable Law; (B)&nbsp;within four Business Days from the date of submitting the Merger
Proposal to the Companies Registrar, send a notice, in a form acceptable to the Parties, by registered mail to all of its &#147;Substantial Creditors&#148; (as such term is defined in the Israeli Companies Regulations (Merger), 5760-2000 (the
&#147;<B>Merger Regulations</B>&#148;)) of which the Company or Merger Sub, as applicable, is aware, in which it shall state that a Merger Proposal was submitted to the Companies Registrar and that the creditors may review the Merger Proposal at
such additional locations, if such locations were determined in the notice referred to in clause (A)&nbsp;above and at such times stated in the notice referred to in clause (A)&nbsp;above; (C) if required under the ICL, send to the Company&#146;s
&#147;workers committee&#148;, if any, or display in a prominent place on the Company&#146;s premises a copy of the notice published in a daily Hebrew newspaper (as referred to in clause (A)&nbsp;above), no later than three Business Days following
the day on which the Merger Proposal was submitted to the Companies Registrar; (v)&nbsp;promptly after the Company and Merger Sub, as applicable, shall have complied with the preceding clauses (iii)&nbsp;and (iv) above, but in any event no more than
three (3)&nbsp;days following the date on which notice was sent to the creditors under clause (iii)&nbsp;above, inform the Companies Registrar, in accordance with Section&nbsp;317(b) of the ICL and Regulation 5 of the Merger Regulations, that notice
was given to their respective creditors under Section&nbsp;318 of the ICL; (vi)&nbsp;not later than three (3)&nbsp;days after the date on which (x)&nbsp;the Company Shareholder Approval is received and (y)&nbsp;the sole shareholder of Merger Sub
approves the Merger, the Contemplated Transactions and this Agreement, the Company or Merger Sub, as applicable, shall inform (in accordance with Section&nbsp;317(b) of ICL) the Companies Registrar of such approval in a form acceptable to the
Parties, and (vii)&nbsp;following fulfillment or waiver of all of the conditions for Closing set forth in<I> Section</I><I></I><I>&nbsp;6</I>, <I>Section</I><I></I><I>&nbsp;7</I> and <I>Section</I><I></I><I>&nbsp;8</I> of this Agreement, inform the
Companies Registrar of such fulfillment or waiver and, in accordance with the customary practice of the Companies Registrar, request that the Companies Registrar declare the Merger effective and issue the Certificate of Merger upon such date, as the
Company and Merger Sub shall advise the Companies Registrar. For the avoidance of doubt, and notwithstanding any provision of this Agreement to the contrary, it is the intention of the Parties that the Merger shall be declared effective and the
Certificate of Merger shall be issued on the Closing Date, as a condition to the Closing taking place. For purposes of this <I>Section</I><I></I><I>&nbsp;5.1(b)</I>, &#147;Business Day&#148; shall have the meaning set forth in the Merger
Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Concurrently with the Company Shareholder Meeting, the sole shareholder of Merger Sub shall approve the Merger,
the Contemplated Transactions and this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_81"></A><B>5.2 Shareholder Approval</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <I>Company Shareholder Meeting</I>. As promptly as practicable after the date of this Agreement (but not before the amendment of
the Company Charter described in <I>Section</I><I></I><I>&nbsp;4.4(b)(iii)</I> of the Company Disclosure Schedule), the Company shall take all action necessary in accordance with applicable Laws and the Company Charter to call, give notice of,
convene and hold a meeting of the Company Shareholders (the &#147;<B>Company Shareholder Meeting</B>&#148;) to consider and vote on proposals to approve this Agreement, the Merger and the other Contemplated Transactions (collectively, the
&#147;<B>Company Shareholder Proposals</B>&#148;). Notwithstanding anything else to the contrary herein, the Company may postpone or adjourn the Company Shareholder Meeting (i)&nbsp;with the consent of Radiant, (ii)&nbsp;for the absence of a quorum,
or (iii)&nbsp;if the Company reasonably determines that the failure to adjourn, postpone or delay the Company Shareholder Meeting would be reasonably likely not to allow sufficient time for the distribution of any required or appropriate supplement
or amendment to the Company Shareholder Meeting Notice. The Board of Directors of the Company has recommended that the Company Shareholders approve the Company Shareholder Proposals (the &#147;<B>Company Recommendation</B>&#148;). The Company shall
ensure that all proxies solicited in connection with the Company Shareholder Meeting are solicited in material compliance with all applicable Laws. All materials (including any amendments thereto) submitted to the shareholders of the Company in
accordance with this <I>Section</I><I></I><I>&nbsp;5.2(a) </I>shall be subject to Radiant&#146;s review and the Company shall consider in good faith all reasonable comments proposed by Radiant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <I>Radiant Shareholder Meeting</I>. As promptly as practicable after the Registration Statement has been declared effective under
the Securities Act, Radiant shall take all action necessary in accordance with applicable Laws and the Radiant Charter and Radiant Bylaws to promptly call, give notice of, convene and hold a meeting of the Radiant Shareholders (the &#147;<B>Radiant
Shareholder Meeting</B>&#148;) to consider and vote on proposals to approve (i)&nbsp;an amendment to the Radiant Charter to effect a reverse stock split of the Radiant Common Stock at a ratio between 1 to 10 and 1 to 15 (the &#147;<B>Reverse Stock
Split</B>&#148;), to be determined at the discretion of the Radiant Board of Directors, subject to the Radiant Board of Directors&#146; discretion to abandon such amendment, (ii)&nbsp;the issuance of the shares of Radiant Common Stock by virtue of
the Merger and the Post-Closing Financing, (iii)&nbsp;an increase in the number of shares of Radiant Common Stock to the number necessary to issue the number of shares of Radiant Common Stock contemplated (1)&nbsp;by this Agreement and (2)&nbsp;by
the Radiant Post-Closing Financing, and (iv)&nbsp;an amendment to Radiant&#146;s 2017 Incentive Award Plan, as amended, increasing the amount of shares of Radiant Common Stock issuable thereunder with share amounts recommended by the Company&#146;s
Board of Directors or a committee thereof (collectively, the &#147;<B>Radiant Shareholder Proposals</B>&#148;) provided, that Radiant shall use commercially reasonable efforts to hold the Radiant Shareholder Meeting no later than sixty
(60)&nbsp;days following the date that the Registration Statement has been declared effective under the Securities Act. In addition, in accordance with Section&nbsp;14A of the Exchange Act and the applicable SEC rules issued thereunder, Radiant
shall seek advisory approval of a proposal to the Radiant Shareholders for a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote to approve certain compensation that may become payable to Radiant&#146;s named executive officers in
connection with the completion of the Merger. Notwithstanding anything else to the contrary herein, Radiant may postpone or adjourn the Radiant Shareholder Meeting (i)&nbsp;with the consent of the Company, (ii)&nbsp;for the absence of a quorum,
(iii)&nbsp;if Radiant reasonably determines that the failure to adjourn, postpone or delay the Radiant Shareholder Meeting would not allow sufficient time under applicable Laws for the distribution of any required or appropriate supplement or
amendment to the Registration Statement or Proxy Statement, (iv)&nbsp;to allow additional solicitation of votes in order to obtain the Radiant Shareholder Approval or (v)&nbsp;in connection with a Radiant Change of Recommendation. Unless the Board
of Directors of Radiant has effected a Radiant Change of Recommendation in accordance with <I>Section</I><I></I><I>&nbsp;4.5</I> and terminated this Agreement to enter into a definitive agreement with respect to a Radiant Superior Offer pursuant to
<I>Section</I><I></I><I>&nbsp;9.1(i) </I>and except as required under applicable Law, Radiant&#146;s obligation to call, give notice of and hold the Radiant Shareholder Meeting in accordance with <I>Section</I><I>&nbsp;5.2(b)</I> shall not be
limited or otherwise affected by the commencement, disclosure, announcement or submission of any Radiant Acquisition Proposal, or by any Radiant Change of Recommendation. Except in the case of a Radiant Change of Recommendation made in compliance
with <I>Section</I><I></I><I>&nbsp;4.5(d)</I> or <I>Section</I><I></I><I>&nbsp;4.5(e)</I>, Radiant agrees that the Board of Directors of Radiant shall recommend that the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Radiant Shareholders approve the Radiant Shareholder Proposals (the &#147;<B>Radiant Recommendation</B>&#148;) and Radiant shall include such Radiant Recommendation in the Proxy Statement. Except
in the case of a Radiant Change of Recommendation made in compliance with <I>Section</I><I></I><I>&nbsp;4.5(d)</I> or <I>Section</I><I></I><I>&nbsp;4.5(e)</I>, Radiant shall use its commercially reasonable efforts to solicit from the Radiant
Shareholders proxies in favor of the Radiant Shareholder Proposals and shall take all other action necessary or advisable to secure the Radiant Shareholder Approvals. Radiant shall ensure that all proxies solicited in connection with the Radiant
Shareholder Meetings are solicited in material compliance with all applicable Laws. Radiant, in its capacity as the sole shareholder of Merger Sub, shall approve the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_82"></A><B>5.3 Regulatory Approvals</B>. Each Party shall use reasonable best efforts to file or otherwise submit, as
soon as practicable after the date of this Agreement but no later than required by applicable Law, all applications, notices, reports and other documents reasonably required to be filed by such Party with or otherwise submitted by such Party to any
Governmental Authority with respect to the Merger and the other Contemplated Transactions, and to submit promptly any additional information requested by any such Governmental Authority. Each Party shall utilize reasonable best efforts to cooperate
fully with the other Party in promptly seeking to obtain all such required consents, authorizations, orders and approvals. The Parties hereto shall not take any action that will have the effect of delaying, impairing or impeding the receipt of any
required consents, authorizations, orders and approvals. The Parties shall each use their reasonable best efforts to resist any assertion that the transactions contemplated hereby constitute a violation of antitrust or merger control Laws, rules or
regulations. All filing fees which are due and owing upon respective filings under antitrust or merger control Laws shall be shared equally between the Company and Radiant. All analyses, appearances, meetings, discussions, presentations, memoranda,
briefs, filings, arguments, and proposals made by or on behalf of either Party before any Governmental Authority or the staff or regulators of any Governmental Authority with respect to the Merger and the other Contemplated Transactions, in
connection with the transactions contemplated by this Agreement shall be disclosed to counsel for the other Party hereunder in advance of any filing, submission or attendance, it being the intent that the Parties will consult and cooperate with one
another, and consider in good faith the views of one another, in connection with any such analyses, appearances, meetings, discussions, presentations, memoranda, briefs, filings, arguments, and proposals. Each Party may, as it deems advisable and
necessary, reasonably designate material provided to the other party as &#147;Outside Counsel Only Material,&#148; and also may reasonably redact the material as necessary to (a)&nbsp;remove personally sensitive information, (b)&nbsp;remove
references concerning the valuation of the Company and its Subsidiaries or Radiant and its Subsidiaries conducted in connection with the approval and adoption of this Agreement and the negotiations and investigations leading thereto, (c)&nbsp;comply
with contractual arrangements, (d)&nbsp;prevent the loss of a legal privilege or (e)&nbsp;comply with applicable Law. To the extent reasonably practicable, each Party shall give notice to counsel for the other party with respect to any meeting,
discussion, appearance or contact with any Governmental Authority or the staff or regulators of any Governmental Authority with respect to the Merger and the other Contemplated Transactions, with such notice being sufficient to provide the other
party with the opportunity to attend and participate in such meeting, discussion, appearance or contact. In the event that any Legal Proceeding is commenced challenging the Merger or any of the other Contemplated Transactions under antitrust,
competition or merger control Laws, and such Legal Proceeding seeks, or would reasonably be expected to seek, to prevent the consummation of all or part of the Merger or the other Contemplated Transactions, the Parties shall cooperate with each
other and use their respective best efforts to contest any such Legal Proceeding and to have vacated, lifted, reversed, or overturned any decree, judgment, injunction or other Order, whether temporary, preliminary, or permanent, that is in effect
and that prohibits, prevents or restricts consummation of the Merger or the other Contemplated Transactions; provided that nothing in this sentence shall require any Party to divest any assets it owns as of the date hereof to the extent such
divestiture would have a material and adverse effect on the businesses of the combined company following consummation of the Merger, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_83"></A><B>5.4 Company Options and Company Warrants</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> At the Effective Time, each Company Option that is outstanding and unexercised immediately prior to the Effective Time whether or
not vested, shall be converted into and become an option to purchase </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Radiant Common Stock, and Radiant shall assume the Company Option Plan and each such Company Option in accordance with its terms (as in effect as of the date of this Agreement). All rights with
respect to Company Ordinary Shares under Company Options assumed by Radiant shall thereupon be converted into rights with respect to Radiant Common Stock. Accordingly, from and after the Effective Time: (i)&nbsp;each Company Option assumed by
Radiant may be exercised solely for shares of Radiant Common Stock; (ii)&nbsp;the number of shares of Radiant Common Stock subject to each Company Option assumed by Radiant shall be determined by multiplying (A)&nbsp;the number of shares of Company
Ordinary Shares that were subject to such Company Option, as in effect immediately prior to the Effective Time by (B)&nbsp;the Exchange Ratio and rounding the resulting number down to the nearest whole number of shares of Radiant Common Stock;
(iii)&nbsp;the per share exercise price for the Radiant Common Stock issuable upon exercise of each Company Option assumed by Radiant shall be determined by dividing (A)&nbsp;the per share exercise price of Company Ordinary Shares subject to such
Company Option, as in effect immediately prior to the Effective Time, by (B)&nbsp;the Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&nbsp;any restriction on the exercise of any Company Option assumed
by Radiant shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Company Option shall otherwise remain unchanged; <U>provided</U><I>, </I><U>however</U>, that: (A)&nbsp;to the extent
provided under the terms of a Company Option, each Company Option assumed by Radiant in accordance with this <I>Section</I><I></I><I>&nbsp;5.4(a)</I> shall, in accordance with its terms, be subject to further adjustment as appropriate to reflect any
stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification, recapitalization or other similar transaction with respect to Radiant Common Stock subsequent to the Effective Time; and
(B)&nbsp;Radiant&#146;s Board of Directors or a committee thereof shall succeed to the authority and responsibility of Company&#146;s Board of Directors or any committee thereof with respect to each Company Option assumed by Radiant. Notwithstanding
anything to the contrary in this <I>Section</I><I></I><I>&nbsp;5.4(a)</I>, the conversion of each Company Option (regardless of whether such option qualifies as an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the
Code) into an option to purchase shares of Radiant Common Stock shall be made in a manner consistent with Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.424-1,</FONT> such that the conversion of a Company Option shall not
constitute a &#147;modification&#148; of such Company Option for purposes of Section&nbsp;409A or Section&nbsp;424 of the Code. Notwithstanding anything to the contrary in this <I>Section</I><I></I><I>&nbsp;5.4(a)</I>, the conversion of the Company
Options that are Company 102 Options into options to purchase Radiant Common Stock shall be effected subject to and in accordance with the Options Tax Ruling and the Ordinance and applicable Law to ensure that the options to purchase Radiant Common
Stock shall enjoy the tax benefits set forth in the Options Tax Ruling. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> At the Effective Time, each Company Warrant that is
outstanding and unexercised immediately prior to the Effective Time, whether or not exercisable, shall be converted into and become a warrant to purchase Radiant Common Stock, and Radiant shall assume each such Company Warrant in accordance with its
terms (as in effect as of the date of this Agreement). All rights with respect to Company Ordinary Shares or Company Preferred Shares under Company Warrants assumed by Radiant shall thereupon be converted into rights with respect to Radiant Common
Stock. Accordingly, from and after the Effective Time: (i)&nbsp;each Company Warrant assumed by Radiant may be exercised solely for shares of Radiant Common Stock; (ii)&nbsp;the number of shares of Radiant Common Stock subject to each Company
Warrant assumed by Radiant shall be determined by multiplying (A)&nbsp;the number of shares of Company Ordinary Shares or Company Preferred Shares that were subject to such Company Warrant, as in effect immediately prior to the Effective Time by
(B)&nbsp;the Exchange Ratio and rounding the resulting number down to the nearest whole number of shares of Radiant Common Stock; (iii)&nbsp;the per share exercise price for the Radiant Common Stock issuable upon exercise of each Company Warrant
assumed by Radiant shall be determined by dividing (A)&nbsp;the per share exercise price of Company Ordinary Shares or the Company Preferred Shares subject to such Company Warrant, as in effect immediately prior to the Effective Time, by
(B)&nbsp;the Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv)&nbsp;any restriction on the exercise of any Company Warrant assumed by Radiant shall continue in full force and effect and the term,
exercisability, vesting schedule and other provisions of such Company Warrant shall otherwise remain unchanged; <U>provided</U>, <U>however</U>, that to the extent provided under the terms of a Company Warrant, such Company Warrant assumed by
Radiant in accordance with this <I>Section</I><I></I><I>&nbsp;5.4(b)</I> shall, in accordance with its terms, be subject to further adjustment as appropriate to reflect any stock split, division or subdivision of shares, stock dividend, reverse
stock split, consolidation of shares, reclassification, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recapitalization or other similar transaction with respect to Radiant Common Stock subsequent to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Radiant shall file with the SEC promptly following the Effective Time, a registration statement on Form <FONT
STYLE="white-space:nowrap">S-8,</FONT> for use by Radiant, relating to the shares of Radiant Common Stock issuable with respect to Company Options assumed by Radiant in accordance with <I>Section</I><I></I><I>&nbsp;5.4(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Prior to the Effective Time, the Company shall take all actions that may be reasonably necessary (under the Company Option Plan,
the Company Warrants and otherwise) to effectuate the provisions of this <I>Section</I><I></I><I>&nbsp;5.4</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <I>15D
Exemption</I>. Radiant shall use its reasonable best efforts to obtain promptly following the Effective Time from the Israel Securities Authority (&#147;<B>ISA</B>&#148;) an exemption under Section&nbsp;15D of the Israeli Securities Law, 5728-1968,
such that the conversion and assumption of the Company Options by Radiant as set forth in <I>Section</I><I></I><I>&nbsp;5.4(a) </I>shall not be deemed to be an &#147;offer to the public&#148; under such law or require a prospectus approved by the
ISA (the &#147;<B>15D Exemption</B>&#148;). The Company and Radiant shall cooperate to comply with the terms of the 15D Exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Following the Effective Time, Radiant will promptly enter into a warrant agreement with each holder of Company Warrants to reflect
the exchange described in this <U>Section</U><U></U><U>&nbsp;5.4</U> and such warrant agreement shall be consistent in all reasonable material respects with the terms and conditions of the Warrant Issuance Agreement, dated as of October&nbsp;11,
2016, by and between the Company and Madryn Health Partners, LP (f/k/a Visium Healthcare Partners, LP), if such holder of Company Warrants is a party to such agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_84"></A><B>5.5 Radiant Stock Options</B>. At the Effective Time, each Radiant Stock Option or Radiant restricted stock
award that is outstanding and unexercised immediately prior to the Effective Time, whether or not vested, shall be continued and survive the Closing and remain outstanding in accordance with its terms without acceleration or adjustment under the
terms of the Radiant Stock Option Plans by reason of the Contemplated Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_85"></A><B>5.6 Indemnification
of Officers and Directors</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Subject to applicable Law, from the Effective Time through the seventh anniversary of the date
on which the Effective Time occurs, each of Radiant and the Surviving Company shall indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a director or
officer of Radiant and its Subsidiaries or the Company and its Subsidiaries, respectively (the &#147;<B>D&amp;O Indemnified Parties</B>&#148;), against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and
expenses, including attorneys&#146; fees and disbursements, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to the fact that the
D&amp;O Indemnified Party is or was a director or officer of Radiant or of the Company or any of their Subsidiaries (each, a &#147;<B>Proceeding</B>&#148;), whether asserted or claimed prior to, at or after the Effective Time, in each case, to the
fullest extent permitted under applicable Law. Subject to applicable law, each D&amp;O Indemnified Party will be entitled to advancement of expenses incurred in the defense of any Proceeding from each of Radiant and the Surviving Company, jointly
and severally, upon receipt by Radiant or the Surviving Company from the D&amp;O Indemnified Party of a request therefor; <U>provided</U> that any such person to whom expenses are advanced provides an undertaking to Radiant or the Surviving Company,
as applicable, to the extent then required by applicable Law, to repay such advances if it is ultimately determined that such person is not entitled to indemnification. The provisions of the Radiant Charter and Radiant Bylaws with respect to
indemnification, advancement of expenses and exculpation of present and former directors and officers of Radiant that are presently set forth in the Radiant Charter and Radiant Bylaws shall not be amended, modified or repealed for a period of seven
(7)&nbsp;years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or directors of Radiant, unless such modification is required by applicable
Law. To the extent permitted by applicable Law, the articles </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of association of the Surviving Company shall contain, and Radiant shall cause the articles of association of the Surviving Company to so contain, provisions no less favorable with respect to
indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the Radiant Charter and Radiant Bylaws and the Company Charter. From and after the Effective Time, (i)&nbsp;the
Surviving Company shall fulfill and honor in all respects the obligations of the Company to D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Company Charter and pursuant to any
indemnification agreements between the Company and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)&nbsp;Radiant shall fulfill and honor in all respects the
obligations of Radiant to D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Radiant Charter or Radiant Bylaws and pursuant to any indemnification agreements between Radiant and
such D&amp;O Indemnified Parties that were in effect prior to the date of this Agreement, with respect to claims arising out of matters occurring at or prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> From and after the Effective Time, Radiant shall maintain directors&#146; and officers&#146; liability insurance policies, with an
effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Radiant. In addition, Radiant shall purchase, prior to the Effective Time, a
seven-year prepaid &#147;D&amp;O tail policy&#148; for the <FONT STYLE="white-space:nowrap">non-cancellable</FONT> extension of the directors&#146; and officers&#146; liability coverage of Radiant&#146;s existing directors&#146; and officers&#146;
insurance policies and Radiant&#146;s existing fiduciary liability insurance policies for the Persons who, as of the date of this Agreement are covered by Radiant&#146;s existing directors&#146; and officers&#146; insurance policies and/or the
Company&#146;s existing directors&#146; and officers&#146; insurance, as applicable, in each case for a claims reporting or discovery period of at least seven years from and after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> From and after the Effective Time, Radiant shall pay all expenses, including reasonable attorneys&#146; fees, that are incurred by
the persons referred to in this <I>Section</I><I></I><I>&nbsp;5.6</I> in connection with their successful enforcement of the rights provided to such persons in this <I>Section</I><I></I><I>&nbsp;5.6</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> The provisions of this <I>Section</I><I></I><I>&nbsp;5.6</I> are intended to be in addition to the rights otherwise available to
the current and former officers and directors of Radiant and the Company by law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Parties, their heirs and their
representatives. In the event Radiant or the Surviving Company or any of their respective successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such
consolidation or merger, or (ii)&nbsp;transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Radiant or the Surviving Company,
as the case may be, shall succeed to the obligations set forth in this <I>Section</I><I></I><I>&nbsp;5.6</I>. Radiant shall cause the Surviving Company to perform all of the obligations of the Surviving Company under this
<I>Section</I><I></I><I>&nbsp;5.6</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> The covenants contained in this <I>Section</I><I></I><I>&nbsp;5.6</I> are intended to
be for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Parties and their respective heirs and shall not be deemed exclusive of any other rights to which any such Person is entitled, whether pursuant to Law, contract or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_86"></A><B>5.7 Additional Agreements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Without limiting any other provision of this Agreement, including, without limitation, the conditions to the Closing in
<I>Sections 6</I>, <I>7</I> and <I>8</I> and subject to <I>Sections 5.3 </I>and<I> 5.7(b)</I>, the Parties shall use commercially reasonable efforts to cause to be taken all actions necessary to consummate the Merger and make effective the other
Contemplated Transactions. Without limiting the generality of the foregoing but subject to <I>Sections 5.3 </I>and<I> 5.7(b),</I> each Party to this Agreement shall use commercially reasonable efforts to (i)&nbsp;make all filings and other
submissions (if any) and give all notices (if any) required to be made and given by such Party in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the Merger and the other Contemplated Transactions; (ii)&nbsp;obtain each consent (if any) reasonably required to be obtained (pursuant to any applicable Law or Contract, or
otherwise) by such Party in connection with the Merger or any of the other Contemplated Transactions or for such Contract to remain in full force and effect; (iii)&nbsp;lift any injunction prohibiting, or any other legal bar to, the Merger or any of
the other Contemplated Transactions; (iv)&nbsp;satisfy the conditions precedent to the consummation of this Agreement and (v)&nbsp;execute and deliver any additional instruments that are or may become reasonably necessary, proper or advisable to
consummate the transactions contemplated by this Agreement, including the Merger, and to carry out fully the purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Notwithstanding anything to the contrary contained in this Agreement, and subject to <I>Section</I><I></I><I>&nbsp;5.3</I>, no
Party shall have any obligation under this Agreement: (i)&nbsp;to dispose of or transfer or cause any of its Subsidiaries to dispose of or transfer any assets; (ii)&nbsp;to discontinue or cause any of its Subsidiaries to discontinue offering any
product or service; (iii)&nbsp;to license or otherwise make available, or cause any of its Subsidiaries to license or otherwise make available to any Person any Intellectual Property; (iv)&nbsp;to hold separate or cause any of its Subsidiaries to
hold separate any assets or operations (either before or after the Closing Date); (v) to make or cause any of its Subsidiaries to make any commitment or agree to any undertaking (to any Governmental Authority or otherwise) regarding its future
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Each of Radiant and Merger Sub will take all actions necessary to (i)&nbsp;cause Merger Sub to perform its
obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement and (ii)&nbsp;ensure that Merger Sub prior to the Effective Time shall not conduct any business, incur or guarantee any
Indebtedness or any other liabilities or make any investments, other than those activities incident to its obligations under this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_87"></A><B>5.8 Disclosure</B>. Without limiting any Party&#146;s obligations under the Confidentiality Agreement, no
Party shall, and no Party shall permit any of its Subsidiaries or any Representative of such Party to, issue any press release or make any disclosure (to any customers or employees of such Party, to the public or otherwise) regarding the Merger or
any of the other Contemplated Transactions unless: (a)&nbsp;the other Party shall have approved such press release or disclosure in writing; or (b)&nbsp;such Party shall have determined in good faith, upon the advice of outside legal counsel, that
such disclosure is required by applicable Laws and, to the extent practicable, before such press release or disclosure is issued or made, such Party advises the other Party of, and consults with the other Party regarding, the text of such press
release or disclosure; <U>provided</U>, <U>however</U>, that each of the Company and Radiant may make any public statement in response to specific questions by the press, analysts, investors or those attending industry conferences or financial
analyst conference calls, so long as any such statements are consistent with previous press releases, public disclosures or public statements made by the Company or Radiant in compliance with this <I>Section</I><I></I><I>&nbsp;5.8.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_88"></A><B>5.9 Listing</B>. At or prior to the Effective Time, Radiant shall use its reasonable best efforts to
(a)&nbsp;cause the shares of Radiant Common Stock being issued in the Merger to be approved for listing (subject to notice of issuance) on the NASDAQ Capital Market or NASDAQ Global Market prior to the Effective Time and in a manner that does not
delay the Effective Time and (b)&nbsp;maintain the continuous listing of the currently outstanding shares of Radiant Common Stock on the NASDAQ Capital Market or NASDAQ Global Market through the Effective Time. Radiant will promptly provide copies
of any correspondence received from NASDAQ regarding the listing of Radiant Common Stock. The Company will cooperate with Radiant as reasonably requested by Radiant with respect to the listing application for the Radiant Common Stock and promptly
furnish to Radiant all information concerning the Company and its shareholders that may be required or reasonably requested in connection with any action contemplated by this <I>Section</I><I></I><I>&nbsp;5.9</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_89"></A><B>5.10 Tax Matters</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Radiant, Merger Sub and the Company shall use their respective commercially reasonable best efforts to cause the Merger to
qualify, and agree not to, and not to permit or cause any Affiliate or any Subsidiary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to, take any actions or cause any action to be taken that would reasonably be expected to prevent the Merger from qualifying as a &#147;reorganization&#148; under Section&nbsp;368(a) of the Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> This Agreement is intended to constitute, and the parties hereto hereby adopt this Agreement as, a &#147;plan of
reorganization&#148; within the meaning Treasury Regulation Sections <FONT STYLE="white-space:nowrap">1.368-2(g)</FONT> and <FONT STYLE="white-space:nowrap">1.368-3(a).</FONT> Radiant, Merger Sub and the Company shall treat, and shall not take any
tax reporting position inconsistent with the treatment of, the Merger as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code for U.S. federal, state and other relevant Tax purposes, unless otherwise required pursuant
to a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> All transfer, documentary, sales, use,
stamp, registration and other such Taxes and fees (including any penalties and interest) incurred in connection with this Agreement (collectively, &#147;<B>Transfer Taxes</B>&#148;) shall be paid (or cause to be paid) by Radiant when due, and
Radiant will, at its own expense, file (or cause to be filed) all necessary Tax Returns and other documentation with respect to all such Transfer Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> As soon as reasonably practicable after the date of this Agreement, the Company shall instruct its Israeli counsel, advisors
and/or accountants to prepare and file with the ITA an application for rulings (collectively, the &#147;<B>Options Tax Ruling</B>&#148;) confirming that (i)&nbsp;the deemed transfer of the Company 102 Shares and payment or delivery of the Merger
Consideration for such shares in accordance with <I>Section</I><I></I><I>&nbsp;1.5(a)(i)</I> and conversion of the Company 102 Options in accordance with <I>Section</I><I></I><I>&nbsp;5.4(a)</I> shall not be regarded as a violation of the
&#147;requisite holding period&#148; (as such term is defined in Section&nbsp;102 of the Ordinance) so long as the Merger Consideration for the Company 102 Shares and options into which the Company 102 Options are converted (and shares issued upon
the exercise thereof) are deposited with the 102 Trustee until the end of their applicable holding period under Section&nbsp;102 of the Ordinance, (ii)&nbsp;the Merger Consideration for the Company 102 Shares and options into which the Company 102
Options are converted shall continue, after the Effective Time, to benefit from the provisions of Section&nbsp;102 of the Ordinance and to qualify thereunder as grants made through a trustee pursuant to the capital gains tax route according to
Section&nbsp;102(b)(2) of the Ordinance, and (iii)&nbsp;the exchange of Company Options granted pursuant to Section&nbsp;3(i) of the Ordinance for options to purchase shares of Radiant Common Stock shall not be subject to payment of Israeli Tax
until the exercise of such Company Option (which ruling may be subject to customary conditions and adjustments regularly associated with such a ruling). The Company shall include in the request for the Options Tax Ruling a request to exempt Radiant,
the Surviving Company, the Exchange Agent and their respective agents from any withholding obligation in relation to any payments and deliveries made with respect to any Company 102 Shares or the conversion of Company 102 Options. The Company shall
use reasonable best efforts to obtain the Options Tax Ruling prior to the Closing. If the Options Tax Ruling is not granted prior to the Closing, or in accordance with the instructions of the ITA, the Company shall seek to obtain prior to the
Closing an interim tax ruling confirming, among other things, that Radiant, the Surviving Company, the Exchange Agent and their respective agents and any other Person acting on their behalf shall be exempt from Israeli withholding tax in relation to
any payments and deliveries made with respect to any Company 102 Shares or the conversion of Company 102 Options to the Exchange Agent, the 102 Trustee or the Surviving Company in connection with the Merger (the &#147;<B>Interim Options Tax
Ruling</B>&#148;). To the extent that prior to the Closing an Interim Options Tax Ruling shall have been obtained, then all references herein to the Options Tax Ruling shall be deemed to refer to such Interim Options Tax Ruling, until such time that
a final definitive Options Tax Ruling is obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> As soon as reasonably practicable following the date of this Agreement,
the Company shall instruct its Israeli counsel, advisors and/or accountants to prepare and file with the ITA an application for a ruling (collectively, the &#147;<B>Withholding Tax Ruling</B>&#148;) that (i)&nbsp;stipulates that the transfer of any
Merger Consideration or consideration contemplated under <I>Section 5.4</I> to the Exchange Agent or 102 Trustee is not subject to a tax withholding obligation, or clarifies that no such obligation exists; (ii)&nbsp;with respect to holders of record
of Company Share Capital (other than Company 102 Shares), Company Options (other than Company 102 Options or any other Company Options covered by the Options Tax Ruling) and Company Warrants, in each case, that are
<FONT STYLE="white-space:nowrap">non-Israeli</FONT> residents (as defined in Israeli Tax Law), exempts Radiant, the Exchange Agent, the Surviving Company and their respective agents from any obligation to withhold Israeli Tax from any consideration
payable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or otherwise deliverable pursuant to this Agreement, including, without limitation, the Merger Consideration, or clarifies that no such obligation exists, all in accordance with the terms of the
Withholding Tax Ruling; and (iii)&nbsp;with respect to holders of record of Company Share Capital (other than Company 102 Shares) and Company Options (other than Company 102 Options or any other Company Options covered by the Options Tax Ruling) and
Company Warrants that are Israeli residents (as defined in Israeli Tax Law), (A) exempts Radiant, the Exchange Agent, the Surviving Company and their respective agents from any obligation to withhold Israeli Tax from any consideration payable or
otherwise deliverable pursuant to this Agreement, including, without limitation, the Merger Consideration, or clarifies that no such obligation exists, in each case as of the Effective Time and/or (B)&nbsp;instructs Radiant, the Exchange Agent, the
Surviving Company and their respective agents as to the dates upon which such withholding is to be executed and on how such withholding is to be executed with respect to holders of record of Company Share Capital (other than Company 102 Shares),
Company Options (other than Company 102 Options or any other Company Options covered by the Options Tax Ruling) and Company Warrants and the rate or rates of withholding tax to be applied, in each case, in accordance with Section&nbsp;104(H) of the
Ordinance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Without limiting the generality of <I>Section</I><I></I><I>&nbsp;5.10(d)</I>, and
<I>Section</I><I></I><I>&nbsp;5.10(e)</I>, each of the Company and Radiant shall cause their respective Israeli counsel, advisors and accountants to coordinate all material activities, and to cooperate with each other, with respect to the
preparation and filing of such applications and in the preparation of any written or oral submissions that may be necessary, proper or advisable to obtain the Options Tax Ruling (including the Interim Options Tax Ruling) and the Withholding Tax
Ruling. The final text of the Interim Options Tax Ruling, the Options Tax Ruling and the Withholding Tax Ruling and any application submitted to the ITA with respect to any Tax ruling, shall be subject to the prior written consent of Radiant or its
counsel, which consent shall not be unreasonably withheld, conditioned or delayed. Subject to the terms and conditions hereof, the Company shall use reasonable best efforts to promptly take, or cause to be taken, all actions and to do, or cause to
be done, all things necessary, proper or advisable under applicable Laws to obtain the Interim Options Tax Ruling, the Options Tax Ruling and the Withholding Tax Ruling, as promptly as practicable. The Company shall keep Radiant reasonably informed
of all material developments and events relating to the Interim Options Tax Ruling, the Options Tax Ruling and the Withholding Tax Ruling (including promptly forwarding copies to Radiant of any related correspondence, and shall provide Radiant with
an opportunity to review and comment on any material correspondence before the Company sends such correspondence to the ITA). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>
Cooperation. Each Party shall cooperate reasonably with the other Party and shall provide the other Party with such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of their obligations under
this Agreement, to cause the Closing to occur as promptly as reasonably possible and to enable the combined entity to continue to meet its obligations following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_90"></A><B>5.11 Directors</B><B> and Officers</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The Parties shall use reasonable best efforts and take all necessary action so that the Board of Directors of Radiant consists of
nine (9)&nbsp;directors, out of which two (2)&nbsp;directors shall be identified by Radiant to the Company as the &#147;<B>Radiant Appointees</B>&#148; and seven (7)&nbsp;directors shall be identified by the Company to Radiant as the
&#147;<B>Company Appointees</B>&#148;, each no later than fifteen (15)&nbsp;Business Days prior to filing of the Proxy Statement, to serve in such positions effective as of the Effective Time until successors are duly elected or appointed and
qualified in accordance with applicable Law. The Parties shall use reasonable best efforts to cause any other Persons being directors of Radiant to cease to hold such inconsistent position, including via termination of such Persons&#146; positions.
If any Radiant Appointee or Company Appointee is unable or unwilling to serve as director of Radiant, the Party appointing such Person shall designate a successor; <I>provided</I>, <I>however</I>, the Parties acknowledge that so long as Radiant
remains a public reporting company, the Board of Directors of Radiant will continue to satisfy applicable securities laws, including, without limitation, maintaining an independent audit committee, and the nominations by Company and Radiant
hereunder will allow Radiant to comply with such applicable Law. Each new member of the Board of Directors of Radiant that was not a member of the Board of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Directors of Radiant immediately before the Effective Time shall enter into an indemnification agreement with Radiant, on a form to be mutually agreed between Radiant and Company (and absent such
agreement, on Radiant&#146;s form indemnification agreement), within fifteen (15)&nbsp;days of their appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> No later
than fifteen (15)&nbsp;Business Days prior to filing of the Proxy Statement, the Company will identify to the Board of Directors of Radiant, and prior to the Effective Time, the Board of Directors of Radiant will appoint, effective as of the
Effective Time, the Persons who will serve as the officers of Radiant immediately following the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_91">
</A><B>5.12 Section</B><B></B><B>&nbsp;16</B><B> Matters</B>. Prior to the Effective Time, Radiant shall take all such steps as may be required to cause any acquisitions of Radiant Common Stock and any options to purchase Radiant Common Stock in
connection with the Contemplated Transactions, by each individual who is reasonably expected to become subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act with respect to Radiant, to be exempt under Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_92"></A><B>5.13 Allocation
Certificate</B>. The Company will prepare and deliver to Radiant at least two (2)&nbsp;Business Days prior to the Closing Date (and may update same within two (2)&nbsp;Business Days of the Closing Date) a certificate signed by the Chief Financial
Officer or Chief Administrative Officer of the Company in a form reasonably acceptable to Radiant setting forth (as of immediately prior to the Effective Time)&nbsp;(a) each holder of Company Share Capital, Company Options and Company Warrants,
(b)&nbsp;such holder&#146;s name and address of record; (c)&nbsp;the number and type of Company Share Capital held and/or underlying the Company Options or Company Warrants as of the Closing Date for each such holder (including identifying whether
such shares or options are Company 102 Shares and Company 102 Options, as applicable); and (d)&nbsp;the number of shares of Radiant Common Stock to be issued to such holder, or to underlie any Radiant Stock Option or Radiant Warrant to be issued to
such holder, pursuant to this Agreement in respect of the Company Share Capital, Company Options and or Company Warrants held by such holder as of immediately prior to the Effective Time (the &#147;<B>Allocation Certificate</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_93"></A><B>5.14 Shareholder Litigation</B>. Until the earlier of the termination of this Agreement in accordance with
its terms or the Effective Time, Radiant shall (a)&nbsp;promptly advise the Company in writing of any shareholder litigation or investigation against it or its directors or officers relating to this Agreement, the Merger, or the Contemplated
Transactions and shall keep the Company fully informed regarding such shareholder litigation and (b)&nbsp;give the Company the opportunity to participate in the defense or settlement of any shareholder litigation or investigation relating to this
Agreement or any of the Contemplated Transactions, and shall not settle any such litigation or investigation without the Company&#146;s written consent, which will not be unreasonably withheld, conditioned or delayed. Without otherwise limiting the
D&amp;O Indemnified Parties&#146; rights with regard to the right to counsel, following the Effective Time, the D&amp;O Indemnified Parties shall be entitled to continue to retain Reed Smith, Gornitzky&nbsp;&amp; Co. or such other counsel selected
by such D&amp;O Indemnified Parties prior to the Effective Time to defend any transaction litigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_94"></A><B>5.15 Confidentiality</B>. The parties acknowledge that Radiant and the Company have previously executed the
Confidentiality Agreement, which shall continue in full force and effect in accordance with its terms, except as expressly modified by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_95"></A><B>5.16 Effect</B><B> of Knowledge</B>. The representations, warranties, covenants and agreements made herein,
as modified by the Disclosure Schedules are intended, among other things, to allocate the economic cost and the risks inherent in the transactions contemplated hereby between the Parties and, accordingly, the rights of the Company to any remedy or
any termination right under this Agreement or in law or equity or otherwise shall not be impacted or limited by any knowledge that the Company or any of its Representatives may have acquired, could have acquired or had reason to acquire, whether
before or after the date hereof, nor by any investigation or diligence by the Company. Radiant and Merger Sub hereby acknowledge that, regardless of any investigation made (or not made) by or on behalf of the Company, and regardless of the results
of any such investigation, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company has entered into this transaction in express reliance upon the representations, warranties, covenants and other agreements of Radiant and Merger Sub made in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_96"></A>Section&nbsp;6. CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of each Party to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are
subject to the satisfaction or, to the extent permitted by applicable Law, the written waiver by each of the Parties, at or prior to the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_97"></A><B>6.1 No Restraints</B><B></B>. No temporary restraining order, preliminary or permanent injunction, or other
order issued by any court of competent jurisdiction or other legal or regulatory restraint or prohibition preventing the consummation of the transactions contemplated hereby shall be in effect, and no statute, rule, regulation, or order shall have
been enacted, entered, enforced, or reasonably deemed applicable to the transactions contemplated hereby, which makes the consummation of the transactions contemplated hereby illegal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_98"></A><B>6.2 Shareholder Approval</B>. The Company Shareholder Proposals shall have been duly approved by the Company
Shareholder Approval, and the Radiant Shareholder Proposals shall have been duly approved by the Radiant Shareholder Approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_99">
</A><B>6.3 Effective Registration Statement and Proxy Statement</B>. The Registration Statement shall have become effective and no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for
that purpose shall have been initiated or threatened by the SEC or any other Governmental Authority and no similar proceeding in respect of the Proxy Statement shall have been initiated or threatened by the SEC or any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_100"></A><B>6.4 Listing</B>. The shares of Radiant Common Stock to be issued in the Merger pursuant to this Agreement
shall have been approved for listing (subject to official notice of issuance) on the NASDAQ Capital Market or NASDAQ Global Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_101">
</A><B>6.5 Statutory Waiting Periods</B>. Fifty (50)&nbsp;days shall have elapsed after the filing of the Merger Proposal with the Companies Registrar and thirty (30)&nbsp;days shall have elapsed after the approval of the Merger by the shareholders
of each of the Company and Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_102"></A><B>6.6 Equity Commitment Letter</B>. The Equity Commitment Letter
shall be in full force and effect on the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_104"></A>Section&nbsp;7. ADDITIONAL CONDITIONS PRECEDENT
TO OBLIGATIONS OF RADIANT AND MERGER SUB </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of Radiant and Merger Sub to effect the Merger and otherwise consummate the
transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by Radiant, at or prior to the Closing, of each of the following additional conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_105"></A><B>7.1 Accuracy of Representations</B>. (a)&nbsp;Each of the representations and warranties (other than the
Company Fundamental Representations and the Company Capitalization Representation) of the Company set forth in this Agreement shall be true and correct on the date of this Agreement, and as of the Closing Date, as if made at and as of such date
(except to the extent expressly made as of an earlier date, in which case as of such date), except where the failure of such representations and warranties to be so true and correct (without giving effect to any limitation as to
&#147;materiality&#148; or &#147;Material Adverse Effect&#148; set forth therein), individually or in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
aggregate, has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, (b)&nbsp;the Company Fundamental Representations shall be true and correct in all material
respects on the date of this Agreement, and as of the Closing Date, as if made at and as of such date (except to the extent expressly made as of an earlier date, in which case as of such date) and (c)&nbsp;the Company Capitalization Representation
shall be true and correct in all material respects on the date of this Agreement, and as of the Closing Date, as if made at and as of such date (except to the extent expressly made as of an earlier date, in which case as of such date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_106"></A><B>7.2 Performance of Covenants</B>. Each of the covenants and obligations in this Agreement that the Company
is required to comply with or to perform at or prior to the Closing shall have been complied with and performed by the Company in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_107"></A><B>7.3 Officers</B><B>&#146;</B><B> Certificate</B>. Radiant shall have received a certificate executed by a
duly authorized officer of the Company confirming that the conditions set forth in <I>Sections 7.1</I>, <I>7.2</I> and 7.4<I> </I>have been duly satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_108"></A><B>7.4 No Company Material Adverse Effect</B>. Since the date of this Agreement, there shall not have occurred
any Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_109"></A>Section&nbsp;8. ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF
THE COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of the Company to effect the Merger and otherwise consummate the transactions to be consummated at the
Closing are subject to the satisfaction or the written waiver by the Company, at or prior to the Closing, of each of the following additional conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_110"></A><B>8.1 Accuracy of Representations</B>. (a)&nbsp;Each of the representations and warranties (other than the
Radiant Fundamental Representations and the Radiant Capitalization Representation) of Radiant and Merger Sub set forth in this Agreement shall be true and correct on the date of this Agreement, and as of the Closing Date, as if made at and as of
such date (except to the extent expressly made as of an earlier date, in which case as of such date), except where the failure of such representations and warranties to be so true and correct, individually or in the aggregate, has not had, and would
not reasonably be expected to have, a Radiant Material Adverse Effect, (b)&nbsp;the Radiant Fundamental Representations shall be true and correct in all material respects on the date of this Agreement, and as of the Closing Date, as if made at and
as of such date (except to the extent expressly made as of an earlier date, in which case as of such date) and (c)&nbsp;the Radiant Capitalization Representation shall be true and correct in all respects subject to<I>&nbsp;de
minimis</I>&nbsp;inaccuracies on the date of this Agreement, and as of the Closing Date, as if made at and as of such date (except to the extent expressly made as of an earlier date, in which case as of such date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_111"></A><B>8.2 Performance of Covenants</B>. All of the covenants and obligations in this Agreement that Radiant or
Merger Sub is required to comply with or to perform at or prior to the Closing shall have been complied with and performed in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_112"></A><B>8.3 Documents</B>. The Company shall have received the following documents, each of which shall be in full
force and effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> a certificate executed by a duly authorized officer of Radiant confirming that the conditions set forth in
<I>Sections 8.1</I>, <I>8.2</I> and <I>8.4 </I>have been duly satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> written resignations in forms satisfactory to the
Company, dated as of the Closing Date and effective as of the Closing executed by the officers and directors of Radiant who are not to continue as officers or directors of Radiant or Radiant&#146;s Subsidiaries pursuant to
<I>Section</I><I></I><I>&nbsp;5.11</I> hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> a payoff letter issued by Solar Capital Ltd., in a form reasonably
satisfactory to the Company, not earlier than five (5)&nbsp;Business Days prior to the Closing Date, which (i)&nbsp;sets forth the amounts required to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
repay in full all Indebtedness owed to such holder on the Closing Date, (ii)&nbsp;sets forth the wire transfer instructions for the repayment of such Indebtedness to such holder, and
(iii)&nbsp;provides for a release of all Liens granted by Radiant and its Subsidiaries to Solar Capital Ltd. or otherwise arising with respect to such Indebtedness, effective upon repayment of such Indebtedness and the termination of all loan and
collateral documentation evidencing such Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_113"></A><B>8.4 No Radiant Material Adverse Effect</B>.
Since the date of this Agreement, there shall not have occurred any Radiant Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_114"></A><B>8.5 Tax Rulings</B><B>. </B>The Options Tax Ruling (or Interim Options Tax Ruling) and Withholding Tax
Ruling shall have been obtained from the ITA and be in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_115"></A>Section&nbsp;9. TERMINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_116"></A><B>9.1 Termination</B>. This Agreement may be terminated prior to the Effective Time (whether before or after
approval of the Company Shareholder Proposals by the Company&#146;s shareholders and whether before or after approval of the Radiant Shareholder Proposals by Radiant&#146;s shareholders and whether before or after approval of the Merger, the other
Contemplated Transactions and this Agreement by the sole shareholder of Merger Sub, unless otherwise specified below): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> by
mutual written consent of Radiant and the Company duly authorized by the Boards of Directors of Radiant and the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> by
either Radiant or the Company if the Merger shall not have been consummated by October&nbsp;31, 2019 (the &#147;<B>Drop Dead Date</B>&#148;); <U>provided</U><I>, </I><U>however</U>, that the right to terminate this Agreement under this
<I>Section</I><I></I><I>&nbsp;9.1(b)</I> shall not be available to any Party whose action or failure to act has been a principal cause of the failure of the Merger to occur on or before such date and such action or failure to act constitutes a
breach of this Agreement; <U>provided</U>, <U>further</U>, <U>however</U>, in the event the Registration Statement is still being reviewed or commented on by the SEC on the Drop Dead Date, either Party shall be entitled to extend the date for
termination of this Agreement pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(b)</I> for one additional sixty (60)&nbsp;day period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> by either Radiant or the Company if a court of competent jurisdiction or other Governmental Authority shall have issued a final
and <FONT STYLE="white-space:nowrap">non-appealable</FONT> Order, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> by Radiant or the Company if the Company Shareholder Approval shall not have been obtained within seventy (70)&nbsp;days of the
date of the effectiveness of the Registration Statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> by either Radiant or the Company if (i)&nbsp;the Radiant
Shareholders Meeting (including any adjournments and postponements thereof) shall have been held and completed and Radiant&#146;s shareholders shall have taken a final vote on the Radiant Shareholder Proposals and (ii)&nbsp;the Radiant Shareholder
Proposals shall not have been approved at the Radiant Shareholders Meeting (or at any adjournment or postponement thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B>
by the Company (at any time prior to the approval of the Radiant Shareholder Proposals) if a Radiant Change of Recommendation shall have occurred; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> by the Company, upon a breach of any representation, warranty, covenant or agreement on the part of Radiant or Merger Sub set
forth in this Agreement, or if any representation or warranty of Radiant or Merger Sub shall have become inaccurate, in either case such that the conditions set forth in <I>Section</I><I></I><I>&nbsp;8.1</I> or <I>Section</I><I></I><I>&nbsp;8.2</I>
would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided, that the Company is not then in material breach of any representation, warranty, covenant or agreement
under this Agreement; <U>provided</U>, <U>further</U>, that if such inaccuracy in Radiant&#146;s or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Merger Sub&#146;s representations and warranties or breach by Radiant or Merger Sub is curable by Radiant or Merger Sub, then this Agreement shall not terminate pursuant to this
<I>Section</I><I></I><I>&nbsp;9.1(g)</I> as a result of such particular breach or inaccuracy until the earlier of (i)&nbsp;the expiration of a 30 day period commencing upon delivery of written notice from the Company to Radiant or Merger Sub of such
breach or inaccuracy and its intention to terminate pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(g)</I> and (ii)&nbsp;Radiant or Merger Sub (as applicable) ceasing to exercise commercially reasonable efforts to cure such breach or inaccuracy
following delivery of written notice from the Company to Radiant or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(g)</I> (it being understood that this Agreement shall not
terminate pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(g)</I> as a result of such particular breach or inaccuracy if such breach or inaccuracy by Radiant or Merger Sub is cured prior to such termination becoming effective); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> by Radiant, upon a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in this
Agreement, or if any representation or warranty of the Company shall have become inaccurate, in either case such that the conditions set forth in <I>Section</I><I></I><I>&nbsp;7.1</I> or <I>Section</I><I></I><I>&nbsp;7.2</I> would not be satisfied
as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided, that Radiant is not then in material breach of any representation, warranty, covenant or agreement under this Agreement;
<U>provided</U>, <U>further</U>, that if such inaccuracy in the Company&#146;s representations and warranties or breach by the Company is curable by the Company then this Agreement shall not terminate pursuant to this
<I>Section</I><I></I><I>&nbsp;9.1(h)</I> as a result of such particular breach or inaccuracy until the earlier of (i)&nbsp;the expiration of a 30 day period commencing upon delivery of written notice from Radiant to the Company of such breach or
inaccuracy and its intention to terminate pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(h)</I> and (ii)&nbsp;the Company ceasing to exercise commercially reasonable efforts to cure such breach or inaccuracy following delivery of written notice
from Radiant to the Company of such breach or inaccuracy and its intention to terminate pursuant to this <I>Section</I><I></I><I>&nbsp;9.1(h) </I>(it being understood that this Agreement shall not terminate pursuant to this
<I>Section</I><I></I><I>&nbsp;9.1(h)</I> as a result of such particular breach or inaccuracy if such breach or inaccuracy by the Company is cured prior to such termination becoming effective); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> by Radiant in connection with Radiant entering into a definitive agreement to effect a Radiant Superior Offer, <U>provided</U>
that, (i)&nbsp;Radiant has complied in all material respects with the requirements of <I>Section</I><I></I><I>&nbsp;4.5 </I>and (ii)&nbsp;concurrently with the termination of this Agreement, Radiant pays, or causes to be paid, the Termination Fee.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_117"></A><B>9.2 Effect of Termination</B>. In the event of the termination of this Agreement as provided in
<I>Section</I><I></I><I>&nbsp;9.1</I>, this Agreement shall be of no further force or effect; <U>provided</U><I>, </I><U>however</U>, that (a)&nbsp;this <I>Section</I><I></I><I>&nbsp;9.2</I>, <I>Section</I><I></I><I>&nbsp;9.3</I>, and
<I>Section</I><I></I><I>&nbsp;10</I> shall survive the termination of this Agreement and shall remain in full force and effect, and (b)<I>&nbsp;subject to Section</I><I></I><I>&nbsp;9.3</I>, the termination of this Agreement shall not relieve any
Party from any liability for fraud or for any willful and material breach of any representation, warranty, covenant, obligation or other provision contained in this Agreement. No termination of this Agreement will affect the obligations of the
parties contained in the Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_118"></A><B>9.3 Expenses; Termination Fees</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Except as set forth in this <I>Section</I><I></I><I>&nbsp;9.3</I>, all fees and expenses incurred in connection with this
Agreement and the Contemplated Transactions shall be paid by the Party incurring such expenses, whether or not the Merger is consummated; <U>provided</U>, <U>however</U>, that Radiant and the Company shall each pay fifty percent (50%) of all filing
fees required to be paid to the SEC in connection with the Registration Statement, all NASDAQ listing fees and all proxy solicitation, printing and mailing costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> If (i) (A)&nbsp;this Agreement is terminated by Radiant or the Company pursuant to <I>Section</I><I></I><I>&nbsp;9.1(b)</I> <I>or
9.1(e)</I>, or (B)&nbsp;if this Agreement is terminated by the Company pursuant to <I>Section</I><I></I><I>&nbsp;9.1(g)</I>, (ii) at any time after the date of this Agreement and prior to the Radiant Shareholders Meeting a Radiant Acquisition
Proposal shall have been publicly announced, disclosed or otherwise communicated to the Board of Directors of Radiant and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iii)&nbsp;within nine (9)&nbsp;months after the date of such termination, Radiant enters into a definitive written agreement with respect to a Subsequent Transaction and ultimately consummates
such Subsequent Transaction (which, for the avoidance of doubt, may be consummated any time within, on or after nine (9)&nbsp;months after the date of such Agreement), then Radiant shall pay, or cause to be paid, to the Company, upon the
consummation of such Subsequent Transaction, a nonrefundable fee in an amount equal to $1,115,000 (the &#147;<B>Termination Fee</B>&#148;), less any amounts previously paid by Radiant pursuant to <I>Section</I><I></I><I>&nbsp;9.3(c)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> If this Agreement is terminated by the Company pursuant to <I>Section</I><I></I><I>&nbsp;9.1(e)</I> or <I>9.1(g)</I>, then Radiant
shall reimburse the Company for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses incurred by the Company in connection with this Agreement and the Contemplated
Transactions (such expenses, collectively, the &#147;<B>Third Party Expenses</B>&#148;), up to a maximum of $200,000, by wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds within three (3)&nbsp;Business Days following the date
of termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> If (i)&nbsp;this Agreement is terminated by Radiant pursuant to <I>Section</I><I></I><I>&nbsp;9.1(i)</I> or
(ii)&nbsp;this Agreement is terminated by the Company pursuant to <I>Section</I><I></I><I>&nbsp;9.1(f)</I>, then Radiant shall pay, or cause to be paid, to the Company, concurrent with such termination (in the case of clause (i), or within four
(4)&nbsp;Business Days thereafter in the case of clause (ii), the Termination Fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> If Radiant fails to pay when due any
amount payable by it under this <I>Section</I><I></I><I>&nbsp;9.3</I>, then (i)&nbsp;Radiant shall reimburse the Company for reasonable costs and expenses (including reasonable fees and disbursements of counsel) incurred in connection with the
collection of such overdue amount and the enforcement by the Company of its rights under this <I>Section</I><I></I><I>&nbsp;9.3</I>, and (ii)&nbsp;Radiant shall pay to the Company interest on such overdue amount (for the period commencing as of the
date such overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to the Company in full) at a rate per annum equal to the &#147;prime rate&#148; (as announced by Bank of America or any successor
thereto) in effect on the date such overdue amount was originally required to be paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> The Parties agree that, subject to
<I>Section</I><I></I><I>&nbsp;9.2</I>, the payment of the fees and expenses set forth in this <I>Section</I><I></I><I>&nbsp;9.3</I> shall be the sole and exclusive remedy of the Company against Radiant and Radiant&#146;s shareholders, directors,
officers, affiliates and other representatives, for any loss or damage based upon, arising out of or relating to this Agreement or the negotiation, execution or performance hereof or the Contemplated Transactions. Solely for purposes of establishing
the basis for the amount thereof, and without in any way increasing the amount of the Termination Fee, expanding the circumstances in which the Termination Fee is to be paid or restricting or modifying the other rights of any party hereunder, in the
event of the valid termination of this Agreement under circumstances in which the Termination Fee or the Third Party Expenses are payable pursuant to this <I>Section</I><I></I><I>&nbsp;9.3</I>, being understood that such amounts are liquidated
damages, and not a penalty, and the payment thereof in such circumstances is supported by due and sufficient consideration. In no event shall Radiant be required to pay (x)&nbsp;both the Third Party Expenses or the Termination Fee (unless such Third
Party Expenses previously paid by Radiant are deducted from the subsequently payable Termination Fee) or (y)&nbsp;either the Third Party Expenses or the Termination Fee payable pursuant to this <I>Section</I><I></I><I>&nbsp;9.3</I> on more than one
occasion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><A NAME="ex21toc723118_119"></A>Section&nbsp;10. MISCELLANEOUS PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_120"></A><B>10.1</B> <B><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations and Warranties</B>. The
representations and warranties of the Company, Merger Sub and Radiant contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement shall terminate at the Effective Time, and only the covenants that by their terms
survive the Effective Time and this <I>Section</I><I></I><I>&nbsp;10</I> shall survive the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_121"></A><B>10.2</B><B> Amendment</B>. This Agreement may be amended with the approval of the respective Boards of
Directors of the Company and Radiant at any time (whether before or after approval of the Company Shareholder Proposals by the Company&#146;s shareholders and whether before or after approval of the Radiant Shareholder Proposals by Radiant&#146;s
shareholders and whether before or after approval of the Merger, the other Contemplated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Transactions and this Agreement by the sole shareholder of Merger Sub); <U>provided</U><I>, </I><U>however</U>, that after any such adoption and approval of this Agreement by a Party&#146;s
shareholders, no amendment shall be made which by Law requires further approval of the shareholders of such Party without the further approval of such shareholders. This Agreement may not be amended except by an instrument in writing signed on
behalf of each of the Company and Radiant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_122"></A><B>10.3</B><B> Waiver</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the
part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall
preclude any other or further exercise thereof or of any other power, right, privilege or remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Any provision hereof may be
waived by the waiving Party solely on such Party&#146;s own behalf, without the consent of any other Party. No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this
Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party; and any such waiver shall not be applicable or have any effect except
in the specific instance in which it is given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_123"></A><B>10.4</B> <B>Entire Agreement; Counterparts; Exchanges
by Facsimile</B>. This Agreement, the Confidentiality Agreement and the other agreements, schedules and exhibits referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and
oral, among or between any of the Parties with respect to the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same
instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by facsimile or electronic transmission via &#147;.pdf&#146; shall be sufficient to bind the Parties to the terms and conditions of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_124"></A><B>10.5</B> <B>Governing Law; Jurisdiction; Waiver of Trial by Jury</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> This Agreement and any claim, controversy or dispute arising out of or related to this Agreement, any of the transactions
contemplated hereby, the relationship of the Parties, and/or the interpretation and enforcement of the rights and duties of the Parties, whether arising in contract, tort, equity or otherwise, shall be governed by, and construed in accordance with,
the laws of the State of Delaware (including in respect of the statute of limitations or other limitations period applicable to any such claim controversy or dispute), without regard to any applicable principles of conflicts of law that might
require the application of the laws of any other jurisdiction, except that (i)&nbsp;the internal affairs of the corporations party hereto that are organized and existing under the ICL and (ii)&nbsp;all other provisions of, or transactions
contemplated by, this Agreement that are expressly or otherwise required to be governed by the ICL; shall be construed, performed, governed and enforced in accordance with the Laws of the State of Israel, without giving effect to any choice or
conflict of law provision or rule (whether of the State of Israel or of any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Israel. The Parties hereby acknowledge and agree that, to the
fullest extent permitted by law, they intend that this Agreement be, and that it will be treated and construed as, a contract under seal under Delaware law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Each of the Parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement or for
recognition and enforcement of any judgment in respect hereof brought by any other Party or its successors or assigns shall be brought and determined by the Court of Chancery of the State of Delaware or if jurisdiction is not proper in such court,
in Superior Court seated in New Castle County Delaware, and each of the Parties hereby irrevocably submits to the exclusive jurisdiction of the aforesaid court for itself </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby
(and agrees not to commence any action, suit or proceeding relating thereto except in such courts). Each of the Parties further agrees to accept service of process in any manner permitted by such court. Each of the Parties hereby irrevocably and
unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (i)&nbsp;any claim that
it is not personally subject to the jurisdiction of the above-named courts for any reason other than the failure lawfully to serve process, (ii)&nbsp;that it or its property is exempt or immune from jurisdiction of any such court or from any legal
process commenced in such court (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (iii)&nbsp;to the fullest extent permitted by Law, that
(A)&nbsp;the suit, action or proceeding in any such court is brought in an inconvenient forum, (B)&nbsp;the venue of such suit, action or proceeding is improper or (C)&nbsp;this Agreement, or the subject matter hereof, may not be enforced in or by
such courts. Each of the parties hereto irrevocably agrees that, subject to any available appeal rights, any decision, order, or judgment issued by such above named courts shall be binding and enforceable, and irrevocably agrees to abide by any such
decision, order, or judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN
ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_125">
</A><B>10.6</B> <B>Expenses</B>. Except as otherwise expressly provided herein, each of the Parties hereto shall pay all of its own fees, costs and expenses (including fees, costs and expenses of legal counsel, investment bankers, brokers or other
representatives and consultants and appraisal fees, costs and expenses) incurred in connection with the negotiation of this Agreement, and the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_126"></A><B>10.7</B><B> Assignability</B>. This Agreement shall be binding upon, and shall be enforceable by and inure
solely to the benefit of, the parties hereto and their respective successors and assigns; <U>provided</U>, <U>however</U>, that neither this Agreement nor any of a Party&#146;s rights or obligations hereunder may be assigned or delegated by such
Party without the prior written consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Party&#146;s prior written consent shall be void and of no
effect. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than: (a)&nbsp;the parties hereto; and (b)&nbsp;the D&amp;O Indemnified Parties referred to in <I>Section</I><I></I><I>&nbsp;5.6(a)</I> to
the extent of their respective rights pursuant to <I>Section</I><I></I><I>&nbsp;5.6</I>) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_127"></A><B>10.8</B><B> Notices</B>. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly delivered and received hereunder (a)&nbsp;one Business Day (four Business Days if sent internationally) after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service,
(b)&nbsp;upon delivery in the case of delivery by hand, or (c)&nbsp;on the date delivered in the place of delivery if sent by email or facsimile (with a written or electronic confirmation of delivery) prior to 6:00 p.m. New York City time, otherwise
on the next succeeding Business Day, in each case to the intended recipient as set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to Radiant or Merger Sub: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Restoration Robotics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">128
Baytech Drive San Jose, California 95134 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: (408) <FONT STYLE="white-space:nowrap">883-6888</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: markh@restorationrobotics.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Chief Financial Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp;Watkins LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">140 Scott Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Menlo Park, CA
94025 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-463-3014</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Brian J. Cuneo, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: brian.cuneo@lw.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Yigal Arnon&nbsp;&amp; Co. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1 Azrieli Center </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">Tel-Aviv,</FONT> Israel 6702101 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+972-2-623-9200</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Barry Levenfeld </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: barry@arnon.co.il </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to
the Company: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Venus Concept Ltd. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">255 Consumers Road, Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Toronto, ON M2J 1R4 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Canada </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: (877) <FONT STYLE="white-space:nowrap">848-8430</FONT> ext 183 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Domenic Di Sisto, General Counsel and Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: Ddisisto@venusconcept.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Reed Smith LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">599 Lexington
Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-549-0408</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Mark G. Pedretti, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: mpedretti@reedsmith.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Gornitzky&nbsp;&amp; Co. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">45
Rothschild Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Tel Aviv 6578403 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Israel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+972-3-710-9191</FONT></FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Attention: Chaim Friedland, Adv. and Oded Uni, Adv. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Email: friedland@gornitzky.com and odedu@gornitzky.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_128"></A><B>10.9</B> <B>Cooperation</B>. Each Party agrees to cooperate fully with the other Party and to execute and
deliver such further documents, certificates, agreements and instruments and to take such other actions as may be reasonably requested by the other Party to evidence or reflect the Contemplated Transactions and to carry out the intent and purposes
of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_129"></A><B>10.10</B> <B>Severability</B>. Any term or provision of this Agreement that is
invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction
declares that any term or provision of this Agreement is invalid or unenforceable, the Parties hereto agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to
replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so
modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve,
to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_130">
</A><B>10.11 Other Remedies; Specific Performance</B>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law
or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms
and provisions hereof in any court of the United States or any state having jurisdiction, this being the addition to any other remedy to which they are entitled at Law or in equity, and each of the Parties waives any bond, surety or other security
that might be required of any other Party with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><A NAME="ex21toc723118_131"></A><B>10.12</B><B> Construction</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The Parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting
Party shall not be applied in the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> As used in this Agreement, the words
&#147;include&#148; and &#147;including,&#148; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#147;without limitation.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> All references to &#147;days&#148; shall be to calendar days unless otherwise indicated as a &#147;Business Day.&#148; Except as
otherwise specifically indicated, for purposes of measuring the beginning and ending of time periods in this Agreement (including for purposes of &#147;Business Day&#148; and for hours in a day or Business Day), the time at which a thing, occurrence
or event shall begin or end shall be deemed to occur in the Eastern time zone of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> The phrases
&#147;provided to,&#148; &#147;furnished to,&#148; &#147;made available&#148; and phrases of similar import when used herein, unless the context otherwise requires, means that a copy of the information or material referred to has been provided to
the Party to which such information or material is to be provided in the virtual data room set up by Radiant and hosted by Donnelley Financial Solutions, or by the Company and hosted by OneHub, as applicable, in connection with this Agreement at
least three (3)&nbsp;Business Days prior to the date hereof and/or, with respect to such information or materials of Radiant, was publicly available on the SEC EDGAR databased prior to the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> References to &#147;$&#148; and &#147;dollars&#148; are to the currency of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Except as otherwise indicated, all references in this Agreement to
&#147;Sections,&#148; &#147;Exhibits&#148; and &#147;Schedules&#148; are intended to refer to Sections of this Agreement and Exhibits and Schedules to this Agreement, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of
this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of page
intentionally left blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date
first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>RESTORATION ROBOTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>RADIANT MERGER SUB LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>VENUS CONCEPT LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Definitions </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>102
Amount</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.6(f)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>102 Trustee</B>&#148; means the trustee
appointed by the Company from time to time in accordance with the provisions of the Ordinance, and approved by the ITA, with respect to the Company 102 Options and Company 102 Shares and consideration paid for such options and shares under this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acceptable Confidentiality Agreement</B>&#148; means a confidentiality agreement containing terms not less
restrictive to the counterparty thereto than the terms of the Confidentiality Agreement and that expressly permits the Company or Radiant, as applicable, to comply with the terms of <I>Section</I><I></I><I>&nbsp;4.5</I>. Notwithstanding the
foregoing, a Person who has previously entered into a confidentiality agreement with a Party relating to a purchase of, or business combination with, such Party shall not be required to enter into a new or revised confidentiality agreement, and such
existing confidentiality agreement shall be deemed to be an Acceptable Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means with
respect to any Person, any other Person controlling, controlled by, or under common control with such Person. As used in this definition, &#147;control&#148; (including, with its correlative meanings, &#147;controlled by&#148; and &#147;under common
control with&#148;) means the possession, directly or indirectly, of power to direct or cause the direction of the management and policies of a Person whether through the ownership of voting securities, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Agreement</B>&#148; has the meaning set forth in the Preamble and shall include the Exhibits and Schedules annexed hereto or referred
to herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Allocation Certificate</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.13</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ancillary Agreements</B>&#148; means any other agreement referred to herein and contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Board of Directors</B>&#148; means the board of directors of either the Company or Radiant, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Book-Entry Shares</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day other than (a)&nbsp;a Saturday or Sunday, or (b)&nbsp;a day on which banking institutions are
authorized or required by Laws to be closed in New York, New York, or Israel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Merger</B>&#148; has the meaning
set forth in <I>Section</I><I></I><I>&nbsp;1.2</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificates</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clinical Trial Application</B>&#148; means a submission made to the applicable
Radiant Regulatory Agency or Company Regulatory Agency, the purpose of which is to gain necessary clearance, licensure, or approval by such agency to lawfully distribute a product to perform a human clinical trial of such product that at the time of
such submission is not otherwise lawfully able to be distributed or marketed in interstate commerce under the laws of the relevant jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.2</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Closing Date</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.2</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Companies Registrar</B>&#148; has the meaning set forth in Section&nbsp;1.2. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B> <B>102 Options</B>&#148; means Company Options subject to Section&nbsp;102 of the Ordinance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B> <B>102 Shares</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.6(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;Company Alternative Transaction</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.9</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Ancillary Lease Documents</B>&#148; means all subleases, overleases and other ancillary agreements or documents materially
pertaining to the tenancy at each such parcel of the Company Leased Real Property that materially affect or would reasonably be likely to materially affect the tenancy at any Company Leased Real Property and having an aggregate annual value for each
such ancillary agreement which exceeds $250,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Balance Sheet</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.5</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Business</B>&#148; means the business of the Company and any of its Subsidiaries
as currently conducted and currently proposed to be conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Capitalization Representation</B>&#148; means the
representations and warranties of the Company set forth in <I>Section</I><I></I><I>&nbsp;2.2</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Charter</B>&#148;
means the articles of association of the Company, as amended and in effect on the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Contingent
Workers</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.15(b)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Contract</B>&#148; means any
Contract together with any amendments, waivers or other modifications thereto, to which the Company is a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Created
IP</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.9(k)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Disclosure Schedule</B>&#148; has
the meaning set forth in <I>Section</I><I></I><I>&nbsp;2</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Employee Program</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.14(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Financial Statements</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.5</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Fundamental Representations</B>&#148; means the representations and warranties of
the Company set forth in <I>Sections 2.1</I>, <I>2.3</I>, <I>2.24</I> and <I>2.25</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Intellectual Property</B>&#148;
means all Intellectual Property owned or purportedly owned by or licensed to the Company or any of its Subsidiaries, used or held for use by the Company or any of its Subsidiaries in the Company Business or any Company Product, or developed for the
Company or a Subsidiary by full or part time employees or consultants of the Company or the Subsidiaries. Company Intellectual Property includes, without limitation, Company Products, Company Patents, Company Marks, and Company Trade Secrets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Leased Real Property</B>&#148; means the real property leased, subleased or licensed by the Company or its Subsidiaries that
is related to or used in connection with the Company Business, and the real property leased, subleased or licensed by the Company or its Subsidiaries as tenant, subtenant, licensee or other similar party, together with, to the extent leased,
licensed or owned by the Company or its Subsidiaries, all buildings and other structures, facilities or leasehold improvements, currently or hereafter located thereon, where the annual rent for each such lease, sublease or license exceeds $250,000.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company <FONT STYLE="white-space:nowrap">Licenses-In</FONT></B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.9(a)</I>. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company <FONT STYLE="white-space:nowrap">Licenses-Out</FONT></B>&#148; has the
meaning set forth in <I>Section</I><I></I><I>&nbsp;2.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement</B>&#148; has the meaning set forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Marks</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse Effect</B>&#148; means any change, circumstance, condition,
development, effect, event, occurrence, result or state of facts that, individually or when taken together with any other such change, circumstance, condition, development, effect, event, occurrence, result or state of facts, has or could reasonably
be expected to have a material adverse effect on (a)&nbsp;the business, financial condition, assets, liabilities or results of operations or prospects of the Company and its Subsidiaries (taken as a whole), except that none of the following shall be
taken into account in determining whether there has been a Company Material Adverse Effect: (i)&nbsp;changes in general economic or political conditions or the securities market in general (whether as a result of acts of terrorism, war (whether or
not declared), armed conflicts or otherwise) to the extent they do not disproportionately affect the Company and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (ii)&nbsp;changes in or affecting
the industries in which the Company or its Subsidiaries operate to the extent they do not disproportionately affect the Company and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry;
(iii)&nbsp;changes, effects or circumstances resulting from the announcement of this Agreement; (iv)&nbsp;any change in GAAP, applicable accounting principles or applicable Law or the interpretation thereof after the date hereof to the extent they
do not disproportionately affect the Company and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (v)&nbsp;the commencement or continuation of war, terrorism or hostilities, or natural disasters
or political events to the extent they do not disproportionately affect the Company and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (vi)&nbsp;any change in the cash position of the Company
which results from operations in the Ordinary Course of Business; (vii)&nbsp;any failure of the Company or any of its Subsidiaries to meet internal or published projections, forecasts, revenue or earnings predictions (it being understood, however,
that any Effect causing or contributing to any such failure to meet projections, forecasts, revenue or earnings predictions may constitute a Company Material Adverse Effect and may be taken into account in determining whether a Company Material
Adverse Effect has occurred), or (viii)&nbsp;any shareholder litigation or other claims arising from allegations of breach of fiduciary duty relating to this Agreement or (b)&nbsp;the ability of the Company to consummate the Contemplated
Transactions or to perform any of its covenants or obligations under this Agreement in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material
Contract</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.10</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Ordinary Share</B>&#148; means
an ordinary share of the Company with a nominal value of NIS 0.001 each. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Option</B>&#148; means an option to purchase
Company Ordinary Shares issued under the Company Option Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Option Plan</B>&#148; means the Venus Concept Ltd. 2010
Employee Share Option Plan, as adopted by the Company, and as may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Patents</B>&#148; has
the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Permits</B>&#148; means all approvals, clearances,
permits, licenses, variances, registrations, exemptions, Orders, consents, certifications, authorizations and approvals from a Company Regulatory Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred A Share</B>&#148; means a Series A Preferred share of the Company with a nominal value of NIS 0.001 each. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred B Share</B>&#148; means a Series B Preferred share of the Company with a nominal value of NIS 0.001 each. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred C Share</B>&#148; means a Series C Preferred share of the Company
with a nominal value of NIS 0.001 each. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Share</B>&#148; means a
Series <FONT STYLE="white-space:nowrap">C-1</FONT> Preferred share of the Company with a nominal value of NIS 0.001 each. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred D Share</B>&#148; means a Series D Preferred share of the Company with a nominal value of NIS 0.001 each. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred Share</B>&#148; means a Company Preferred A Share, a Company Preferred B Share, a Company Preferred C Share, a
Company Preferred <FONT STYLE="white-space:nowrap">C-1</FONT> Share and a Company Preferred D Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Products</B>&#148;
means the products or services produced, marketed, licensed, sold, distributed or performed by or on behalf of the Company or any of its Subsidiaries and all products or services currently under development by the Company or any of its Subsidiaries.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Public Company Financials</B>&#148; means (a)&nbsp;the Company&#146;s audited balance sheet at December&nbsp;31, 2018
and the Company&#146;s audited statements of operations, cash flows and shareholders&#146; equity for the years ended December&nbsp;31, 2018 and December&nbsp;31, 2017, (b) unaudited interim financial statements for each interim period completed
prior to the Closing that would be required to be included in the Registration Statement and (c)&nbsp;any other financial statements of the Company as may be required to be included in the Proxy Statement, in each of clauses (a)&nbsp;and (b) in a
form that satisfies all applicable requirements for including in the Proxy Statement and/or Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company
Regulatory Agency</B>&#148; means the FDA and any other Governmental Authority that is concerned with the quality, identity, strength, purity, safety, efficacy, Manufacturing, supply or distribution of any of the Company Products necessary for the
lawful operating of the businesses of the Company and each of its Subsidiaries as currently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company
Recommendation</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.2(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Share Capital</B>&#148;
means the Company Ordinary Shares and Company Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Shareholder</B>&#148; means each holder of Company Share
Capital immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Shareholder Approval</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.24</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Shareholder Meeting Notice</B>&#148; means the notice of the Company Shareholder
Meeting to be sent by the Company in accordance with the Company Charter and ICL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Shareholders</B>&#148; means the
holders of the share capital of the Company immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Trade Secrets</B>&#148; has the
meaning set forth in <I>Section</I><I></I><I>&nbsp;2.9(l)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Voting Agreements</B>&#148; has the meaning set forth in
the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Warrants</B>&#148; means the warrants listed on <I>Section</I><I></I><I>&nbsp;2.2 </I>of the Company
Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidentiality Agreement</B>&#148; means that certain confidentiality agreement, dated as of
December&nbsp;8, 2018, by and between the Company and Radiant, as amended or modified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contemplated Transactions</B>&#148; means
the transactions proposed under this Agreement, including the Merger. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148; means any loan or credit agreement, bond, debenture, note,
mortgage, indenture, lease, supply agreement, license agreement, development agreement or other contract, agreement, arrangement, understanding, obligation, commitment or instrument that is legally binding, whether written or oral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>D&amp;O Indemnified Parties</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.6(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Data Privacy and Security Laws</B>&#148; means all applicable Laws relating to privacy, data protection, confidentiality, security,
integrity and protection of Personal Information, including federal and state Laws (including but not limited to HIPAA) as well as consumer protection and anti-spam Laws and the EU Data Protection Directive 95/46/EC, the EU General Data Protection
Regulation 2016/679, the EU ePrivacy Directive 2002/58/EC as amended by Directive 2009/136/EC, each as amended, the Information Technology Act, 2000, the Israeli Privacy Protection Law, 1981 and related regulations and any applicable Laws, rules and
regulations implementing the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DGCL</B>&#148; means the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DOJ</B>&#148; means U.S. Department of Justice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Drop Dead Date</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;9.1(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Economic</B> <B>Competition Law</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.23(a).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Time</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.2</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Employee Program</B>&#148; means (a)&nbsp;all employee benefit plans within the meaning of ERISA Section&nbsp;3(3), including, but
not limited to, multiple employer welfare arrangements (within the meaning of ERISA Section&nbsp;3(40)), plans to which more than one unaffiliated employer contributes and employee benefit plans (such as foreign or excess benefit plans) which are
not subject to ERISA; (b)&nbsp;all stock option plans, stock purchase plans, bonus or incentive award plans, severance pay policies or agreements, deferred compensation agreements, supplemental income arrangements, vacation plans, and all other
written employee benefit plans, agreements, and arrangements not described in (a)&nbsp;above, including without limitation, any arrangement intended to comply with Code Section&nbsp;120, 125, 127, 129 or 137; and (c)&nbsp;all plans or arrangements
providing compensation to employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. In the case of an Employee Program funded through a trust described in Code Section&nbsp;401(a) or an organization described in Code
Section&nbsp;501(c)(9), or any other funding vehicle, each reference to such Employee Program shall include a reference to such trust, organization or other vehicle. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Encumbrance</B>&#148; means any mortgage, deed of trust, pledge, security interest, attachment, hypothecation, lien (statutory or
otherwise), charge, right of first offer, right of first refusal, encumbrance, encroachment, servient easement, right of way, deed restriction, adverse claim, reversion, reverter, preferential arrangement or charge of any kind (including, without
limitation, any conditional sale or title retention agreement or lease in the nature thereof) or any agreement to file any of the foregoing, any sale of receivables with recourse against either the Company or Radiant, as the case may be, or any
subsidiary, shareholder or Affiliate thereof, and any filing or agreement to file any financing statement as debtor under the Uniform Commercial Code or any similar statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environment</B>&#148; means soil, surface waters, groundwater, land, stream sediments, surface or subsurface strata and ambient air
and biota living in or on such media. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Laws</B>&#148; means Laws relating to protection of the Environment or the
protection of human health as it relates to the Environment, including, without limitation, the federal Comprehensive Environmental Response, Compensation and Liability Act, the Resource Conservation and Recovery Act, the Israeli Hazardous
Substances Law, 1993 and regulations promulgated thereunder, the Clean Air Act, the Clean Water Act, the Toxic Substances Control Act, the Endangered Species Act and similar foreign, federal, state and local Laws as in effect on the Closing Date.
</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Equity Commitment Letter</B>&#148; means the Equity Commitment Letter attached
hereto as <U>Exhibit&nbsp;F</U>, by and among Radiant, the Company and the Persons named therein, as amended or modified from time to time, pursuant to which such Persons have agreed to purchase the number of shares of Radiant Common Stock set forth
therein in connection with the Radiant Post-Closing Financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act
of 1974, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA Affiliate</B>&#148; has the meaning ascribed thereto in <I>Sections 2.14(h)(ii)</I> and
<I>3.14(i)(ii)</I> hereof, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Agent</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.6(a).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Fund</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.6(a).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Ratio</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.5(a)(i).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Federal Health Care Program</B>&#148; means Medicare, Medicaid or any other federal or state health program, as defined in 42 U.S.C.
&#167; <FONT STYLE="white-space:nowrap">1320a-7b(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FDA</B>&#148; means the U.S. Food and Drug Administration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FDCA</B>&#148; means the Federal Food, Drug and Cosmetic Act of 1938, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Financing Consent Letters</B>&#148; means (a)&nbsp;that certain commitment letter dated as of the date hereof by and among the
Company, certain Subsidiaries of the Company, Madryn Health Partners, LP, as administrative agent and a lender and Madryn Health Partners (Cayman Master), LP (the &#147;Madryn Financing Consent Letter&#148;) and (b)&nbsp;that certain Consent dated
as of the date hereof by and among the Material Subsidiaries and City National Bank of Florida, in each case, as amended, restated, supplemented or modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Form <FONT STYLE="white-space:nowrap">S-4</FONT></B>&#148; has the meaning set forth in<I> Section</I><I></I><I>&nbsp;5.1(a)</I>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means generally accepted accounting principles and practices in effect from time to time within the United States
applied consistently throughout the period involved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any U.S. or foreign, federal, state,
or local governmental commission, board, body, bureau, or other regulatory authority, agency, including courts and other judicial bodies, or any self-regulatory body or authority, including any instrumentality or entity designed to act for or on
behalf of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Grant</B>&#148; means any grant, incentive, subsidy, award, loan, participation,
exemption, status, cost sharing arrangement, reimbursement arrangement or other benefit, relief or privilege provided or made available by or on behalf of or under the authority of any Governmental Authority, including by or on behalf of or under
the authority of the OCS or affiliated authorities or programs (including without limitation the Incubator Administration, Tnufa, Nofar, Magnet and Magneton), the Investment Center, the ITA (solely with respect to &#147;benefit&#148; or
&#147;approved&#148; enterprise or factory status or similar programs), the State of Israel, and any other <FONT STYLE="white-space:nowrap">bi-</FONT> or multi-national grant program, framework or foundation (including the BIRD foundation) for
research and development, the Fund for Encouragement of Marketing Activities of the Israeli Government or any other Governmental Authority.<U></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous Material</B>&#148; means any pollutant, toxic substance, hazardous waste, hazardous materials, hazardous substances,
petroleum or petroleum-containing products as defined in, or listed under, any Environmental Law. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Health Care Law</B>&#148; means any and all applicable criminal or civil health
care Laws, including, and without limitation, the U.S. federal Anti-Kickback Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b)),</FONT> Stark Law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(f)),</FONT> the
Israeli Public Health Ordinance &#150; 1940, the Israeli National Insurance Law &#150; 1995, the Israeli National Health Insurance Law &#150; 1994; the Israeli Patients&#146; Rights Law &#150; 1996, and any other state or federal or foreign Laws
that govern activities in the healthcare industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HIPAA</B>&#148; means Health Insurance Portability and Accountability Act of
1996, as amended by the Health Information Technology for Economic and Clinical Health Act, and all implementing regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ICL</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>IDE</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.12(h).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indebtedness</B>&#148; means payment obligations, including any accrued but unpaid interest, fees and other expenses, and including
any call premium, prepayment or other penalty or premium or fee due upon repayment thereof, in respect of (a)&nbsp;any indebtedness for borrowed money, (b)&nbsp;any indebtedness evidenced by any note, bond, debenture or other debt security,
(c)&nbsp;any indebtedness for the deferred purchase price of property or services with respect to which a Person is liable, contingently or otherwise, as obligor or otherwise, (d)&nbsp;any commitment by which a Person assures a creditor against loss
(including contingent reimbursement liability with respect to letters of credit), (e) any indebtedness guaranteed in any manner by a Person (including guarantees in the form of an agreement to repurchase or reimburse), (f) any liabilities under
leases that are considered capital leases by the lessee or would be required to be capitalized under GAAP, (g)&nbsp;all obligations for the reimbursement of any obligor on any letter of credit, banker&#146;s acceptance or similar credit transaction
that has been drawn and not paid, (h)&nbsp;any indebtedness of the types described in this definition other than this clause (h)&nbsp;of another Person that is secured by an Encumbrance, (i)&nbsp;any payments, contingent or otherwise, including, but
not limited to escrow amounts, holdback amounts or <FONT STYLE="white-space:nowrap">earn-out</FONT> payments, for which a Person is or may be obligated to pay in connection with acquisitions by such Person and (j)&nbsp;the net termination cost of
any interest rate swap, currency or commodity swaps or similar hedging instruments or arrangements,. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnified Party</B>&#148;
has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.8(h)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means all right, title,
and interest in or relating to intellectual property and <FONT STYLE="white-space:nowrap">know-how,</FONT> whether protected, created or arising under the laws of the United States or any other jurisdiction, including: (a)&nbsp;patents and patent
applications, including all continuations, divisionals, and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part</FONT></FONT> thereof and patents issuing thereon, along with all reissues, reexaminations and
extensions thereof, inventions, discoveries and invention disclosures (whether or not patentable) (collectively, &#147;<B>Patents</B>&#148;); (b) rights in registered and unregistered trademarks, service marks, trade names, trade dress, logos,
packaging design, slogans and Internet domain names, and registrations and applications for registration of any of the foregoing, and other source or business identifiers and general intangibles of a like nature whether registered under either the
Lanham Act or state law or not registered, including all common law rights thereto (to the extent transferable) and with the goodwill associated with any of the foregoing, along with all applications, registrations, renewals and extensions thereof
(collectively, &#147;<B>Marks</B>&#148;); (c) copyrights in both published and unpublished works, and mask works, including without limitation all compilations, databases and computer programs, manuals and other documentation and all copyright
registrations and applications, and all derivatives, translations, adaptations and combinations of the above (collectively, &#147;<B>Copyrights</B>&#148;); (d) rights in <FONT STYLE="white-space:nowrap">know-how,</FONT> trade secrets, confidential
or proprietary information, research in progress, algorithms, data, designs, processes, formulae, drawings, schematics, blueprints, flow charts, models, strategies, prototypes, techniques, Beta testing procedures and Beta testing results
(collectively, &#147;<B>Trade Secrets</B>&#148;); (e) any and all other intellectual property rights and/or proprietary rights relating to any of the foregoing; and (f)&nbsp;goodwill, franchises, licenses, permits, consents, approvals, and claims of
infringement and misappropriation against third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Interim Options Tax Ruling</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;5.10(d)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment Center</B>&#148; means the Authority for Investment and Development of
Industry and the Economy of the State of Israel (formerly known as the Investment Center) of the Israeli Ministry of Economy and Industry established under the Israel Law for the Encouragement of Capital Investments, 5719-1959. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>IRS</B>&#148; means the Internal Revenue Service of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ITA</B>&#148; means the Israeli Tax Authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>IT Systems</B>&#148; means the information and communications technologies used by a Party or any of its Subsidiaries, including
hardware, software and networks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Employee</B>&#148; means each of Dom Serafino, Domenic DiSisto, Domenic Della Penna,
S&oslash;ren Maor Sinay, Bill Kelley, Anna Georgiadis, Yoni Iger, Boris Vaynberg, Glenn Normoyle, Melissa Kang, and Sean Carr. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge of Radiant</B>&#148; means the actual knowledge of any of Ryan Rhodes, Mark Hair and Gabriele Zingaretti after due inquiry
by each such individual of each such individual&#146;s direct reports. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge of the Company</B>&#148; means the actual
knowledge of any of Dom Serafino, Domenic DiSisto, or Domenic Della Penna after due inquiry by each such individual of each such individual&#146;s direct reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; or &#147;<B>Laws</B>&#148; means any federal, state, local, municipal, foreign (including foreign political
subdivisions) and including the laws of the State of Israel, or other law, Order, statute, constitution, principle of common law or equity, resolution, ordinance, code, writ, edict, decree, directive, consent, approval, concession, franchise,
permit, rule, regulation, judicial or administrative ruling, franchise, license, judgment, injunction, treaty, convention or other governmental certification, authorization or requirement issued, enacted, adopted, promulgated, implemented or
otherwise put into effect by or under the authority of any Governmental Authority, and the term &#147;applicable&#148; with respect to such Laws and in the context that refers to one or more Persons means that such Laws apply to such Person or
Persons or its or their business, undertaking, property or security and put into effect by or under the authority of a Governmental Authority having jurisdiction over the Person or Persons or its or their business, undertaking, property or security.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Legal Proceeding</B>&#148; means any action, arbitration, cause of action, claim, complaint, criminal prosecution, demand
letter, governmental or other examination or investigation, hearing, inquiry, administrative or other proceeding, or notice by any Person alleging potential liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Liability</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.11</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Manufacturing</B>&#148; includes (a)&nbsp;the qualification of suppliers and raw materials; (b)&nbsp;the purchasing, testing,
qualification, storage, issuance and use of ingredients, raw materials, and components; (c)&nbsp;the generation of intermediate materials, bulk solutions, assemblies, and finished products; and (d)&nbsp;the testing, release, and distribution of
finished products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Subsidiary</B>&#148; means each of Venus Concept USA Inc. and Venus Concept Canada Corp. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Merger</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Merger Consideration</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.5(a)(i)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Merger Sub</B>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Multiemployer Plan</B>&#148; means an employee pension benefit plan or welfare benefit plan described in Section&nbsp;4001(a)(3) of
ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>NIS</B>&#148; means New Israeli Shekel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>OCS</B>&#148; means the Israeli National Authority for Technological Innovation or any Person related thereto (including, for
example, the Magnet Administration, the Incubator Administration, MATIMOP). </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Options Tax Ruling</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;5.10(d)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ordinance</B>&#148; means the Israeli Income Tax Ordinance&nbsp;New Version, 1961,
and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Order</B>&#148; means any judgment, order, writ, injunction, ruling,
decision or decree of, or any plea agreement, corporate integrity agreement, resolution agreement, or deferred prosecution agreement with, or any settlement under the jurisdiction of, any Court or Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ordinary Course of Business</B>&#148; means, in the case of each of the Company and Radiant, such actions taken in the ordinary
course of its normal operations and consistent with its past practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Party</B>&#148; or &#147;<B>Parties</B>&#148; means
Radiant, Merger Sub and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Payor</B>&#148; means any Person that pays or reimburses the Company or its Subsidiaries
any amounts for products sold, dispensed or distributed by Company or its Subsidiaries, including all commercial or private payor programs and all programs established and/or maintained by a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permit</B>&#148; means any franchise, authorization, approval, Order, consent, license, certificate, permit, registration,
qualification or other right or privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Encumbrances</B>&#148; means (a)&nbsp;statutory Encumbrances for current
Taxes or other governmental charges, assessments or levies that are not yet due and payable or liens for Taxes being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP in,
with respect to the Company and its Subsidiaries, the Company Financial Statements and, with respect to Radiant and its Subsidiaries, the Radiant Financial Statements, (b)&nbsp;statutory landlord&#146;s, mechanic&#146;s, carrier&#146;s,
workmen&#146;s, repairmen&#146;s or other similar Encumbrances arising or incurred in the Ordinary Course of Business, the existence of which does not, and would not reasonably be expected to, materially impair the marketability, value or use and
enjoyment of the asset subject to such Encumbrances, (c)&nbsp;liens incurred or deposits made in the Ordinary Course of Business in connection with workers&#146; compensation, unemployment insurance or other types of social security; and
(d)&nbsp;licenses and other similar rights granted and obligations incurred in the Ordinary Course of Business that are not material to the operation of the applicable business, (e)&nbsp;Encumbrances and other conditions, easements and reservations
of rights, including rights of way, for sewers, electric lines, telegraph and telephone lines and other similar purposes, and affecting the fee title to any real property leased by the Company or its Subsidiaries and being transferred to Radiant or
Merger Sub at Closing which are of record as of the date of this Agreement and the existence of which does not, and would not reasonably be expected to, materially impair use and enjoyment of such real property, and (f)&nbsp;with respect to Company
Leased Real Property only, Encumbrances (including Indebtedness) encumbering the fee title interested in any Company Leased Real Property which are not attributable to the Company or its Subsidiaries. Notwithstanding the foregoing, any Encumbrances
for Indebtedness of the Company or its Subsidiaries as of the Closing will not be a Permitted Encumbrance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148;
means any individual, corporation, firm, partnership, joint venture, association, trust, company, Governmental Authority, syndicate, body corporate, unincorporated organization, or other legal entity, or any governmental agency or political
subdivision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Personal Information</B>&#148; means (a)&nbsp;any information or data that can be used, directly or
indirectly, alone or in combination with other information to identify an individual; (b)&nbsp;any other information or data relating to an identified or identifiable natural person (including, without limitation, name, address, telephone number,
email address, credit or payment card information, bank account number, financial data or account information, username and password combinations, customer account number, date of birth, government-issued identifier, Social Security number or other
identification number, race, ethnic origin/nationality, photograph and mental or physical health or medical information, any persistent identifier that can be used to recognize a user over time and across different websites, or one or more factors
specific to the physical, physiological, generic, mental, economic, cultural or social identity of that natural person, and (c)&nbsp;that is otherwise governed, regulated or protected by one or more Data Privacy and Security Laws. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>PHSA</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;2.12(b)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</B>&#148; has the meaning
set forth in <I>Section</I><I></I><I>&nbsp;4.1</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Proceeding</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;5.6(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Product Liability Claim</B>&#148; means a written demand for money or services or
injunctive relief reasonably likely to result in litigation or arbitration proceedings or result in a material <FONT STYLE="white-space:nowrap">pre-litigation</FONT> or <FONT STYLE="white-space:nowrap">pre-arbitration</FONT> settlement amount, or
any civil proceeding or an arbitration proceeding or any appeal therefrom, relating to or resulting from a product defect, personal injury, bodily injury, or death, in each case as a result of the ownership, possession, or proper use of any Radiant
Product or Company Product, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Proxy Statement</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;5.1(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant</B>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Acquisition Proposal</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.5(b)(i)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Ancillary Lease Documents</B>&#148; means all subleases, overleases and other ancillary agreements or documents materially
pertaining to the tenancy at each such parcel of the Radiant Leased Real Property that materially affect or would reasonably be likely to materially affect the tenancy at any Radiant Leased Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Business</B>&#148; means the business of Radiant and any of its Subsidiaries as currently conducted and currently proposed to
be conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Bylaws</B>&#148; means the Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> of
Radiant, as amended and in effect on the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Capitalization Representation</B>&#148; means the
representations and warranties of the Company set forth in <I>Section</I><I></I><I>&nbsp;3.2(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Change of
Recommendation</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.5(c)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Charter</B>&#148; means
the Amended and Restated Certificate of Incorporation of Radiant, as amended and in effect on the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Common Stock</B>&#148; means the common stock, par value $0.0001 per share, of Radiant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Contingent Workers</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.15(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Contract</B>&#148; means any Contract together with any amendments, waivers or other modifications thereto, to which Radiant
or any of its Subsidiaries is a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Copyrights</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.9(a).</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Created IP</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.9(j)</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Disclosure Schedule</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Employee Programs</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.14(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Financial Statements</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.5(c)</I>. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Fundamental Representations</B>&#148; means the representations and
warranties of Radiant and Merger Sub set forth in <I>Sections 3.1,</I> <I>3.3,</I> 3.25 and <I>3.26</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Intellectual
Property</B>&#148; means all Intellectual Property owned by Radiant or any of its Subsidiaries or used or held for use by Radiant or any of its Subsidiaries in the Radiant Business or any Radiant Product. Radiant Intellectual Property includes,
without limitation, Radiant Products, Radiant Patents, Radiant Trade Secrets, Radiant Marks and Radiant Copyrights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant
Intervening Event</B>&#148; means a material event, circumstance, change, development or condition (other than a Radiant Acquisition Proposal) that affects the business, assets or operations of Radiant that occurs or arises after the date of this
Agreement that (a)&nbsp;did not result from or arise out of the announcement or pendency of, or any actions required to be taken by Radiant (or to be refrained from being taken by Radiant) pursuant to, this Agreement and (b)&nbsp;was not known to,
or reasonably foreseeable by, Radiant or the Board of Directors of Radiant as of the date of this Agreement; <U>provided</U>, <U>however</U>, that in no event shall the following events, circumstances, or changes in circumstances, developments or
conditions constitute a Radiant Intervening Event: (a)&nbsp;the receipt, existence, or terms of a Radiant Acquisition Proposal or any matter relating thereto or consequence thereof or any inquiry, proposal, offer, or transaction from any third party
relating to or in connection with a transaction of the nature described in the definition of &#147;Radiant Acquisition Proposal&#148;; (b) any change in the price, or change in trading volume, of Radiant Common Stock (provided, however, that the
exception to this clause or (b)&nbsp;shall not apply to the underlying causes giving rise to or contributing to such change or prevent any of such underlying causes from being taken into account in determining whether a Radiant Intervening Event has
occurred). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Key Employee</B>&#148; means Mark Hair, Gabriele Zingaretti, Ryan Rhodes, Keith Sullivan, Gwen Drain and Tuan
Le.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Leased Real Property</B>&#148; means the real property leased, subleased or licensed by Radiant, or any
Subsidiary thereof, that is related to or used in connection with the Radiant Business, and the real property leased, subleased or licensed by Radiant or any Subsidiary thereof, in each case, as tenant, subtenant, licensee or other similar party,
together with, to the extent leased, licensed or owned by Radiant or any Subsidiary thereof, all buildings and other structures, facilities or leasehold improvements, currently or hereafter located thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Leases</B>&#148; means the lease, license, sublease or other occupancy agreements and all amendments, modifications,
supplements, and assignments thereto, together with all exhibits, addenda, riders and other documents constituting a part thereof for each parcel of Radiant Leased Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant <FONT STYLE="white-space:nowrap">Licenses-In</FONT></B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant <FONT STYLE="white-space:nowrap">Licenses-Out</FONT></B>&#148; has the meaning
set forth in <I>Section</I><I></I><I>&nbsp;3.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement</B>&#148; has the meaning set forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Marks</B>&#148; has the meaning set forth in
<I>Section</I><I></I><I>&nbsp;3.9(a)</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Material Adverse Effect</B>&#148; means any change, circumstance, condition,
development, effect, event, occurrence, result or state of facts that, individually or when taken together with any other such change, circumstance, condition, development, effect, event, occurrence, result or state of facts, has or could reasonably
be expected to have a material adverse effect on (a)&nbsp;the business, financial condition, assets, liabilities or results of operations or prospects of Radiant and its Subsidiaries (taken as a whole), except that none of the following shall be
taken into account in determining whether there has been a Radiant Material Adverse Effect: (i)&nbsp;changes in general economic or political conditions or the securities market in general (whether as a result of acts of terrorism, war (whether or
not declared), armed conflicts or otherwise) to the extent they do not disproportionately affect Radiant and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (ii)&nbsp;changes in or affecting the
industries in which Radiant or its Subsidiaries </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operate to the extent they do not disproportionately affect Radiant and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (iii)&nbsp;changes,
effects or circumstances resulting from the announcement of this Agreement; (iv)&nbsp;any change in GAAP, applicable accounting principles or applicable Law or the interpretation thereof after the date hereof to the extent they do not
disproportionately affect the Company and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (v)&nbsp;the commencement or continuation of war, terrorism or hostilities, or natural disasters or
political events to the extent they do not disproportionately affect Radiant and its Subsidiaries (taken as a whole) in relation to similarly situated companies in the same industry; (vi)&nbsp;any change in the cash position of Radiant which results
from operations in the Ordinary Course of Business; (vii)&nbsp;any failure of Radiant or any of its Subsidiaries to meet internal or published projections, forecasts, revenue or earnings predictions or any change in the price or trading volume of
Radiant Common Stock (it being understood, however, that any Effect causing or contributing to any such failure to meet projections, forecasts, revenue, earnings predictions or change in price or trading volume may constitute a Radiant Material
Adverse Effect and may be taken into account in determining whether a Radiant Material Adverse Effect has occurred); or (viii)&nbsp;any shareholder litigation or other claims arising from allegations of breach of fiduciary duty relating to this
Agreement or (b)&nbsp;the ability of Radiant to consummate the Contemplated Transactions or to perform any of its covenants or obligations under this Agreement in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Material Contract</B>&#148; has the meaning set forth in Section&nbsp;3.10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Patents</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.9(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Permits</B>&#148; means all approvals, clearances, permits, licenses, variances, registrations, exemptions, Orders, consents,
certifications, authorizations and approvals from any Radiant Regulatory Agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Post-Closing Financing</B>&#148; means
an acquisition of Radiant Common Stock to be consummated immediately following the Closing pursuant to the Equity Commitment Letter with aggregate gross proceeds to Radiant as set forth therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Preferred Stock</B>&#148; means the preferred stock, par value $0.0001 per share, of Radiant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Products</B>&#148; means the products or services produced, marketed, licensed, sold, distributed or performed by or on
behalf of Radiant or any of its Subsidiaries and all products or services currently under development by Radiant or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Qualified Bidder</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.5(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Recommendation</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.2(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Regulatory Agency</B>&#148; means the FDA and any other Governmental Authority that is concerned with the quality, identity,
strength, purity, safety, efficacy, Manufacturing, supply or distribution of any of the Radiant Products necessary for the lawful operating of the businesses of Radiant and each of its Subsidiaries as currently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant SEC Reports</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.5(a)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Shareholder Approval</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.25</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Shareholder Meeting</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.2(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Shareholder Proposals</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.2(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Shareholders</B>&#148; means the holders of the capital stock of Radiant immediately prior to the Effective Time. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Stock Option Plans</B>&#148; means the Radiant 2005 Stock Plan, Radiant
2015 Equity Incentive Plan and Radiant 2017 Incentive Award Plan and <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program, each as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Stock Options</B>&#148; means options to purchase Radiant Common Stock issued under any of the Radiant Stock Option Plans.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Superior Offer</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;4.5(b)(ii)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Trade Secrets</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;3.9(l)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Voting Agreements</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Radiant Warrants</B>&#148; means the warrants listed on <I>Section</I><I></I><I>&nbsp;3.2(d)</I>of the Radiant Disclosure Schedule.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reed Smith</B>&#148; means Reed Smith LLP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.1</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Release</B>&#148; means any releasing, disposing, discharging, injecting, spilling, leaking, pumping, dumping, emitting, escaping or
emptying of a Hazardous Material into the Environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means the directors, officers, employees,
Affiliates, investment bankers, financial advisors, attorneys, accountants, brokers, finders or representatives of the Company, Merger Sub, Radiant or any of their respective Subsidiaries, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsequent Transaction</B>&#148; means any Radiant Acquisition Proposal (with all references to twenty-five percent (25%) in the
definition of Radiant Acquisition Proposal being treated as references to 50% for these purposes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; or
&#147;<B>Subsidiaries</B>&#148; means, when used with reference to a party, any corporation or other organization, whether incorporated or unincorporated, of which such party or any other Subsidiary of such party is a general partner (excluding
partnerships the general partnership interests of which held by such party or any Subsidiary of such party do not have a majority of the voting interests in such partnership) or serves in a similar capacity, or, with respect to such corporation or
other organization, more than 50% of the securities or other interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions is directly or indirectly owned or controlled by
such party or by any one or more of its Subsidiaries, or by such party and one or more of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Surviving
Company</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;1.1</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; or &#147;<B>Taxes</B>&#148;
means any and all taxes, including, without limitation, taxes based upon or measured by income, gross receipts, excise, real or personal property, ad valorem, value added, estimated, alternative minimum, stamp, sales, withholding, social security
(or similar), unemployment, disability, occupation, premium, windfall, use, service, service use, license, net worth, payroll, pension, franchise, severance, customs, transfer, capital stock and recording taxes and governmental charges in the nature
of a tax, imposed by the IRS, the ITA or any other Taxing Authority (whether U.S. or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> including, without limitation, any U.S. or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state, county,
local government or any subdivision or taxing agency thereof (including a United States or Israeli possession)), whether computed on a separate, consolidated, unitary, combined, or any other basis; and such term shall include any interest, fines,
penalties, inflation linkage differentials or additional amounts attributable to, or imposed upon, or with respect to, any such amounts, whether disputed or not. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any report, return, document, declaration, election,
schedule or other information or filing, or any amendment thereto, required to be supplied to any Taxing Authority or jurisdiction (foreign or domestic) with respect to Taxes, including, without limitation, information returns and any documents with
respect to or accompanying payments of estimated Taxes or requests for the extension of time in which to file any such report, return, document, declaration, other information or filing, or any amendment thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Taxing Authority</B>&#148; means any Governmental Authority responsible for the imposition of any Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Termination Fee</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;9.3(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Third Party Intellectual Property</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.6(g)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer Taxes</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.10(c)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Untitled Letter</B>&#148; means an official correspondence sent by the FDA to an individual or firm that is intended to cite
regulatory violations that may not meet the threshold of regulatory significance to warrant a Warning Letter or request correction of the violations, and does not include a statement that warns the individual or firm that failure to promptly correct
the violation may result in enforcement action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Valid Tax Certificate</B>&#148; means a valid certificate, ruling or any other
written instructions (including electronic mail) regarding Tax withholding, issued by the ITA in customary form and substance reasonably satisfactory to Radiant, that is applicable to the payments to be made to any Company Shareholder, holder of
Company Options and/or holder of Company Warrants pursuant to this Agreement stating that no withholding, or reduced withholding rate, of any Israeli Tax is required with respect to such payment or any providing other instructions regarding such
payment or withholding tax or providing other instructions regarding such payment or withholding tax (including the transfer of the withholding Tax amount to a trustee). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Voting Agreements</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WARN Act</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;2.15(b)</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Warning Letter</B>&#148; means an official FDA correspondence notifying a firm or individual that FDA considers such firm or
individual to be in violation of the FDCA, its implementing regulations, or other federal statutes, and is issued for violations of regulatory significance (i.e., violations that may lead to an FDA enforcement action if the documented violations are
not promptly and adequately corrected) to allow such firm or individual to take voluntary corrective action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Warranty
Claim</B>&#148; means a written demand for money or services reasonably likely to result in litigation or arbitration proceedings or result in a material <FONT STYLE="white-space:nowrap">pre-litigation</FONT> or
<FONT STYLE="white-space:nowrap">pre-arbitration</FONT> settlement amount, or any civil proceeding or an arbitration proceeding or any appeal therefrom, relating to or resulting from a breach of warranty or guaranty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Withholding Tax Ruling</B>&#148; has the meaning set forth in <I>Section</I><I></I><I>&nbsp;5.10(b)</I>. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
